Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3012336	p-haptog	g/l (g/l)	10773	17634	0.00%
3012336	s-haptog	g/l (g/l)	6695	10410	0.78%
3012336	p-haptog	— (—)	2769	4793	100.00%	Distribution not available
3012336	s-haptog	— (—)	1737	2776	100.00%	Distribution not available
3012336	p-haptog	g/l_______ (g/l)	439	667	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Atherosclerosis, excluding cerebral and coronary sclerosis

2484

8524

2.46

323.01

1.8

1.6

1.70

1.55

g/l

10.66

2173

7226

Hypertensive Heart Disease

1370

3303

3.40

322.61

1.8

1.6

1.59

1.51

g/l

2.30

1169

2749

Other disorders of kidney and ureter

997

2761

4.16

320.43

2.3

1.7

1.57

1.54

g/l

0.31

903

2388

Type 1 diabetes

1275

4078

3.34

316.86

2.1

1.7

1.52

1.43

g/l

2.79

1163

3467

Any reimbursement code in KELA

1721

2897

3.06

315.05

2.0

1.8

1.49

1.27

g/l

13.23

1511

2443

Calcific aortic valvular stenosis

1982

7793

2.67

314.59

1.9

1.6

1.43

1.58

g/l

9.60

1609

6685

Calcific aortic valvular stenosis, operated

1982

7793

2.67

314.59

1.9

1.6

1.43

1.58

g/l

9.60

1609

6685

Calcific aortic valvular stenosis, including rheumatic fever

1986

7809

2.67

314.33

1.9

1.6

1.43

1.59

g/l

10.05

1613

6698

Calcific aortic valvular stenosis, diagnosis (helper)

1980

7785

2.67

314.25

1.9

1.6

1.43

1.58

g/l

9.62

1608

6677

Operations 2 for CAVS

1980

7785

2.67

314.25

1.9

1.6

1.43

1.58

g/l

9.62

1608

6677

Other diseases of intestines

4173

12034

1.99

314.18

1.8

1.54

1.48

g/l

3.34

3645

10299

Antihypertensive medication - note that there are other indications

1862

3470

2.89

312.94

2.2

1.8

1.42

1.30

g/l

5.31

1644

3005

Acute myeloid leukaemia and myelodysplastic syndromes

358

401

13.58

311.92

2.1

1.6

1.26

1.52

g/l

4.24

313

350

Diabetes, insulin treatment (Kela reimbursement)

4237

13265

1.96

310.72

1.9

1.7

1.64

1.49

g/l

18.95

3718

11282

Glomerulonephritis

768

1799

4.99

310.69

2.6

1.8

1.55

1.51

g/l

0.49

701

1550

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1062

3142

3.84

307.89

2.0

1.7

1.12

1.57

g/l

47.15

910

2720

COPD/asthma related infections

3976

10108

2.03

307.82

1.9

1.7

1.58

1.45

g/l

12.68

3473

8663

COPD/asthma/ILD related infections

3976

10108

2.03

307.82

1.9

1.7

1.58

1.45

g/l

12.68

3473

8663

Hypertensive diseases

3196

6473

2.91

307.65

2.0

1.7

1.52

1.46

g/l

2.81

2821

5439

Other septicaemia

3070

7472

4.37

307.65

2.2

1.5

1.63

1.48

g/l

11.17

2674

6323

Condition for Implicit Sepsis (Organ dysfunction codes)

5074

11087

3.40

307.65

2.0

1.6

1.57

1.50

g/l

5.34

4404

9448

Bacterial Sepsis

4083

8336

4.59

307.65

2.0

1.6

1.65

1.53

g/l

10.20

3562

7061

Atrial fibrillation and flutter with reimbursement

1194

1539

5.25

307.65

1.8

1.6

1.56

1.53

g/l

0.40

1065

1273

Other CVD (FINNGEN)

705

923

6.50

307.65

1.9

1.5

1.57

1.54

g/l

0.31

611

770

Certain infectious and parasitic diseases

3969

8378

2.46

307.65

1.9

1.6

1.57

1.42

g/l

15.05

3475

7098

Coronary revascularization (ANGIO or CABG)

3441

9589

2.27

307.65

1.8

1.7

1.55

1.58

g/l

0.76

2962

8221

General symptoms and signs

4584

9634

2.48

307.65

1.9

1.7

1.53

1.48

g/l

2.84

3977

8235

Major coronary heart disease event

3588

10419

2.14

307.65

1.8

1.7

1.57

1.58

g/l

0.12

3097

8936

Intestinal infectious diseases

4204

16039

2.02

307.65

2.0

1.7

1.55

1.50

g/l

2.07

3659

13752

Continuous positive airway pressure

1011

1711

5.36

307.65

1.9

1.7

1.63

1.52

g/l

2.23

890

1444

Percutaneous Coronary Intervention

3468

9588

2.30

307.65

1.8

1.7

1.55

1.58

g/l

1.06

2983

8220

Erysipelas

3081

9624

2.94

307.65

1.9

1.6

1.65

1.48

g/l

17.21

2661

8149

Diseases of the digestive system

2614

11091

2.49

307.65

1.8

1.7

1.48

1.55

g/l

3.44

2274

9469

Erysipelas, including avohilmo

3871

10232

2.97

307.65

1.9

1.6

1.63

1.47

g/l

19.76

3360

8667

Anaemia in chronic diseases classified elsewhere

419

330

21.86

307.65

2.5

2.0

1.53

1.50

g/l

0.19

376

293

Atrial fibrillation and flutter

1384

1818

5.24

307.65

1.9

1.5

1.51

1.49

g/l

0.23

1196

1518

Septicaemia

3434

8030

4.39

307.65

2.2

1.5

1.64

1.48

g/l

13.69

2996

6803

Peripheral artery disease

2651

8919

2.52

307.65

1.8

1.6

1.71

1.55

g/l

14.07

2319

7564

Hernia of abdominal wall, postoperative

895

2198

4.34

307.65

1.8

1.4

1.57

1.46

g/l

2.61

772

1877

Acquired haemolytic anaemia

520

400

27.79

307.65

8.6

1.6

0.88

1.49

g/l

21.48

378

357

Acute renal failure

2628

4369

7.60

307.65

2.2

1.6

1.65

1.54

g/l

6.06

2354

3641

L04AD Calcineurin inhibitors

1405

1592

12.14

307.65

2.8

1.7

1.38

1.54

g/l

6.26

1313

1373

Anaemias

2622

669

30.70

307.65

2.4

1.8

1.42

1.08

g/l

19.01

2275

576

Bacterial infection, other or unspecified, including avohilmo

4750

9510

4.59

307.65

2.0

1.6

1.72

1.47

g/l

42.58

4141

8046

Covid-19 confirmed case

2392

8845

2.93

307.65

2.1

1.7

1.58

1.53

g/l

2.10

2138

7528

Hypertension, essential

3134

6345

2.92

307.65

1.9

1.7

1.56

1.46

g/l

5.24

2749

5322

Secondary hypertension

901

674

16.97

307.65

2.5

1.6

1.48

1.46

g/l

0.16

826

566

Diabetic nephropathy

1373

4345

3.67

307.65

2.2

1.7

1.65

1.60

g/l

1.04

1292

3731

Purpura and other haemorrhagic conditions

1114

2620

4.96

307.65

2.4

1.7

1.29

1.55

g/l

13.31

956

2262

Thrombocytopenia, unspecified

730

1378

6.64

307.65

2.5

1.8

1.19

1.53

g/l

14.83

625

1199

Other diseases of the digestive system

2005

8000

2.71

307.65

1.8

1.6

1.48

1.56

g/l

3.51

1745

6818

Heart failure, strict

4358

9247

3.64

307.65

1.8

1.6

1.58

1.59

g/l

0.16

3772

7861

Acute tubulo-interstitial nephritis

3352

9784

3.08

307.65

1.9

1.6

1.69

1.46

g/l

28.36

2918

8210

Liquid cancers, including Hilmo

3011

6620

4.58

307.65

2.2

1.6

1.39

1.58

g/l

18.55

2600

5654

Unspecified kidney failure

1286

1998

8.40

307.65

2.2

1.6

1.60

1.53

g/l

1.54

1175

1655

All chronic kidney diseases

5825

8019

6.86

307.65

2.1

1.6

1.60

1.49

g/l

10.65

5273

6700

Used for control exclusion in common control thyroid runs

4342

10960

2.06

307.65

2.0

1.6

1.48

1.51

g/l

0.97

3777

9392

GASTRO-related operations

3068

4999

3.20

307.65

1.9

1.6

1.49

1.39

g/l

5.34

2657

4317

Abnormalities of breathing

3597

9957

2.13

307.65

1.9

1.7

1.54

1.50

g/l

1.80

3122

8574

Renal failure

6044

8637

7.47

307.65

2.1

1.5

1.60

1.54

g/l

3.44

5448

7198

Other septicaemia, including avohilmo

3117

7589

4.34

307.65

2.2

1.5

1.63

1.48

g/l

11.07

2720

6424

Gout, FINNGEN

2148

7302

3.25

307.65

1.9

1.6

1.61

1.53

g/l

3.14

1924

6173

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

4684

10108

2.86

307.65

2.0

1.7

1.62

1.45

g/l

22.57

4116

8663

Diabetes, varying definitions

4199

12050

2.09

307.65

1.9

1.7

1.60

1.45

g/l

17.77

3691

10255

Myelodysplastic syndrome, including Hilmo

475

565

13.05

307.65

2.3

1.6

1.15

1.52

g/l

10.99

413

483

Polyarthropathies

3801

8756

2.96

307.65

1.8

1.60

1.48

g/l

8.59

3342

7495

Insulin medication

3250

11021

2.59

307.65

2.0

1.7

1.64

1.48

g/l

15.51

2897

9357

Insulin, intermediate and long-acting

2933

12574

2.38

307.65

1.9

1.7

1.64

1.52

g/l

8.16

2613

10705

Insulin, fast-acting

1954

7640

2.73

307.65

2.0

1.7

1.59

1.50

g/l

4.03

1755

6511

Iron deficiency anaemia secondary to blood loss (chronic)

1475

3027

5.78

307.65

1.9

1.7

1.51

1.55

g/l

0.77

1297

2578

Implicit Sepsis, including avohilmo

5170

11156

3.57

307.65

2.0

1.6

1.58

1.50

g/l

6.52

4492

9506

Iron deficiency anaemia

4405

8750

5.83

307.65

1.7

1.57

1.54

g/l

1.15

3811

7468

Other and unspecified anaemias

6511

7637

10.72

307.65

2.0

1.5

1.53

1.58

g/l

2.25

5671

6435

Dental caries

1814

4526

4.20

307.65

2.5

1.6

1.52

1.54

g/l

0.40

1609

3891

Bleeding

4344

13171

2.44

307.65

1.9

1.7

1.49

1.58

g/l

7.50

3764

11242

GI-bleeding

2005

8027

2.70

307.65

1.8

1.7

1.48

1.56

g/l

3.36

1747

6842

Valvular heart disease excluding rheumatic fever

2856

5882

3.77

307.65

1.9

1.6

1.42

1.60

g/l

15.54

2335

5021

Non-ischemic cardiomyopathy

2110

4957

3.74

307.65

1.9

1.6

1.54

1.59

g/l

1.45

1830

4174

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2915

10500

2.30

307.65

1.8

1.7

1.71

1.51

g/l

23.32

2538

8919

Valvular operations

990

2433

4.59

307.65

2.0

1.6

1.18

1.59

g/l

27.28

709

2073

Complications of medical and surgical care

3584

15098

2.23

307.65

2.0

1.7

1.57

1.52

g/l

2.41

3100

12948

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1416

2614

3.55

307.65

2.0

1.6

1.49

1.40

g/l

2.32

1241

2212

Pneumonia, organism unspecified

4951

12240

2.94

307.65

2.0

1.6

1.64

1.46

g/l

26.08

4318

10448

Haemolytic anaemias

640

560

20.23

307.65

7.6

1.6

0.89

1.53

g/l

30.12

472

502

Persons encountering health services for specific procedures and health care

5334

12446

2.65

307.65

2.0

1.7

1.56

1.48

g/l

6.85

4693

10577

All pneumoniae

5318

13007

2.80

307.65

2.0

1.7

1.63

1.45

g/l

30.24

4661

11129

Care involving dialysis

1639

1337

22.70

307.65

2.9

1.7

1.52

1.47

g/l

0.88

1549

1161

Aplastic and other anaemias

6914

8024

10.46

307.65

2.0

1.5

1.53

1.58

g/l

2.75

6033

6757

ILD medications: prednisolone, methylprednisolone, prednisone

5510

11750

2.74

307.65

2.1

1.6

1.56

1.48

g/l

6.38

4823

10010

Dialysis, with operation codes

2235

1964

18.36

307.65

2.8

1.6

1.51

1.50

g/l

0.03

2090

1651

Implicit viral Sepsis

1564

3971

4.44

307.65

2.2

1.6

1.58

1.49

g/l

3.00

1392

3359

Implicit bacterial Sepsis

3681

7770

4.64

307.65

2.0

1.6

1.65

1.54

g/l

8.24

3225

6563

Heart failure and antihypertensive medication

1893

1603

8.79

307.65

2.0

1.7

1.58

1.49

g/l

2.15

1657

1355

Pure hypercholesterolaemia

3427

9777

2.32

307.65

1.7

1.64

1.54

g/l

7.01

2978

8286

Gout, strict definition

1402

4594

3.47

307.65

1.8

1.7

1.66

1.55

g/l

4.17

1250

3918

Inflammatory bowel disease treatment related agents

5379

13388

2.32

307.65

2.0

1.7

1.57

1.48

g/l

7.64

4705

11447

Hypertensive heart and/or renal disease

1731

3438

4.05

307.65

1.9

1.6

1.59

1.51

g/l

2.67

1513

2864

Diseases of arteries, arterioles and capillaries

3888

11813

2.58

307.65

1.9

1.6

1.63

1.55

g/l

5.01

3379

10045

Insulin, combination of fast acting with intermediate-acting or long-acting

3252

13345

2.33

307.65

2.0

1.7

1.64

1.52

g/l

9.83

2899

11360

Other disorders of fluid, electrolyte and acid-base balance

2241

6290

3.72

307.65

1.8

1.7

1.60

1.55

g/l

1.39

1969

5324

All-cause Heart Failure

4273

9146

3.61

307.65

1.8

1.6

1.58

1.59

g/l

0.17

3700

7767

Cardiovascular diseases

1916

3191

3.29

307.65

2.2

1.8

1.44

1.27

g/l

8.82

1690

2752

ILD medications: azathioprine

852

1972

4.76

307.65

2.4

1.5

1.46

1.48

g/l

0.27

773

1688

4684

10108

2.86

307.65

2.0

1.7

1.62

1.45

g/l

22.57

4116

8663

Infections, IBD-co-morbidities

1117

1092

8.04

307.65

2.4

1.7

1.54

1.45

g/l

1.48

1006

929

Any death

3319

10287

2.40

307.65

1.8

1.6

1.65

1.55

g/l

6.57

2851

8851

Other heart diseases, wide

3863

9099

2.68

307.65

2.0

1.7

1.52

1.51

g/l

0.26

3320

7853

Hypertension

3193

6469

2.91

307.65

2.0

1.7

1.52

1.46

g/l

2.79

2819

5435

ILD medications: immunosuppressive drugs

4144

10253

3.98

307.65

2.1

1.6

1.51

1.49

g/l

0.28

3677

8753

Other and unspecified iron deficiency

3635

6858

6.35

307.65

1.7

1.58

1.53

g/l

2.12

3141

5849

Other diseases of blood and blood-forming organs, wide

1483

4452

3.72

307.65

2.3

1.7

1.37

1.57

g/l

10.87

1281

3841

Emergency coronary revascularization (for ACS)

3851

11078

2.19

307.65

1.8

1.7

1.55

1.58

g/l

1.36

3304

9483

Fever of other and unknown origin

3592

8716

3.86

307.65

2.1

1.7

1.63

1.49

g/l

10.42

3134

7426

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5237

13125

2.80

307.65

2.0

1.7

1.64

1.45

g/l

29.49

4581

11235

Liquid cancers

2713

5900

5.09

307.65

2.2

1.6

1.37

1.57

g/l

19.30

2344

5040

All kidney diseases

6724

11241

4.37

307.65

2.0

1.6

1.60

1.45

g/l

25.21

5967

9465

Coagulation defects, purpura and other haemorrhagic conditions

1415

3819

4.18

307.65

2.4

1.7

1.31

1.54

g/l

14.70

1223

3296

Asthma, unspecified (mode), excluding more controls

2045

5595

2.72

307.65

1.7

1.59

1.43

g/l

9.90

1786

4783

Diabetic nephropathy, excluding more controls

1362

2719

4.88

307.65

2.2

1.7

1.65

1.60

g/l

1.08

1281

2315

Implicit bacterial Sepsis, including avohilmo

3929

8196

4.52

307.65

2.0

1.6

1.64

1.53

g/l

8.50

3438

6934

Provisional assignment of new diseases of uncertain etiology

2890

11916

2.55

307.65

2.1

1.7

1.58

1.50

g/l

4.12

2587

10184

Malaise and fatigue

3127

7736

3.41

307.65

1.8

1.6

1.57

1.51

g/l

2.76

2716

6587

Codes for special purposes

2893

11936

2.55

307.65

2.1

1.7

1.57

1.50

g/l

4.05

2590

10200

Transplanted organ and tissue status

1418

1440

14.24

307.65

2.7

1.7

1.39

1.54

g/l

5.21

1331

1243

Implicit Sepsis

5100

10856

3.77

307.65

1.9

1.6

1.61

1.50

g/l

9.20

4434

9221

Oedema, not elsewhere classified

1847

5974

3.25

307.65

1.9

1.6

1.57

1.53

g/l

1.21

1635

5086

Gout, unspecified

1507

5165

3.28

307.65

1.9

1.6

1.63

1.54

g/l

3.05

1357

4390

Hypertensive diseases (excluding secondary)

2056

2773

4.54

307.65

2.2

1.6

1.52

1.40

g/l

4.83

1828

2348

Tramadol

3751

9028

2.62

307.65

1.8

1.7

1.61

1.46

g/l

13.95

3284

7729

Oral corticosteroids

4975

13155

2.31

307.65

2.0

1.7

1.61

1.48

g/l

13.27

4321

11244

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

9902

8894

8.73

307.65

2.0

1.4

1.50

1.55

g/l

3.14

8568

7605

Chronic kidney disease

4536

6547

8.79

307.65

2.3

1.5

1.58

1.53

g/l

2.53

4151

5460

Cardiovascular diseases (excluding rheumatic etc)

2168

3693

3.49

307.65

2.2

1.8

1.47

1.30

g/l

10.29

1903

3170

Diseases of oesophagus, stomach and duodenum

4943

13377

2.27

307.65

1.8

1.7

1.52

g/l

0.20

4300

11450

Glomerular disorders in diseases classified elsewhere

1513

2270

9.05

307.65

2.7

1.7

1.59

1.51

g/l

1.93

1414

1949

Dialysis

642

525

19.90

307.65

2.7

1.7

1.49

g/l

0.04

615

456

Diseases of arteries, arterioles and capillaries (FINNGEN)

1497

1556

7.37

307.65

1.9

1.6

1.64

1.50

g/l

3.98

1315

1296

Bacterial infection, other or unspecified

4482

9195

4.64

307.65

2.0

1.6

1.72

1.48

g/l

38.93

3907

7780

Dyspnoea

4347

14702

2.23

307.65

1.9

1.7

1.56

1.52

g/l

1.54

3753

12620

Other disorders of skin and subcutaneous tissue

3466

14538

2.10

307.65

1.9

1.7

1.60

1.53

g/l

3.61

3036

12422

Explicit Sepsis, including avohilmo

3555

8445

4.27

307.65

2.2

1.6

1.64

1.51

g/l

9.20

3108

7150

Autoimmune diseases excluding thyroid diseases

5184

11702

2.51

307.65

2.1

1.6

1.50

1.51

g/l

0.42

4511

10041

Glomerular diseases

1968

3492

7.07

307.65

2.6

1.6

1.59

1.52

g/l

2.36

1828

2989

Type 2 diabetes

4049

11698

2.07

307.65

1.9

1.7

1.62

1.46

g/l

18.77

3547

9943

Autoimmune diseases

4720

11751

2.11

307.65

2.0

1.6

1.49

1.51

g/l

0.99

4107

10079

Gout

2148

5539

3.72

307.65

1.9

1.7

1.61

1.54

g/l

2.60

1924

4720

Influenza and pneumonia

5338

12739

2.72

307.65

2.0

1.7

1.62

1.44

g/l

26.62

4687

10900

Ischemic heart diseases

3452

9784

2.18

307.65

1.8

1.7

1.56

1.58

g/l

0.25

2985

8395

Heart failure,strict

3982

6825

4.58

307.65

1.9

1.5

1.58

g/l

0.05

3458

5738

Nephropathy related operations

2056

2285

14.16

307.65

2.8

1.7

1.50

1.53

g/l

0.69

1929

1957

L04AX Other immunosuppressants

2728

11431

2.52

307.65

1.9

1.8

1.55

1.52

g/l

0.70

2375

9856

Viral Sepsis

1564

3975

4.43

307.65

2.2

1.6

1.58

1.49

g/l

3.01

1392

3363

Implicit viral Sepsis, including avohilmo

2085

6046

3.80

307.65

2.1

1.6

1.58

1.52

g/l

2.16

1839

5120

Cerebrovascular diseases (FINNGEN)

1251

1979

4.69

307.65

2.0

1.6

1.58

1.46

g/l

3.43

1081

1656

Disorders resulting from impaired renal tubular function

614

628

16.40

307.65

2.5

2.0

1.57

1.55

g/l

0.17

574

551

Presence of cardiac and vascular implants and grafts

2752

7831

2.79

307.65

1.8

1.6

1.49

1.60

g/l

6.15

2266

6704

Oxycodone

2149

7108

2.75

307.65

1.8

1.7

1.75

1.51

g/l

19.82

1828

6068

Other bacterial diseases

6262

11596

3.88

307.65

2.0

1.6

1.66

1.45

g/l

40.78

5476

9861

Gout, idiopatic and unspecified

1779

6472

3.06

307.65

1.8

1.7

1.63

1.54

g/l

4.10

1592

5511

Any gastric operation

3068

4999

3.20

307.65

1.9

1.6

1.49

1.39

g/l

5.34

2657

4317

Second line medication for Crohn's disease

2794

11726

2.51

307.65

1.9

1.8

1.55

1.52

g/l

0.62

2436

10119

Metabolic disorders

4624

10998

2.65

307.65

1.8

1.7

1.56

1.50

g/l

3.37

4040

9346

Non-rheumatic valve diseases

2829

5853

3.75

307.65

1.9

1.6

1.42

1.60

g/l

15.89

2312

4996

Ulcer of lower limb, not elsewhere classified

1307

3353

4.60

307.65

2.0

1.6

1.70

1.55

g/l

5.76

1172

2872

Non-invasive ventilation

1010

2284

4.03

307.65

1.9

1.7

1.57

1.43

g/l

4.10

898

1948

Examination and observation for other reasons

2959

5942

2.96

307.65

1.9

1.7

1.47

1.52

g/l

2.29

2576

5064

Other dialysis

537

502

19.08

307.65

2.8

1.9

1.49

1.51

g/l

0.17

518

445

Preparatory care for dialysis

989

799

28.59

307.65

2.7

1.9

1.54

1.52

g/l

0.21

955

701

Hard cardiovascular diseases

3439

9362

2.26

307.65

1.8

1.7

1.56

g/l

0.01

2976

8012

Cardiac arrhythmias

2109

4866

2.88

307.65

2.0

1.7

1.45

1.42

g/l

0.54

1819

4178

Other heart diseases

2130

2858

5.15

307.65

2.0

1.6

1.51

1.38

g/l

5.06

1855

2422

Type 2 diabetes, wide definition

3918

10363

2.51

307.65

1.8

1.7

1.66

1.50

g/l

19.56

3440

8790

Renal tubulo-interstitial diseases

6895

11317

4.97

307.65

2.0

1.6

1.62

1.46

g/l

28.28

6125

9522

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3943

11440

2.12

307.65

1.9

1.7

1.64

1.48

g/l

19.26

3463

9717

Diabetes mellitus

4223

12041

2.09

307.65

1.9

1.7

1.60

1.45

g/l

17.86

3710

10249

Heart failure, not strict

5523

8540

4.86

307.65

2.0

1.5

1.57

1.56

g/l

0.13

4884

7201

Heart failure and bmi 25plus

2364

4660

3.76

307.65

1.9

1.6

1.64

1.63

g/l

0.25

2043

3906

Complications of procedures, not elsewhere classified

3640

14645

2.08

307.65

2.0

1.7

1.56

1.52

g/l

2.04

3140

12561

Kidney transplant status

897

730

20.61

307.65

3.0

1.8

1.41

1.47

g/l

0.83

856

633

Heart failure and coronary heart disease

3071

7023

3.40

307.65

1.8

1.7

1.58

1.60

g/l

0.53

2637

5983

L04AA Selective immunosuppressants

1836

3786

5.64

307.65

2.5

1.7

1.49

1.54

g/l

1.33

1676

3256

Other bacterial diseases, including avohilmo

6060

11342

3.57

307.65

2.0

1.6

1.65

1.43

g/l

41.66

5314

9647

Benign neoplasm of colon, rectum, anus and anal canal

3274

13240

2.20

307.65

1.8

1.7

1.57

g/l

0.08

2849

11285

Autoimmune diseases excluding thyroid diseases, strict definition

5006

11386

2.50

307.65

2.1

1.6

1.50

1.51

g/l

0.27

4354

9767

First line medication for Crohn's disease

5313

11540

2.59

307.65

2.0

1.6

1.56

1.46

g/l

8.35

4640

9830

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

4991

10940

3.28

307.65

2.0

1.6

1.56

1.48

g/l

5.45

4337

9340

Other medical care

2485

8965

2.46

307.65

1.8

1.6

1.68

1.53

g/l

8.19

2154

7579

Diseases of liver

2000

7357

2.94

307.65

1.9

1.7

1.29

1.58

g/l

35.30

1709

6338

Extracorporeal dialysis

1121

1131

17.55

307.65

3.0

1.8

1.54

1.50

g/l

0.49

1054

989

Primary_lymphoid and hematopoietic malignant neoplasms

2066

5459

4.40

307.65

2.3

1.6

1.44

1.58

g/l

6.99

1788

4659

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4758

12464

2.52

307.65

2.0

1.7

1.49

1.53

g/l

1.80

4123

10746

Other anaemias

6534

7679

10.64

307.65

2.0

1.5

1.53

1.58

g/l

2.34

5692

6469

Other autoimmune haemolytic anaemias

289

215

34.35

307.65

9.5

1.5

0.89

1.51

g/l

13.06

225

195

Disorders of lipoprotein metabolism and other lipidaemias

3719

10116

2.33

307.65

1.7

1.62

1.53

g/l

5.33

3234

8575

Explicit Sepsis

3496

8329

4.28

307.65

2.2

1.6

1.64

1.52

g/l

8.49

3053

7051

Nutritional anaemias

4849

10115

5.31

307.65

1.8

1.7

1.56

1.54

g/l

0.79

4176

8630

Diverticular disease of intestine

3468

9602

2.36

307.65

1.7

1.6

1.60

1.55

g/l

2.03

3034

8159

Complications of surgical and medical care, not elsewhere classified

4738

15029

2.19

307.65

2.0

1.7

1.57

1.51

g/l

3.73

4096

12884

ILD medications

5663

11855

2.70

307.65

2.0

1.6

1.54

1.47

g/l

5.00

4949

10103

Pneumonias (Asthma/COPD co-morbidities)

5310

12931

2.83

307.65

2.0

1.7

1.64

1.45

g/l

30.21

4655

11055

Caries of dentine

1619

4081

4.26

307.65

2.4

1.7

1.53

1.54

g/l

0.05

1428

3521

Lymphoid leukaemia

597

1169

6.60

306.29

3.0

1.8

1.25

1.52

g/l

8.56

521

1019

Chronic lymphocytic leukaemia

405

549

10.71

301.83

3.4

1.6

1.25

1.54

g/l

6.75

362

481

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

405

549

10.71

301.83

3.4

1.6

1.25

1.54

g/l

6.75

362

481

Chronic lymphocytic leukaemia, helper endpoint

405

549

10.71

301.83

3.4

1.6

1.25

1.54

g/l

6.75

362

481

Insulin, fast-acting or short human

1959

8091

2.58

300.59

2.0

1.7

1.59

1.51

g/l

2.88

1759

6902

STROKE

2147

5939

2.54

300.01

1.8

1.7

1.56

1.54

g/l

0.49

1849

5043

Azathioprine

852

2182

4.29

299.97

2.4

1.6

1.46

g/l

0.06

773

1881

Codeine

3577

9615

2.07

298.44

1.8

1.57

1.43

g/l

12.32

3086

8261

Hypertensive Renal Disease

418

582

9.28

298.29

2.4

1.6

1.61

1.50

g/l

1.32

399

478

Abnormal findings on examination of blood, without diagnosis

2537

10593

2.30

295.74

1.8

1.7

1.61

1.54

g/l

3.29

2214

9057

Osteopathies and chondropathies

2688

11588

2.22

294.24

2.0

1.7

1.60

1.54

g/l

2.36

2337

9896

Autoimmune diseases related-to ILD

3651

15926

1.98

293.98

2.0

1.7

1.57

1.51

g/l

3.26

3174

13678

Medical observation and evaluation for suspected diseases and conditions

2664

6018

2.34

292.98

1.9

1.6

1.51

1.53

g/l

0.36

2288

5123

Diarrhoea and gastroenteritis of presumed infectious origin

3118

13848

2.09

292.67

2.0

1.7

1.55

1.50

g/l

2.02

2705

11879

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2881

13794

2.14

291.34

2.0

1.7

1.57

1.53

g/l

1.57

2481

11819

Type 1 diabetes, wide definition, subgroup 1

1039

3097

3.60

289.92

2.0

1.7

1.53

1.41

g/l

3.57

945

2647

Hyperkalaemia

576

1139

6.19

288.34

2.2

1.7

1.56

1.50

g/l

0.68

514

971

Diabetes medication

4204

13182

1.92

288.23

1.9

1.7

1.63

1.46

g/l

23.96

3694

11231

Conduction disorders

1497

4312

2.96

287.85

1.7

1.6

1.52

1.61

g/l

3.02

1265

3672

Syncope and collapse

2067

7297

2.48

287.01

1.7

1.6

1.54

1.52

g/l

0.54

1746

6210

Endocrine, nutritional and metabolic diseases

2720

6173

2.29

285.03

1.9

1.7

1.50

1.40

g/l

5.35

2391

5223

Hypo-osmolality and hyponatraemia

1111

3520

3.44

280.74

1.7

1.58

1.56

g/l

0.17

974

2989

Coronary atherosclerosis

2856

8601

2.19

279.48

1.7

1.62

1.60

g/l

0.49

2499

7359

Hypothyroidism (congenital or acquired)

679

688

5.71

279.39

2.2

1.8

1.38

1.09

g/l

9.19

586

597

Pain in limb

3562

11720

2.00

278.06

1.9

1.8

1.55

1.49

g/l

2.51

3102

10053

Persons encountering health services in other circumstances, wide

4687

13433

1.84

276.44

1.9

1.7

1.52

1.53

g/l

0.23

4125

11429

Opioids

3662

9715

2.00

275.83

1.8

1.55

1.43

g/l

10.23

3166

8344

Explicit bacterial Sepsis, including avohilmo

751

1886

4.48

273.98

2.3

1.6

1.66

1.49

g/l

3.66

648

1601

Benign neoplasm: Colon

2772

12817

2.14

273.65

1.8

1.7

1.57

1.58

g/l

0.07

2419

10934

Major coronary heart disease event excluding revascularizations

2783

8826

2.18

271.39

1.7

1.65

1.60

g/l

2.06

2434

7555

Asthma, unspecified (mode)

2151

6732

2.39

271.33

1.7

1.59

1.44

g/l

10.63

1876

5743

Disorders of lens

2881

8641

2.15

270.93

1.9

1.7

1.55

1.57

g/l

0.55

2509

7426

Certain infectious and parasitic diseases, including avohilmo

2648

6043

2.26

269.18

1.8

1.6

1.55

1.43

g/l

7.32

2320

5111

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4503

13334

1.85

268.31

1.9

1.7

1.51

1.53

g/l

0.30

3952

11358

Bacterial pneumoniae

1989

7545

2.44

267.43

1.9

1.6

1.68

1.49

g/l

14.83

1752

6404

Streptococcal septicaemia, including avohilmo

672

1610

4.78

262.42

2.3

1.6

1.69

1.45

g/l

6.61

584

1364

Type 1 diabetes, wide definition

1058

3408

3.31

259.82

2.0

1.7

1.53

1.42

g/l

3.05

963

2897

Explicit bacterial Sepsis

726

1849

4.41

259.78

2.4

1.6

1.65

1.49

g/l

3.33

626

1567

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

484

905

6.77

259.64

2.1

1.6

1.43

1.53

g/l

1.36

413

788

Hypothyroidism and >3 levothyroxin purchases

652

687

5.49

258.81

2.1

1.8

1.37

1.09

g/l

8.19

562

596

Hypothyroidism, levothyroxine purchases

652

687

5.49

258.81

2.1

1.8

1.37

1.09

g/l

8.19

562

596

AV-block

1063

2894

3.40

258.08

1.7

1.6

1.51

1.61

g/l

2.26

899

2437

Reimbursement for rheumatic diseases

2508

12102

2.15

257.82

1.8

1.7

1.56

1.53

g/l

0.77

2160

10374

Intestinal infectious diseases, including avohilmo, including avohilmo

4703

15045

1.79

256.24

1.9

1.7

1.54

1.51

g/l

0.92

4080

12891

Myocardial infarction

2322

7496

2.28

254.29

1.7

1.68

1.60

g/l

2.88

2043

6410

Other bacterial intestinal infections

1113

3773

3.22

254.17

2.1

1.6

1.63

1.54

g/l

2.03

986

3226

Haemorrhage from respiratory passages

1789

6693

2.50

253.81

1.8

1.7

1.45

1.57

g/l

6.47

1524

5706

Bacterial pneumonia, not elsewhere classified

1896

7212

2.43

253.61

1.9

1.6

1.68

1.48

g/l

14.21

1676

6122

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3105

14152

1.99

252.00

1.9

1.7

1.62

1.54

g/l

3.41

2641

12131

Streptococcal septicaemia

650

1570

4.73

251.09

2.3

1.6

1.67

1.44

g/l

6.16

565

1328

Adjustment and management of implanted device

1178

4162

3.11

250.95

1.8

1.6

1.41

1.52

g/l

3.85

1034

3530

Symptoms and signs involving the urinary system

3383

13654

1.94

249.51

1.8

1.7

1.58

1.54

g/l

1.51

2872

11723

Ischaemic heart disease, wide definition

3223

10308

2.00

248.62

1.7

1.61

1.57

g/l

1.51

2820

8791

Chronic gastritis

1484

5946

2.68

244.49

1.8

1.7

1.47

1.59

g/l

4.62

1284

5045

Cardiomyopathy

923

2865

3.49

242.96

1.8

1.6

1.52

1.58

g/l

0.95

810

2447

Bacterial intestinal infections, IBD co-morbidities

1128

3959

3.11

242.36

2.1

1.6

1.63

1.55

g/l

1.77

999

3392

Implicit fungal Sepsis, including avohilmo

548

1194

5.35

242.10

2.0

1.7

1.58

1.49

g/l

1.17

482

1015

Diaphragmatic hernia

1868

8346

2.38

240.49

1.6

1.7

1.63

1.58

g/l

1.77

1620

7141

Other bacterial intestinal infections, including avohilmo

1280

4805

2.86

240.15

2.1

1.6

1.60

1.54

g/l

1.36

1122

4109

Other soft tissue disorders, not elsewhere classified

3798

11882

1.87

240.15

1.9

1.8

1.54

1.49

g/l

1.96

3298

10194

Failure and rejection of transplanted organs and tissues

209

154

21.89

239.51

3.2

1.7

1.39

1.43

g/l

0.18

194

141

Pain in throat and chest

3172

9783

1.97

237.89

1.8

1.7

1.52

1.50

g/l

0.44

2723

8418

Finngen Rheumatological endpoints

3585

11010

1.90

237.68

1.8

1.57

1.45

g/l

9.10

3091

9461

Paroxysmal tachycardia

782

1771

3.85

234.75

2.1

1.6

1.44

1.43

g/l

0.04

668

1474

Systemic connective tissue disorders

1743

7657

2.41

232.92

2.2

1.7

1.70

1.55

g/l

7.06

1525

6556

Gastroduodenal ulcer

1467

5969

2.62

232.20

1.8

1.6

1.55

1.57

g/l

0.29

1272

5053

Care involving use of rehabilitation procedures

2491

11177

2.07

231.71

1.8

1.6

1.57

1.51

g/l

2.43

2200

9464

Fibrosis and cirrhosis of liver

610

1506

4.75

231.20

2.1

1.8

1.08

1.56

g/l

28.58

529

1315

Endocarditis

348

522

8.36

231.19

2.2

1.6

1.42

1.52

g/l

0.84

285

453

Cytomegalovirus infection, IBD co-morbidity

268

301

12.34

229.95

3.3

1.9

1.45

1.49

g/l

0.23

246

268

Type 2 diabetes, definitions combined

3575

11414

1.87

228.64

1.8

1.7

1.64

1.47

g/l

19.30

3093

9699

Codeine or tramadol medication

4440

14055

1.76

228.63

1.8

1.57

1.49

g/l

6.01

3833

12075

Type 2 diabetes, strict (exclude DM1)

3597

11518

1.87

227.97

1.8

1.7

1.64

1.47

g/l

19.56

3115

9790

Myelodysplastic syndrome

232

226

18.14

226.99

2.3

1.7

1.06

1.58

g/l

10.03

202

200

Nausea and vomiting

1400

5486

2.64

226.16

2.2

1.7

1.55

1.53

g/l

0.37

1216

4684

Parasetamol

2532

6158

2.13

225.43

1.8

1.52

1.39

g/l

8.20

2210

5298

Asthma, excluding more controls

2405

5845

2.17

223.92

1.8

1.7

1.57

1.42

g/l

10.57

2117

5007

Multiple myeloma, including Hilmo

434

843

6.44

222.93

2.3

1.6

1.38

1.53

g/l

2.56

396

732

Enterocolitis due to Clostridium difficile

775

2320

3.77

220.35

2.2

1.7

1.65

1.52

g/l

2.82

688

1975

Malignant neoplasm

3124

9762

1.93

218.37

1.8

1.7

1.56

1.52

g/l

1.32

2707

8383

Malignant neoplasm, including Hilmo

3154

9830

1.92

218.04

1.8

1.7

1.56

1.52

g/l

1.22

2731

8434

Other/unspecified cytomegaloviral diseases

247

269

13.20

217.98

3.3

2.0

1.45

1.52

g/l

0.40

226

239

Gastric ulcer

1064

3836

3.02

217.29

1.8

1.6

1.56

g/l

0.04

920

3249

Infections of the skin and subcutaneous tissue

2498

12649

2.02

217.11

2.0

1.7

1.59

1.49

g/l

5.16

2196

10895

Cytomegaloviral disease

268

324

11.24

216.78

3.3

1.9

1.45

1.54

g/l

0.59

246

287

Disorders of choroid and retina

3524

13919

1.83

216.18

1.8

1.7

1.54

1.56

g/l

0.38

3059

11877

Cytomegaloviral disease, including avohilmo

269

328

11.09

215.97

3.3

1.9

1.45

1.53

g/l

0.56

247

290

Rheumatoid arthritis

1495

5557

2.51

214.95

1.5

1.7

1.64

1.52

g/l

4.02

1287

4739

Other pulmonary diagnosis

2779

7075

2.02

214.03

1.8

1.7

1.55

1.43

g/l

7.75

2417

6042

Malignant neoplasm

3113

9785

1.92

213.78

1.8

1.7

1.56

1.52

g/l

1.37

2695

8399

Amputation

759

2293

3.77

213.49

2.1

1.7

1.76

1.52

g/l

8.33

668

1949

Senile cataract

2612

8090

2.04

212.78

1.8

1.7

1.56

1.59

g/l

0.53

2266

6946

Excluding asthma or asthma-COPD overlap

2773

7075

2.02

212.29

1.8

1.7

1.55

1.43

g/l

7.29

2413

6042

Other gastritis (incl. Duodenitis)

1182

4558

2.78

210.57

1.9

1.6

1.49

1.57

g/l

1.78

1039

3885

Asthma (only as main-diagnosis), excluding more controls

2225

5845

2.16

209.61

1.7

1.58

1.42

g/l

10.96

1940

5007

Gastrointestinal diseases

1848

4017

2.36

209.28

1.9

1.7

1.47

1.48

g/l

0.26

1616

3422

Nephrotic syndrome

312

467

8.63

209.01

2.6

1.9

1.54

1.50

g/l

0.23

287

420

Malignant neoplasm, wide definition

3142

9925

1.89

208.07

1.8

1.7

1.57

1.52

g/l

1.58

2720

8511

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2556

13485

1.97

206.32

2.1

1.7

1.56

1.53

g/l

0.88

2192

11559

Other arrhythmias

2174

7931

2.11

205.59

1.8

1.7

1.47

1.54

g/l

2.30

1861

6814

Depression medications

643

713

4.65

205.53

2.0

1.8

1.44

1.08

g/l

14.13

568

620

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

536

814

4.99

205.48

2.4

1.6

1.63

1.51

g/l

1.44

467

687

Cirrhosis of liver, NAS

485

1109

5.33

205.11

2.2

1.8

1.01

1.56

g/l

29.60

417

970

COPD differential diagnosis

2749

7090

1.99

204.25

1.8

1.7

1.55

1.43

g/l

6.65

2392

6065

Hyperlipidaemia, other/unspecified

1826

7680

2.25

204.22

1.7

1.61

1.56

g/l

1.59

1568

6502

Other retinal disorders

2979

12432

1.89

203.78

1.8

1.7

1.55

1.56

g/l

0.23

2593

10605

ILD differential diagnosis

2747

7089

1.99

203.71

1.8

1.7

1.55

1.43

g/l

6.73

2390

6064

Type 2 diabetes, definitions combined, including avohilmo

3488

11396

1.82

202.37

1.8

1.7

1.64

1.47

g/l

19.43

3021

9691

Other disorders involving the immune mechanism, not elsewhere classified

312

483

8.25

202.23

2.8

2.1

1.44

1.43

g/l

0.05

282

428

Vascular disorders of the intestines

545

1373

4.60

200.28

2.1

1.6

1.55

1.53

g/l

0.17

474

1174

Myocardial infarction, strict

2086

7197

2.15

199.82

1.6

1.7

1.68

1.61

g/l

2.62

1838

6148

Pacemaker

2023

9305

2.15

198.97

1.8

1.6

1.48

1.58

g/l

5.16

1711

7942

Fungal Sepsis

369

681

6.58

198.75

2.0

1.7

1.61

1.47

g/l

1.49

318

583

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

298

449

8.56

198.38

2.9

2.1

1.43

g/l

0.04

269

399

L01XX Other antineoplastic agents

511

1253

4.95

197.78

2.4

1.7

1.08

1.55

g/l

24.99

456

1085

Other and unspecified acquired haemolytic anaemias

184

157

22.86

197.60

6.9

1.7

0.74

1.50

g/l

13.38

118

140

Fall on same level

4265

13621

1.71

197.43

1.8

1.51

1.50

g/l

0.21

3695

11720

Cystic kidney disease

312

496

8.03

197.25

2.1

2.0

1.47

1.45

g/l

0.13

294

442

All influenza

1215

4882

2.63

197.02

2.1

1.6

1.54

1.48

g/l

1.43

1052

4140

Peripheral artery operations in Hilmo

853

2892

3.26

196.19

2.0

1.7

1.77

1.53

g/l

10.12

761

2458

Bacterial pneumonia (organism specified)

2160

9902

2.07

195.72

1.9

1.7

1.68

1.52

g/l

10.80

1901

8428

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

597

1640

4.21

194.72

1.8

1.7

2.00

1.53

g/l

16.21

508

1408

Polycystic kidney disease

276

393

9.28

194.16

2.0

1.48

1.46

g/l

0.16

262

351

Diabetic maculopathy, excluding more controls

638

1832

3.84

191.41

2.1

1.7

1.58

1.45

g/l

2.75

577

1564

Myocardial infarction, without ST-elevation

2154

9997

2.05

188.47

1.6

1.7

1.66

1.55

g/l

6.00

1882

8473

Other (not insulin) diabetes medications

3668

12633

1.75

187.65

1.8

1.7

1.68

1.47

g/l

28.02

3193

10744

Symptoms and signs involving the circulatory and respiratory systems

3479

9966

1.79

186.90

1.9

1.7

1.49

g/l

0.01

3029

8582

Cystic kidney disease, including avohilmo

320

550

7.28

186.78

2.0

1.47

1.44

g/l

0.19

301

489

Viral pneumonia

723

2277

3.45

186.67

2.3

1.6

1.58

1.47

g/l

2.47

639

1941

Sub-endpoint used in defining T1D endpoints

1352

5749

2.43

186.04

2.1

1.7

1.55

1.49

g/l

1.29

1236

4882

Cardiomyopathies, Primary/intrinsic

656

1951

3.67

185.84

1.8

1.6

1.52

1.58

g/l

0.83

577

1665

Genitourinary diseases

1936

4532

2.20

185.76

2.0

1.6

1.49

1.46

g/l

0.62

1707

3794

Non-Hodgkin lymphoma, all, including Hilmo

772

2548

3.33

185.50

2.1

1.6

1.58

1.55

g/l

0.30

645

2169

IgA nephropathy (IgA glomerulonephritis)

256

355

9.60

184.52

3.1

2.1

1.41

1.49

g/l

0.57

235

311

Other arthritis (FG)

1337

5785

2.42

183.72

1.7

1.67

1.49

g/l

7.93

1144

4985

COPD (mode)

1399

4719

2.43

183.16

1.6

1.70

1.50

g/l

11.57

1225

3977

Disorders of gallbladder, biliary tract and pancreas

3904

14665

1.70

182.73

1.9

1.7

1.52

1.54

g/l

0.62

3381

12574

Enlarged lymph nodes

753

2449

3.29

182.68

2.0

1.7

1.61

1.49

g/l

1.90

645

2123

Other cataract

1938

7084

2.12

182.51

1.8

1.7

1.52

1.58

g/l

1.83

1710

6069

Pre-eclampsia

740

2376

3.29

182.44

3.2

1.7

1.15

1.53

g/l

22.04

672

2057

Gastro-oesophageal reflux disease

2632

12195

1.88

181.75

1.7

1.58

1.55

g/l

1.11

2250

10429

Asthma

2584

7010

1.95

181.72

1.7

1.58

1.43

g/l

11.53

2268

5991

Exposure to unspecified factor

3957

16398

1.68

181.46

1.8

1.51

1.52

g/l

0.07

3439

14072

Unspecified haematuria

2078

8638

2.05

180.91

1.9

1.7

1.55

g/l

0.09

1781

7427

Peripheral arterial reconstruction

1094

4439

2.70

178.44

1.8

1.6

1.74

1.54

g/l

10.04

962

3791

Cardiomyopathy (excluding other)

663

2036

3.55

178.37

1.8

1.6

1.52

1.57

g/l

0.74

584

1736

Multiple myeloma and malignant plasma cell neoplasms

441

1050

5.17

178.05

2.3

1.7

1.39

1.55

g/l

2.59

399

912

Other special examinations and investigations of persons without complaint or reported diagnosis

2329

6022

2.01

177.83

1.9

1.6

1.49

1.53

g/l

1.06

2006

5125

Implicit fungal Sepsis

334

625

6.47

177.20

2.1

1.7

1.59

1.47

g/l

1.18

289

536

Disorders of mineral metabolism

521

1379

4.21

176.65

2.0

1.7

1.57

1.51

g/l

0.62

456

1200

Hypothyroidism, drug reimbursement

345

387

6.45

176.35

2.1

1.7

1.45

1.13

g/l

5.93

300

332

Cerebrovascular diseases

3169

12763

1.78

176.24

1.8

1.7

1.59

1.56

g/l

0.89

2725

10903

Chronic nephritic syndrome

329

614

6.55

175.52

2.7

1.9

1.57

1.52

g/l

0.36

301

539

Pre-eclampsia or eclampsia

784

2677

3.09

173.72

3.1

1.7

1.16

1.53

g/l

21.90

712

2317

Diabetic retinopathy, excluding more controls

1363

3238

2.53

173.46

2.0

1.7

1.61

1.60

g/l

0.07

1224

2767

Congenital malformations of the urinary system

398

876

5.24

173.37

2.0

1.48

g/l

0.04

366

777

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3872

15180

1.67

173.11

1.9

1.7

1.52

1.51

g/l

0.34

3344

13011

Hypokalaemia

678

2154

3.43

172.85

1.7

1.68

1.54

g/l

2.95

590

1842

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1044

1870

2.87

172.72

2.0

1.7

1.51

1.39

g/l

2.56

925

1580

Diseases of the skin and subcutaneous tissue

3601

10681

1.73

172.50

1.9

1.7

1.52

1.50

g/l

0.82

3107

9125

Symptoms and signs involving cognition, perception, emotional state and behaviour

3709

15043

1.69

172.08

1.8

1.53

g/l

0.00

3188

12938

Pregnancy hypertension

1289

4986

2.39

171.38

2.7

1.7

1.21

1.51

g/l

24.92

1159

4323

Congenital malformations of the urinary system, including avohilmo

412

941

5.01

171.17

2.0

1.9

1.48

g/l

0.06

378

833

Sulfasalazine

1175

4955

2.49

171.02

1.6

1.54

1.50

g/l

0.76

1019

4243

Any event in cancer register

3184

10817

1.76

167.55

1.8

1.7

1.57

1.49

g/l

3.79

2759

9288

Asthma (mode)

2511

7089

1.90

166.41

1.7

1.56

1.43

g/l

9.01

2188

6064

Angina pectoris

2285

8089

1.94

166.16

1.6

1.7

1.57

1.60

g/l

0.80

1964

6905

Volume depletion

615

1896

3.58

165.64

1.9

1.7

1.62

1.50

g/l

2.18

533

1620

Other specified/unspecified arthritis

1185

5097

2.44

165.32

1.7

1.68

1.50

g/l

6.73

1018

4377

Seropositive rheumatoid arthritis

1110

4616

2.52

165.26

1.5

1.7

1.62

1.53

g/l

1.96

964

3941

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

286

503

7.29

164.10

2.3

1.6

1.45

1.54

g/l

0.69

266

433

Multiple myeloma

286

503

7.29

164.10

2.3

1.6

1.45

1.54

g/l

0.69

266

433

Certain disorders involving the immune mechanism

908

3493

2.78

162.55

2.3

1.7

1.47

1.54

g/l

1.14

790

3035

Other and unspecified aplastic anaemias

154

130

17.75

161.83

2.7

1.7

1.22

1.43

g/l

1.24

131

118

Asthma (only as main-diagnosis)

2350

7010

1.92

161.71

1.6

1.7

1.58

1.43

g/l

11.14

2043

5991

Other diseases of intestine

817

2990

2.94

161.55

1.8

1.6

1.61

1.56

g/l

0.75

722

2552

Hernia

3504

14160

1.68

161.24

1.7

1.8

1.55

1.54

g/l

0.14

3027

12152

Abnormal findings on diagnostic imaging of lung

2261

11778

1.90

161.10

1.9

1.6

1.65

1.56

g/l

3.73

1926

10090

Alcohol use disorder, Swedish definition

2276

11371

1.88

159.86

1.6

1.7

1.52

1.53

g/l

0.30

1961

9777

Myeloproliferative diseases

562

1691

3.78

159.26

1.9

1.7

1.11

1.55

g/l

25.22

489

1460

Osteoporosis

1344

5677

2.31

159.22

2.1

1.6

1.57

1.60

g/l

0.55

1145

4840

Disorders of other endocrine glands

1802

9108

2.02

158.08

2.1

1.7

1.56

1.52

g/l

1.04

1572

7833

Amputation of toe

545

1627

3.87

157.49

2.0

1.7

1.73

1.52

g/l

5.22

483

1396

Ascites

510

1449

3.97

157.14

2.1

1.7

1.21

1.53

g/l

9.57

426

1253

Other diseases of urinary system

3722

12875

1.66

156.97

1.8

1.55

1.50

g/l

2.35

3210

11063

Pain, not elsewhere classified

1074

4513

2.48

156.88

1.8

1.7

1.58

1.49

g/l

2.18

943

3900

Substance abuse, excluding more controls

2219

10143

1.88

155.39

1.6

1.8

1.57

1.50

g/l

2.92

1929

8746

Constipation

3493

14544

1.67

155.25

1.7

1.53

1.54

g/l

0.18

2962

12513

Pre-eclampsia or poor fetal growth

944

3732

2.62

155.17

3.0

1.7

1.17

1.45

g/l

18.13

848

3246

Other diseases of pleura

2197

10494

1.90

155.06

1.8

1.6

1.66

1.55

g/l

5.02

1885

8949

Other systemic involvement of connective tissue (FG)

1117

4736

2.43

153.87

2.0

1.7

1.69

1.52

g/l

6.06

970

4040

Asthma-related pneumonia or sepsis

1738

8901

2.03

153.72

1.8

1.7

1.65

1.53

g/l

6.01

1515

7579

Asthma, hospital admissions 3, pneumonia

1738

8901

2.03

153.72

1.8

1.7

1.65

1.53

g/l

6.01

1515

7579

Asthma-related pneumonia

1735

8886

2.03

153.46

1.8

1.7

1.65

1.53

g/l

5.90

1512

7565

Headache

2113

8763

1.91

153.23

1.9

1.7

1.49

1.47

g/l

0.49

1823

7508

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

760

2664

2.96

152.10

2.1

1.8

1.38

1.48

g/l

2.46

645

2316

Use of hypnotics and sedatives

3951

14260

1.62

151.43

1.8

1.7

1.56

1.52

g/l

2.25

3422

12245

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

799

2886

2.87

151.43

2.0

1.8

1.38

1.49

g/l

2.81

670

2504

Other disorders of urethra and urinary system

2747

11105

1.77

151.43

1.8

1.7

1.57

1.50

g/l

3.73

2359

9525

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1384

5618

2.20

151.31

2.6

1.7

1.22

1.52

g/l

26.89

1245

4858

Other nutritional deficiencies

2473

12917

1.80

151.21

1.8

1.62

1.48

g/l

10.38

2134

11205

Other necrotizing vasculopathies

498

1435

3.97

151.11

3.1

1.7

1.84

1.53

g/l

6.98

432

1235

4233

13710

1.60

150.12

1.8

1.7

1.53

1.51

g/l

0.57

3648

11772

Neoplasms

2354

6718

1.88

149.93

2.0

1.8

1.45

1.43

g/l

0.48

2056

5818

2435

12085

1.81

149.51

1.6

1.8

1.52

g/l

0.12

2094

10415

Factors influencing health status and contact with health services

979

1840

2.75

149.42

1.9

1.5

1.52

1.56

g/l

0.58

862

1573

2351

11889

1.82

148.94

1.6

1.8

1.52

1.53

g/l

0.18

2024

10235

Agranulocytosis

613

2022

3.33

147.41

2.0

1.7

1.48

1.56

g/l

0.90

534

1735

Polyneuropathies and other disorders of the peripheral nervous system

1147

5150

2.38

147.13

2.1

1.7

1.56

g/l

0.09

1004

4414

Insulin, fast-acting (human)

643

2165

3.17

147.12

2.1

1.7

1.46

g/l

0.04

590

1860

Biguanides

3530

13239

1.65

146.50

1.7

1.68

1.48

g/l

27.44

3063

11299

Other diseases of pericardium

305

624

5.62

144.76

2.2

1.6

1.63

1.54

g/l

0.67

254

537

Rheumatoid arthritis, including avohilmo

1612

8251

2.04

144.22

1.6

1.7

1.63

1.56

g/l

2.13

1395

7074

Disorders of parathyroid gland

1049

4511

2.45

144.03

2.2

1.6

1.58

1.59

g/l

0.07

924

3850

Symptoms and signs involving the digestive system and abdomen

3627

11291

1.64

144.01

1.9

1.7

1.51

1.52

g/l

0.27

3129

9687

Alcoholic liver disease

603

2005

3.33

143.76

1.7

1.16

1.59

g/l

23.85

497

1742

Other necrotizing vasculopathies (FG)

404

1045

4.41

142.77

2.2

1.7

1.89

1.48

g/l

9.25

354

895

Other functional intestinal disorders

1804

8666

1.95

142.61

1.7

1.54

1.52

g/l

0.36

1546

7347

SLE (Finngen)

235

382

7.15

142.54

2.4

1.5

1.50

1.51

g/l

0.08

211

331

Disorders of calcium metabolism

405

1049

4.34

142.09

2.1

1.7

1.67

1.51

g/l

2.38

357

906

Convulsions, not elsewhere classified

904

3625

2.57

142.07

1.9

1.7

1.47

g/l

0.02

782

3103

Bronchitis

4076

15826

1.58

141.71

1.9

1.7

1.51

1.52

g/l

0.07

3537

13584

Cellulitis

1026

4452

2.43

141.10

2.0

1.7

1.61

1.51

g/l

2.46

905

3837

Cardiomyopathy, other and unspecified

427

1150

4.10

140.95

1.9

1.6

1.62

1.58

g/l

0.33

383

987

Oesophageal varices

329

745

5.27

140.11

2.0

1.7

0.98

1.59

g/l

26.96

282

645

Myeloid leukaemia

258

480

6.80

139.38

1.8

2.0

1.43

1.56

g/l

1.10

229

430

Acute peritonitis

437

1222

4.07

138.42

2.4

1.8

1.56

1.51

g/l

0.42

414

1063

Statin medication

2059

6237

1.90

138.37

1.9

1.8

1.56

1.41

g/l

8.47

1796

5305

Other and unspecified polyneuropathies, also in other diseases

1028

4532

2.43

138.08

2.1

1.7

1.57

1.56

g/l

0.11

898

3895

Noninfective enteritis and colitis

1819

9793

1.92

138.00

1.9

1.7

1.53

1.51

g/l

0.35

1595

8412

Asthma-related infections

2369

13465

1.76

137.15

1.8

1.62

1.50

g/l

8.00

2058

11511

Asthma, hospital admission 2, infections

2369

13465

1.76

137.15

1.8

1.62

1.50

g/l

8.00

2058

11511

Other diseases of liver

833

3336

2.65

136.99

1.9

1.7

1.33

1.57

g/l

10.78

710

2905

Persons encountering health services for specific procedures, not carried out

439

1235

3.86

135.07

1.9

1.7

1.59

1.44

g/l

2.34

389

1083

Other diseases of anus and rectum

1319

6415

2.14

134.32

1.8

1.6

1.52

1.55

g/l

0.74

1135

5439

Persons encountering health services for examination and investigation

2185

6022

1.86

133.76

1.8

1.6

1.48

1.53

g/l

1.06

1892

5125

Symptoms and signs concerning food and fluid intake

539

1738

3.33

132.94

1.6

1.7

1.48

1.51

g/l

0.21

476

1501

596

2034

3.11

132.78

2.5

1.8

1.47

1.48

g/l

0.09

532

1729

General examination and investigation of persons without complaint and reported diagnosis

2113

6003

1.87

132.35

1.8

1.6

1.52

g/l

0.10

1813

5112

Benign neoplasms

3476

11929

1.62

132.25

1.8

1.51

1.49

g/l

0.38

2995

10277

Myeloproliferative diseases (CML excluded)

494

1543

3.62

131.88

1.9

1.8

1.09

1.54

g/l

23.07

428

1330

Retention of urine

1676

7171

1.98

131.56

1.7

1.6

1.64

1.54

g/l

3.93

1424

6148

Presence of other functional implants

2337

9262

1.78

130.83

1.8

1.6

1.55

1.60

g/l

1.89

1993

7924

Disorders of thyroid, IBD co-morbidities

576

1246

3.28

130.35

1.9

1.8

1.49

1.38

g/l

1.47

491

1069

Cutaneous abscess, furuncle and carbuncle

1079

4937

2.29

129.99

2.0

1.8

1.64

1.49

g/l

5.00

944

4251

Other diseases of blood and blood-forming organs

432

1260

3.85

127.92

2.4

1.8

1.20

1.55

g/l

10.96

380

1089

Hepatic failure, not elsewhere classified

294

654

5.35

127.86

2.0

1.9

1.10

1.56

g/l

11.01

226

581

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3576

14609

1.58

126.83

1.8

1.7

1.51

1.55

g/l

1.33

3082

12527

Charcot foot

167

216

9.83

126.64

2.3

2.2

1.65

1.44

g/l

1.68

155

187

Venous thromboembolism

2293

13065

1.75

126.54

2.0

1.7

1.67

1.54

g/l

7.52

2015

11110

Obesity due to excess calories

1714

9353

1.89

124.92

1.8

1.66

1.46

g/l

14.50

1485

8142

Dizziness and giddiness

2851

13783

1.65

124.22

1.8

1.7

1.52

1.54

g/l

0.53

2465

11833

Osteomyelitis

427

1263

3.82

124.09

2.1

1.8

1.81

1.50

g/l

7.42

389

1095

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

209

345

6.84

124.01

2.1

1.7

1.43

1.53

g/l

0.62

197

293

Mental and behavioural disorders due to psychoactive substance use

2283

12394

1.73

123.25

1.6

1.8

1.57

1.51

g/l

2.07

1981

10664

Other diseases of arteries and capillaries

510

1682

3.32

122.77

2.4

1.8

1.55

1.52

g/l

0.34

462

1441

Abnormalities of heart beat

1381

6847

2.02

122.15

1.8

1.7

1.53

g/l

0.01

1180

5850

Substance abuse

2219

12202

1.74

120.73

1.6

1.8

1.57

1.51

g/l

1.93

1929

10501

Acute posthaemorrhagic anaemia

243

479

5.87

120.56

2.0

1.8

1.39

1.52

g/l

1.09

203

413

Other and unspecified diseases of blood and blood-forming organs

227

427

6.53

120.44

2.9

1.8

1.21

1.54

g/l

5.02

207

378

Left ventricular outflow tract obstruction (LVOTO), broad definition

491

1597

3.34

120.43

2.1

1.8

1.29

1.50

g/l

3.85

346

1399

Idiopathic gout

584

2121

3.05

119.40

1.8

1.7

1.70

1.55

g/l

3.36

525

1819

Hyperparathyroidism

914

4023

2.39

119.20

2.2

1.6

1.60

1.59

g/l

0.10

808

3430

Injuries to the head

4007

15916

1.52

118.92

1.7

1.8

1.51

1.52

g/l

0.23

3436

13699

Falls/tendency to fall

3602

11721

1.57

118.30

1.8

1.50

g/l

0.07

3114

10097

Persons encountering health services in other circumstances

1523

8053

1.93

118.27

1.9

1.7

1.53

1.50

g/l

0.51

1328

6877

Chronic tubulo-interstitial nephritis

233

451

5.89

117.41

2.2

1.6

1.48

1.49

g/l

0.05

213

389

Obesity

2224

12499

1.72

117.03

1.8

1.66

1.48

g/l

15.56

1926

10842

Solid cancers, including Hilmo

2736

9805

1.66

117.00

1.7

1.62

1.52

g/l

4.72

2347

8415

Pulmonary heart disease, diseases of pulmonary circulation

1473

7864

1.96

116.82

2.1

1.6

1.67

1.55

g/l

4.31

1290

6708

Follow-up examination after treatment for conditions other than malignant neoplasms

1486

5131

1.98

116.58

1.8

1.6

1.53

1.52

g/l

0.13

1326

4375

Acute myeloid leukaemia

154

204

10.39

116.17

1.7

1.52

1.53

g/l

0.06

136

179

Acute myeloid leukaemia, including Hilmo

154

204

10.39

116.17

1.7

1.52

1.53

g/l

0.06

136

179

Acute myeloid leukaemia, helper endpoint

154

204

10.39

116.17

1.7

1.52

1.53

g/l

0.06

136

179

Obesity and other hyperalimentation

2230

12549

1.71

116.09

1.8

1.66

1.48

g/l

15.59

1929

10887

Vocal cord dysfunction

399

992

3.68

115.64

1.6

1.7

1.65

1.41

g/l

3.87

346

832

Solid cancers

2678

9649

1.66

115.05

1.7

1.62

1.53

g/l

4.46

2292

8277

Coronary artery bypass grafting

1234

4542

2.12

114.90

1.7

1.6

1.61

1.60

g/l

0.26

1046

3864

Other disorders of white blood cells

353

973

4.12

114.19

2.3

1.8

1.35

1.53

g/l

3.21

301

846

Aortic valve malfunction, age under 60 years

460

1495

3.35

113.14

2.1

1.8

1.29

1.51

g/l

4.07

322

1304

Systemic lupus erythematosus

235

476

5.70

113.09

2.4

1.8

1.50

1.52

g/l

0.11

211

413

Stroke, including SAH

2604

11630

1.65

112.48

1.8

1.7

1.59

1.57

g/l

0.24

2235

9939

Later onset COPD, excluding more controls

1014

3597

2.27

112.32

1.6

1.71

1.51

g/l

9.52

879

3030

Other CVD

1089

5338

2.17

111.86

1.8

1.6

1.56

g/l

0.05

929

4548

Pain in joint

2062

7336

1.77

111.81

1.8

1.7

1.58

1.51

g/l

2.32

1798

6261

Other disorders of skin and subcutaneous tissue, not elsewhere classified

701

2859

2.62

111.55

1.9

1.7

1.70

1.55

g/l

3.42

609

2455

Other and unspecified disorders of white blood cells

283

680

4.84

111.14

2.4

1.8

1.27

1.53

g/l

4.71

243

598

SLE, ICD10

227

454

5.82

111.04

2.4

1.9

1.49

1.54

g/l

0.24

204

397

SLE, strict definition

227

454

5.82

111.04

2.4

1.9

1.49

1.54

g/l

0.24

204

397

Idiopathic thrombocytopenic purpura

231

478

5.74

109.40

2.9

1.9

1.14

1.54

g/l

7.76

199

428

Other antidepressants

3696

12565

1.53

109.20

1.7

1.8

1.54

1.50

g/l

1.93

3192

10822

Paralytic ileus and intestinal obstruction

1110

5490

2.11

109.18

1.8

1.6

1.66

1.56

g/l

2.64

968

4659

Chronic myeloproliferative disease

170

274

8.87

108.76

2.5

2.0

0.88

1.46

g/l

13.58

149

250

Spondylopathies

2902

10936

1.60

108.19

1.6

1.7

1.58

1.54

g/l

1.46

2511

9354

Chronic periodontitis, including avohilmo

3581

15299

1.52

108.16

1.9

1.7

1.55

1.53

g/l

0.67

3114

13140

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

118

125

15.37

108.11

2.7

1.6

1.43

1.61

g/l

1.08

105

113

Sequelae of external causes of morbidity and mortality

1138

5716

2.09

108.07

1.9

1.7

1.61

1.54

g/l

1.28

994

4913

Stroke, excluding SAH

2515

11324

1.65

107.88

1.8

1.7

1.59

1.57

g/l

0.46

2161

9673

Injuries to the abdomen, lower back, lumbar spine and pelvis

1698

9542

1.81

107.40

1.9

1.7

1.51

1.53

g/l

0.49

1424

8193

Other noninfective gastroenteritis and colitis

1022

4935

2.16

107.26

2.0

1.7

1.56

1.53

g/l

0.46

905

4240

Periodontitis

3580

15312

1.52

106.93

1.9

1.7

1.56

1.53

g/l

0.88

3115

13151

Malignant neoplasm of digestive organs, including Hilmo

1682

6935

1.84

106.88

1.5

1.6

1.68

1.58

g/l

3.99

1459

5911

Abdominal and pelvic pain

3421

11291

1.55

106.79

1.8

1.7

1.51

1.52

g/l

0.19

2951

9687

Essential (haemorrhagic) thrombocythaemia

260

603

5.00

106.73

1.9

1.6

1.13

1.51

g/l

8.20

227

522

Benzodiazepine use

3612

16462

1.51

105.55

1.6

1.8

1.59

1.51

g/l

5.62

3040

14224

Gestational [pregnancy-induced] hypertension

706

2936

2.48

104.71

2.6

1.7

1.23

1.48

g/l

10.60

639

2536

Viral hepatitis, IBD co-morbidity

206

392

5.59

103.79

1.9

1.8

1.45

1.32

g/l

0.94

169

326

Diseases of peritoneum

532

1971

2.93

103.63

2.2

1.7

1.53

1.54

g/l

0.03

499

1694

Malignant neoplasm of skin, including Hilmo

1930

7568

1.76

103.33

1.8

1.6

1.47

1.57

g/l

5.33

1677

6458

Cystitis

3003

11595

1.57

103.21

1.7

1.8

1.56

1.49

g/l

2.96

2596

9955

Seropositive rheumatoid arthritis, wide

1109

5613

2.07

103.01

1.5

1.7

1.62

1.57

g/l

0.96

964

4818

Other specific joint derangements/joint disorders

2394

9196

1.65

102.94

1.8

1.55

1.45

g/l

5.76

2081

7925

Viral infections characterized by skin and mucous membrane lesions

1605

9122

1.81

102.32

2.0

1.7

1.50

1.52

g/l

0.36

1428

7861

Dermatitis

2339

14347

1.63

102.10

1.8

1.7

1.57

1.52

g/l

1.57

2033

12333

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1712

9844

1.78

101.79

1.6

1.7

1.55

1.53

g/l

0.62

1491

8456

Other acute lower respiratory infections

2088

12136

1.68

101.56

1.9

1.7

1.53

1.52

g/l

0.32

1830

10370

Diseases of the respiratory system

2082

6140

1.73

101.50

1.8

1.7

1.54

1.44

g/l

4.31

1811

5245

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1816

7098

1.78

101.41

1.7

1.6

1.47

1.58

g/l

5.39

1578

6049

Malignant neoplasm of skin

1862

7354

1.76

101.19

1.8

1.6

1.47

1.58

g/l

5.69

1619

6269

Disorder of lipoprotein metabolism, unspecified

637

2605

2.61

100.93

1.8

1.7

1.60

1.55

g/l

0.75

557

2224

Other systemic involvement of connective tissue

1142

5885

2.03

100.49

2.0

1.7

1.69

1.55

g/l

4.45

994

5062

ILD, hospital admission 2, with pulmonary infections

521

1939

2.91

100.47

2.3

1.5

1.64

1.48

g/l

3.02

447

1651

Diabetic retinopathy

1719

6130

1.83

99.90

1.9

1.7

1.62

1.64

g/l

0.16

1525

5310

Unstable angina pectoris

1533

6743

1.85

99.79

1.6

1.57

1.60

g/l

0.67

1302

5756

DVT of lower extremities and pulmonary embolism

1782

10498

1.75

99.37

2.0

1.6

1.69

1.56

g/l

6.74

1561

8960

Hydronephrosis

505

1852

2.91

99.22

1.7

1.6

1.85

1.49

g/l

10.65

446

1559

Mental and behavioural disorders due to alcohol

1917

10986

1.71

98.63

1.6

1.8

1.55

1.52

g/l

0.66

1665

9448

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1072

5447

2.06

98.52

1.5

1.7

1.62

1.57

g/l

0.86

932

4677

Low back pain

2741

11962

1.58

98.30

1.7

1.8

1.56

1.49

g/l

2.95

2346

10299

Hypotension

962

4734

2.16

98.08

1.8

1.6

1.57

1.56

g/l

0.05

824

4022

Other external causes of accidental injury

2664

8452

1.61

97.80

1.8

1.50

g/l

0.02

2298

7278

Vitamin B12 deficiency anaemia

517

1940

2.86

97.76

1.9

1.7

1.45

1.54

g/l

1.17

434

1657

Gout due to impairment of renal function

142

212

9.75

97.74

2.2

2.0

1.71

1.47

g/l

1.83

133

193

Coxarthrosis [arthrosis of hip](FG)

2012

8332

1.70

97.69

1.6

1.7

1.59

1.53

g/l

2.28

1717

7098

Secondary and unspecified malignant neoplasm of lymph nodes

443

1537

3.14

97.54

1.8

1.7

1.65

1.53

g/l

1.46

366

1330

Pain (limb, back, neck, head abdominally)

2472

7716

1.64

97.20

1.8

1.7

1.51

g/l

0.01

2145

6559

Cardiac arrest

283

603

4.26

97.06

1.9

1.5

1.59

1.50

g/l

0.64

245

493

Chronic ulcer of skin, not elsewhere classified

414

1394

3.29

96.86

1.9

1.7

1.78

1.52

g/l

5.19

364

1190

Other/unspecified seropositive rheumatoid arthritis

1084

5565

2.04

96.68

1.5

1.7

1.62

1.57

g/l

0.91

942

4776

Other viral diseases

988

4881

2.09

95.89

2.5

1.8

1.45

1.46

g/l

0.01

887

4225

Pleural effusion

824

3861

2.28

95.62

1.8

1.7

1.67

1.54

g/l

3.01

704

3301

Pulmonary embolism

1296

7082

1.91

95.54

2.0

1.6

1.72

1.56

g/l

6.76

1130

6045

Other and unspecified dermatitis

1959

11975

1.68

95.50

1.8

1.7

1.58

1.51

g/l

1.98

1707

10308

Neurological diseases, wide definition

759

1576

2.47

95.43

1.9

1.8

1.46

1.32

g/l

3.24

675

1357

Malignant immunoproliferative diseases

135

197

10.23

95.21

2.9

2.1

1.48

1.50

g/l

0.06

118

176

Ischaemic Stroke, excluding all haemorrhages

2363

11029

1.62

95.18

1.8

1.7

1.60

1.58

g/l

0.56

2029

9405

Benign neoplasm: Colon, unspecified

1169

6204

1.98

95.14

1.9

1.6

1.55

1.58

g/l

0.46

995

5293

Urinary track infection

1645

4613

1.82

94.94

1.9

1.8

1.54

1.43

g/l

3.88

1435

3955

Systemic lupus erythematosus, unspecified

193

386

5.80

94.43

2.5

2.0

1.47

1.51

g/l

0.19

172

342

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1745

6931

1.76

94.18

1.7

1.6

1.47

1.58

g/l

5.27

1503

5901

Chronic periodontitis, complicated

2131

13007

1.64

94.06

1.8

1.7

1.61

1.55

g/l

1.95

1858

11187

Other (seronegative) rheumatoid arthritis, wide

825

3881

2.24

93.78

1.6

1.7

1.66

1.57

g/l

1.60

705

3337

Diseases of the eye and adnexa

2360

7340

1.64

93.75

2.0

1.8

1.44

1.49

g/l

1.67

2058

6321

Decubitus ulcer and pressure area

402

1359

3.29

93.74

2.1

1.7

1.79

1.53

g/l

5.39

360

1159

Chronic apical periodontitis

3881

15149

1.46

93.69

1.8

1.55

1.51

g/l

1.75

3330

13053

Alcohol use disorder, ICD-based

1572

9127

1.78

93.48

1.6

1.7

1.55

1.53

g/l

0.55

1366

7844

Pulmonary heart disease

1296

7134

1.89

93.33

2.0

1.6

1.72

1.55

g/l

7.01

1130

6098

Basal cell carcinoma, including Hilmo

1748

6953

1.75

93.00

1.8

1.6

1.47

1.58

g/l

5.26

1510

5923

Need for immunization against other single viral diseases

160

276

7.14

92.95

3.1

1.9

1.41

1.49

g/l

0.49

153

248

Accidents

2638

8452

1.59

92.93

1.7

1.8

1.49

1.50

g/l

0.18

2274

7278

Fracture of lumbar spine and pelvis

1068

5527

2.02

92.78

2.0

1.7

1.51

1.57

g/l

1.37

898

4741

Rare circulating lymphoid malignancy, including Hilmo

209

458

5.33

92.18

2.1

1.7

1.46

1.49

g/l

0.11

173

411

Intracranial trauma

1863

7518

1.71

91.87

1.7

1.8

1.51

1.47

g/l

1.09

1581

6496

Pneumocystosis

178

347

6.54

91.85

2.5

2.0

1.56

1.48

g/l

0.37

150

308

Pneumocystosis, including avohilmo

178

347

6.54

91.85

2.5

2.0

1.56

1.48

g/l

0.37

150

308

Haemorrhage, not elsewhere classified

256

656

4.42

91.64

2.1

1.6

1.30

1.50

g/l

2.63

215

565

Pericarditis

211

465

5.11

91.39

1.8

1.7

1.68

1.50

g/l

1.52

183

407

Diabetic retinopathy, strict definition

892

3873

2.20

91.37

2.2

1.8

1.56

1.61

g/l

0.73

805

3384

Seronegative rheumatoid arthritis

502

1917

2.79

91.20

1.6

1.7

1.65

1.51

g/l

1.99

425

1645

Isolated proteinuria

205

447

5.40

91.18

2.4

2.0

1.47

1.50

g/l

0.12

188

390

Nonischemic cardiomyopathy

492

1868

2.83

90.91

1.8

1.7

1.54

g/l

0.03

413

1604

Non-Hodgkin lymphoma, all

298

856

3.95

90.86

2.0

1.6

1.64

1.53

g/l

1.06

243

730

Mycoses

1116

5925

1.96

89.68

1.9

1.7

1.57

1.53

g/l

0.64

964

5107

Spinal stenosis

2054

9410

1.65

89.62

1.6

1.7

1.63

1.57

g/l

1.98

1788

8014

Non-follicular lymphoma

532

2130

2.73

89.48

2.1

1.7

1.55

g/l

0.03

451

1844

Chronic pancreatitis

598

2529

2.53

88.29

1.8

1.7

1.53

1.54

g/l

0.10

538

2180

Mood disorders, excluding more controls

3144

12524

1.50

87.86

1.8

1.53

1.51

g/l

0.60

2734

10794

Acute bronchitis

1614

9416

1.73

87.44

1.8

1.7

1.52

1.53

g/l

0.09

1418

8026

Intestinal stricture

1333

7547

1.84

87.42

1.8

1.7

1.65

1.55

g/l

2.93

1161

6447

Unspecified fall

1979

12174

1.64

87.07

1.8

1.7

1.55

1.53

g/l

0.36

1686

10456

Osteoporosis with pathological fracture (FG)

384

1313

3.19

86.92

1.9

1.6

1.62

1.56

g/l

0.57

335

1125

Arthropathies in other diseases classified elsewhere

230

567

4.61

86.86

2.2

1.9

1.66

1.49

g/l

1.76

212

489

Any mental disorder

3692

12900

1.46

86.00

1.7

1.8

1.56

1.51

g/l

2.78

3174

11091

Methotrexate

553

2277

2.56

85.54

1.6

1.52

g/l

0.06

487

1954

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

3145

16858

1.48

85.39

1.9

1.7

1.49

1.52

g/l

0.64

2762

14473

Amputation of foot

220

540

4.93

85.36

2.0

1.9

1.79

1.52

g/l

3.13

198

470

Missing teeth due to accident, extraction or parodontitis

2368

13836

1.57

85.34

1.7

1.56

g/l

0.12

2019

11897

Osteonecrosis

346

1129

3.38

85.33

1.8

1.70

1.54

g/l

1.99

313

979

Sequelae with surgical and medical care as external cause

897

4512

2.09

85.26

2.0

1.7

1.62

1.55

g/l

1.23

781

3887

Basal cell carcinoma

1677

6807

1.73

85.18

1.8

1.6

1.46

1.59

g/l

6.25

1442

5789

Asthma (diagnoses ohter than nonallergic)

3057

16943

1.48

85.02

1.7

1.8

1.60

1.50

g/l

7.23

2668

14526

Cholelithiasis, broad definition with cholecystitis

3060

13902

1.49

84.83

1.9

1.7

1.51

1.54

g/l

1.03

2624

11901

Budesonide

543

2226

2.56

84.57

1.9

1.6

1.43

1.47

g/l

0.46

490

1910

Cough

1396

7491

1.78

84.33

1.9

1.7

1.55

1.53

g/l

0.32

1193

6398

Cardiodefibrillation

1580

9460

1.73

84.32

1.8

1.6

1.41

1.58

g/l

11.45

1329

8125

Vitreous haemorrhage

518

2099

2.66

84.29

2.2

1.7

1.53

1.55

g/l

0.19

468

1813

Soft tissue disorders

3389

11969

1.47

84.21

1.9

1.8

1.50

1.49

g/l

0.23

2921

10262

Zoster [herpes zoster]

849

4207

2.12

84.21

2.0

1.7

1.48

1.56

g/l

1.40

748

3615

Malignant neoplasm of digestive organs

1497

6675

1.77

83.98

1.5

1.6

1.70

1.58

g/l

4.65

1298

5693

Other reaction to severe stress, and adjustment disorders

1102

5922

1.91

83.82

2.2

1.8

1.42

1.44

g/l

0.23

959

5162

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

492

1950

2.72

83.79

2.0

1.8

1.61

1.53

g/l

0.97

430

1691

Dorsalgia

3326

12169

1.47

82.75

1.7

1.8

1.55

1.49

g/l

2.75

2859

10465

Symptoms and signs involving the skin and subcutaneous tissue

2552

16130

1.52

82.55

1.9

1.7

1.47

1.53

g/l

2.50

2195

13886

Coxarthrosis

1828

7225

1.67

82.05

1.6

1.7

1.60

1.54

g/l

1.56

1555

6152

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

18.41

82.00

2.4

1.6

1.51

1.60

g/l

0.35

ILD, hospital admissions 3, with pneumonia sepsis

459

1784

2.79

81.62

2.2

1.6

1.67

1.49

g/l

3.42

396

1521

Candidiasis, including avohilmo

1112

6075

1.89

81.37

1.8

1.52

1.50

g/l

0.22

973

5250

Other symptoms and signs involving cognitive functions and awareness

1918

10724

1.63

81.35

1.7

1.55

1.57

g/l

0.24

1617

9166

Dermatitis and eczema

3858

16342

1.42

80.82

1.8

1.55

1.51

g/l

1.87

3329

14050

Pneumonia due to other infectious organisms, not elsewhere classified

209

506

4.69

80.82

2.5

1.8

1.57

1.47

g/l

0.66

174

437

Myocarditis

175

361

5.17

80.59

1.9

1.7

1.47

1.41

g/l

0.33

150

302

Protozoal diseases

211

523

4.72

79.96

2.5

2.0

1.53

1.52

g/l

0.04

180

467

Open wound of head

2089

12685

1.58

79.77

1.7

1.53

1.55

g/l

0.61

1790

10864

Hepatomegaly and splenomegaly, not elsewhere classified

121

10.72

79.07

2.3

1.26

1.46

g/l

0.96

108

Injuries to the hip and thigh

1981

11366

1.60

79.02

1.7

1.53

1.55

g/l

0.42

1686

9747

Other disorders of glucose regulation and pancreatic internal secretion

407

1509

2.90

78.92

2.1

1.8

1.45

1.49

g/l

0.40

363

1306

Other or unspecified ileus, impaction or obstruction

787

3877

2.12

78.76

1.7

1.6

1.69

1.55

g/l

3.57

690

3277

Acute pancreatitis

823

4126

2.09

78.69

1.9

1.7

1.61

1.54

g/l

1.21

719

3529

1543

9255

1.69

78.33

1.8

1.59

1.48

g/l

4.25

1348

7944

External causes of morbidity and mortality

2025

6350

1.63

78.17

1.8

1.49

1.48

g/l

0.15

1749

5448

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

822

4048

2.06

78.06

1.9

1.52

1.39

g/l

3.23

711

3519

Benign neoplasm of other and ill-defined parts of digestive system

777

3838

2.13

77.89

1.9

1.7

1.53

1.58

g/l

0.59

666

3318

Status post-ami

1121

4668

1.90

77.82

1.7

1.6

1.65

1.60

g/l

1.02

956

3982

Protozoal diseases, including avohilmo

212

539

4.56

77.48

2.5

2.0

1.53

1.52

g/l

0.04

181

479

Secondary uncertain malignant neoplasm

591

2631

2.37

77.10

1.8

1.6

1.70

1.54

g/l

2.77

490

2245

Diseases of the musculoskeletal system and connective tissue

1602

4744

1.72

77.08

2.0

1.7

1.47

1.42

g/l

1.34

1399

4061

Other neurological diseases

2696

14282

1.49

76.89

1.7

1.54

1.56

g/l

0.34

2310

12213

Amiodarone users

539

2333

2.51

76.54

1.9

1.7

1.42

1.55

g/l

2.66

464

2009

Arthropathies

2791

9559

1.50

75.42

1.8

1.54

1.45

g/l

4.84

2423

8215

Other viral diseases, including avohilmo

1166

6528

1.81

75.32

2.4

1.8

1.45

g/l

0.01

1038

5666

Noninfectious colitis NAS

566

2500

2.38

74.95

2.0

1.7

1.57

1.53

g/l

0.38

508

2156

Hypothyroidism, strict autoimmune

2281

9865

1.54

74.55

1.8

1.6

1.51

g/l

0.03

1942

8448

Folate deficiency anaemia

111

168

8.73

74.19

2.1

1.9

1.44

1.52

g/l

0.33

153

Elevated blood glucose level

399

1514

2.83

74.01

2.1

1.7

1.57

1.51

g/l

0.63

353

1315

COPD

1866

9702

1.61

73.66

1.6

1.7

1.69

1.55

g/l

8.93

1627

8278

Inflammatory bowel disease

1075

5990

1.85

73.61

1.7

1.8

1.51

1.50

g/l

0.11

939

5180

Cholelithiasis

2894

13727

1.46

73.49

1.9

1.7

1.50

1.54

g/l

1.41

2469

11750

Dilated cardiomyopathy

583

2648

2.36

73.42

1.8

1.7

1.53

1.54

g/l

0.07

512

2289

Benign neoplasm: Sigmoid colon

846

4410

2.02

72.89

1.7

1.62

1.57

g/l

0.64

744

3797

Need for other prophylactic measures

292

948

3.37

72.40

2.0

1.9

1.65

1.52

g/l

1.46

262

838

Immunodeficiency with predominantly antibody defects

157

330

5.43

72.36

2.8

1.9

1.42

1.46

g/l

0.18

135

297

Other respiratory diseases principally affecting the interstitium

862

4539

2.00

72.28

2.2

1.6

1.62

1.56

g/l

0.91

744

3870

Abnormal findings on examination of urine, without diagnosis

260

792

3.67

72.20

2.4

2.0

1.48

1.51

g/l

0.17

234

698

Lower back pain or/and sciatica

3657

16463

1.40

71.99

1.7

1.8

1.56

1.51

g/l

2.38

3148

14174

Other abnormal findings of blood chemistry

258

781

3.64

71.91

2.1

1.8

1.41

1.51

g/l

0.92

226

679

Congenital malformations, deformations and chromosomal abnormalities

1776

10750

1.60

71.18

2.0

1.8

1.43

1.48

g/l

1.69

1517

9347

Unspecified privation

475

1995

2.53

71.05

2.3

1.8

1.60

1.52

g/l

1.01

411

1730

Secondary thrombocytopenia

109

168

8.14

70.92

2.2

1.7

1.51

1.52

g/l

0.04

152

Colectomy operation

758

3846

2.08

70.73

1.6

1.7

1.73

1.54

g/l

6.17

664

3309

Viral pneumonia (unknown virus, not influenza)

328

1151

3.08

70.65

2.5

1.9

1.57

1.50

g/l

0.61

294

1005

Diseases of oral cavity, salivary glands and jaws

2119

7097

1.57

70.64

1.7

1.6

1.53

1.57

g/l

0.96

1813

6054

Obesity, other/unspecified

1067

6003

1.83

70.49

1.8

1.66

1.46

g/l

9.08

934

5232

Open wound of lower leg

641

3053

2.20

70.45

1.8

1.57

1.50

g/l

0.89

559

2634

Early onset COPD, excluding more controls

694

3393

2.12

70.26

1.7

1.6

1.70

1.48

g/l

7.24

613

2868

Candidiasis

580

2661

2.29

70.12

1.9

1.7

1.56

1.51

g/l

0.53

501

2291

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1970

11755

1.55

70.01

1.9

1.8

1.42

1.49

g/l

2.46

1672

10245

Misadventures to patients during surgical and medical care

602

2808

2.26

69.96

2.0

1.7

1.48

1.54

g/l

0.75

527

2424

Acute pancreatitis (for exclusion)

823

4301

2.00

69.90

1.9

1.7

1.61

1.55

g/l

1.02

719

3688

Psychiatric diseases

3238

11479

1.43

69.87

1.7

1.8

1.55

1.51

g/l

1.73

2795

9891

Injuries to the thorax

1787

11529

1.59

69.73

1.8

1.7

1.53

1.54

g/l

0.29

1553

9886

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

631

3008

2.20

69.34

1.7

1.6

1.73

1.56

g/l

3.19

529

2575

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

680

2004

2.18

69.19

2.6

2.1

1.11

1.27

g/l

5.17

605

1756

Gonarthrosis [arthrosis of knee](FG)

2374

9181

1.51

69.09

1.6

1.7

1.59

1.52

g/l

3.04

2011

7831

Chronic lower respiratory diseases

3960

15324

1.38

69.01

1.7

1.8

1.57

1.49

g/l

6.22

3449

13150

Sequelae of cerebrovascular disease

1561

8339

1.65

68.84

1.9

1.7

1.60

1.56

g/l

0.74

1324

7088

Complications of internal orthopaedic prosthetic devices, implants and grafts

941

5180

1.89

68.05

1.7

1.6

1.66

1.57

g/l

2.03

777

4419

Pyogenic arthritis

327

1171

3.01

67.86

1.9

1.8

1.75

1.48

g/l

4.02

281

1020

Other chronic obstructive pulmonary disease

1786

9445

1.59

67.84

1.6

1.7

1.70

1.55

g/l

9.68

1556

8058

Microscopic polyangiitis

102

12.59

67.79

2.5

2.3

1.70

1.52

g/l

0.67

Crohn disease

482

2077

2.43

67.41

1.8

1.56

1.49

g/l

0.82

427

1810

Acute upper respiratory infections of multiple and unspecified sites

2548

12839

1.47

67.41

2.0

1.7

1.50

g/l

0.14

2213

11052

Other dorsopathies, not elsewhere classified

3281

12184

1.42

67.28

1.7

1.8

1.53

1.49

g/l

1.62

2816

10476

Zoster [herpes zoster], including avohilmo

1939

12384

1.55

67.09

1.9

1.7

1.52

1.55

g/l

0.88

1684

10584

Other obstetric conditions, not elsewhere classified

684

2054

2.14

66.72

2.6

2.1

1.11

1.27

g/l

5.54

609

1798

Immunodeficiencies

234

704

3.64

65.73

2.4

1.8

1.42

1.52

g/l

0.72

200

620

Concussion

1541

7461

1.63

65.70

1.7

1.8

1.51

1.47

g/l

0.71

1301

6448

Viral pneumonia (known virus, not influenza)

189

498

4.35

65.62

2.5

1.9

1.50

1.49

g/l

0.06

172

446

Other and unspecified coagulation defects

230

684

3.65

65.44

3.2

1.8

1.33

1.52

g/l

2.35

205

613

Renal tubulo-interstitial disorders in diseases classified elsewhere

114

9.72

65.41

2.9

1.7

1.57

1.36

g/l

1.23

103

Hypocalcemia

162

384

4.92

65.04

2.2

2.0

1.63

1.51

g/l

0.71

145

343

Hypoglycaemia, other or unspecified

320

1159

2.97

65.00

2.2

1.8

1.42

1.52

g/l

1.02

283

1010

Anxiety disorders, excluding more controls

2532

11197

1.47

64.66

1.9

1.8

1.49

1.50

g/l

0.12

2199

9669

Biological medication for rheuma

570

2681

2.20

64.10

1.6

1.8

1.58

1.47

g/l

1.70

487

2327

Dysphagia

991

5631

1.82

64.05

1.8

1.6

1.53

1.57

g/l

0.66

840

4825

Personality disorders, excluding more controls

701

3551

2.02

63.47

1.8

1.9

1.54

1.40

g/l

3.41

614

3091

All influenza (not pneumonia)

515

2340

2.29

63.28

2.1

1.6

1.51

1.46

g/l

0.65

447

1996

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

379

1512

2.66

63.23

2.0

1.8

1.65

1.52

g/l

1.43

333

1323

Other coagulation defects

322

1186

2.90

63.14

2.7

1.8

1.38

1.53

g/l

2.18

284

1040

Poisoning by drugs, medicaments and biological substances

724

3737

2.00

62.89

1.7

1.9

1.58

1.45

g/l

3.18

620

3253

Benign neoplasm: Ascending colon

647

3244

2.11

62.75

1.8

1.7

1.59

1.57

g/l

0.25

573

2789

Mycoses, including avohilmo

3060

16865

1.40

62.60

1.7

1.8

1.52

1.51

g/l

0.22

2642

14533

Diabetic maculopathy

627

2940

2.16

62.54

2.1

1.8

1.58

1.61

g/l

0.35

566

2560

Any operation in hilmo

14.72

62.48

2.4

1.3

1.46

1.03

g/l

1.64

Diseases of spleen

138

299

5.50

62.26

2.7

1.9

1.25

1.51

g/l

2.06

114

273

Drug-induced cataract

149

342

5.02

62.06

2.1

2.0

1.45

1.51

g/l

0.31

132

304

Colorectal cancer, including Hilmo

1028

5545

1.79

61.68

1.5

1.6

1.75

1.58

g/l

7.00

897

4718

Mood disorders

3303

15466

1.38

61.11

1.8

1.52

g/l

0.03

2867

13312

Substance use, excluding alcohol

634

3159

2.07

61.09

1.7

1.9

1.64

1.47

g/l

4.05

544

2744

Thoracic aortic aneurysm

637

3207

2.10

60.91

1.8

1.7

1.45

1.52

g/l

1.02

506

2747

Other hereditary haemolytic anaemias

12.28

60.88

4.3

1.5

0.75

1.53

g/l

6.47

Acidosis

147

340

5.03

60.84

2.1

2.0

1.61

1.53

g/l

0.44

138

298

Primary Sclerosing Cholangitis, IBD and UDCA required

126

254

5.61

60.83

2.0

1.16

1.44

g/l

2.76

109

229

Other arthrosis

1727

7522

1.57

60.82

1.6

1.7

1.54

1.53

g/l

0.26

1485

6426

Polyarthrosis

758

3606

1.96

60.80

1.6

1.7

1.59

1.57

g/l

0.22

657

3059

Mood [affective] disorders

3292

15452

1.38

60.67

1.8

1.52

g/l

0.01

2860

13297

Other diseases of stomach and duodenum

311

1153

2.91

60.60

1.9

1.7

1.54

1.57

g/l

0.21

275

986

Depression or dysthymia

2207

8195

1.50

60.20

1.7

1.8

1.53

1.52

g/l

0.24

1890

7078

Unspecified nephritic syndrome

144

330

5.04

60.17

2.4

2.0

1.60

1.57

g/l

0.14

128

296

Viral and other specified intestinal infections, including avohilmo

824

4325

1.88

59.73

2.2

1.8

1.48

1.39

g/l

2.04

730

3751

Acquired pure red cell aplasia [erythroblastopenia]

17.52

59.24

2.9

2.0

1.31

1.42

g/l

0.31

Diseases of pulp and periapical tissues and dental caries

2359

8356

1.47

58.78

1.7

1.54

1.55

g/l

0.19

2028

7111

Depression

3002

14592

1.39

58.55

1.8

1.51

g/l

0.16

2605

12568

Other pleural conditions

523

2491

2.24

58.55

2.0

1.7

1.66

1.54

g/l

1.72

454

2128

Disorders of eyelid, lacrimal system and orbit

2960

15786

1.39

58.46

1.7

1.50

1.54

g/l

1.52

2559

13547

COPD related to multimorbidity

1669

9319

1.56

57.93

1.6

1.7

1.70

1.54

g/l

10.30

1453

7932

Drug-induced osteoporosis with pathological fracture

129

282

5.52

57.84

1.8

1.9

1.67

1.56

g/l

0.47

111

248

Benign neoplasm: Stomach

446

2001

2.38

57.83

1.8

1.7

1.54

1.57

g/l

0.25

381

1722

Polycythaemia vera

197

581

3.80

57.71

1.9

1.5

0.98

1.55

g/l

17.15

173

510

Visual disturbances and blindness

1846

12480

1.51

57.57

1.8

1.7

1.53

1.54

g/l

0.13

1586

10717

Nerve, nerve root and plexus disorders

3558

15961

1.36

57.43

1.7

1.8

1.55

1.52

g/l

0.97

3117

13654

Malignant neoplasm of colon, including Hilmo

747

4017

1.93

57.39

1.5

1.6

1.77

1.57

g/l

7.42

645

3420

Primary biliary cholangitis, wide definition

129

279

5.22

57.39

1.8

1.5

1.17

1.48

g/l

3.02

109

242

Wegener granulomatosis

113

221

6.12

57.33

3.0

2.0

1.76

1.46

g/l

1.85

202

Other chronic obstructive pulmonary disease, including avohilmo

2086

11836

1.48

57.21

1.6

1.7

1.70

1.55

g/l

11.31

1802

10135

Other nonautoimmune haemolytic anaemias

38.24

57.21

7.3

1.5

0.66

1.79

g/l

6.89

Poisoning by medicine

647

3321

2.01

57.21

1.7

1.9

1.57

1.45

g/l

2.44

554

2892

Other/unspecified dorsalgia

1273

7849

1.64

57.04

1.9

1.7

1.57

1.51

g/l

1.68

1101

6726

Dental caries, including avohilmo

2571

9290

1.44

57.02

1.7

1.53

1.55

g/l

0.44

2213

7925

Dental operations

2204

7776

1.48

57.00

1.7

1.53

1.57

g/l

1.12

1888

6654

Aortic aneurysm

991

5715

1.77

56.99

1.8

1.7

1.50

1.51

g/l

0.16

808

4853

Other nutritional anaemias

146

7.75

56.91

3.4

2.0

1.37

1.51

g/l

0.74

132

Caries of dentine, including avohilmo

2727

9945

1.42

56.85

1.8

1.7

1.53

1.54

g/l

0.16

2350

8506

Acute sinusitis

1579

9382

1.56

56.83

2.0

1.8

1.50

1.49

g/l

0.26

1354

8136

Gingivitis and periodontal diseases

3312

12603

1.38

56.81

1.8

1.7

1.51

1.54

g/l

1.22

2846

10824

Diffuse large B-cell lymphoma

256

892

3.15

56.51

1.8

1.6

1.70

1.54

g/l

1.34

209

771

Diffuse large B-cell lymphoma, helper endpoint

256

892

3.15

56.51

1.8

1.6

1.70

1.54

g/l

1.34

209

771

Diffuse large B-cell lymphoma, including Hilmo

256

892

3.15

56.51

1.8

1.6

1.70

1.54

g/l

1.34

209

771

Weight loss

463

2127

2.31

56.47

1.7

1.8

1.47

1.54

g/l

0.92

408

1838

Amputation of ankle bones

158

411

4.47

56.22

2.4

1.9

1.91

1.50

g/l

4.16

139

367

Obesity related asthma

1166

7162

1.67

56.20

1.8

1.7

1.68

1.52

g/l

6.55

1012

6165

Complications of cardiac and vascular prosthetic devices, implants and grafts

152

385

4.62

56.16

3.5

1.8

1.57

1.51

g/l

0.25

131

343

Undetermined asthma, excluding more controls

404

1742

2.40

55.91

1.7

1.6

1.67

1.46

g/l

4.03

356

1487

5-aminosalicylic acid

636

3272

2.00

55.82

1.8

1.6

1.42

1.46

g/l

0.58

550

2818

Spondyloarthritis

629

3231

2.02

55.80

1.7

1.57

1.51

g/l

0.83

544

2771

Other joint disorders

2581

9544

1.43

55.49

1.8

1.50

1.45

g/l

2.01

2210

8204

Problems related to lifestyle

370

1547

2.50

55.34

1.8

1.59

1.47

g/l

1.75

320

1331

Arthrosis

2190

8283

1.47

55.27

1.6

1.7

1.59

1.51

g/l

3.45

1868

7066

Autoimmune hepatitis, wide definition

198

597

3.57

55.08

1.9

1.5

1.36

1.55

g/l

1.94

173

518

Fracture of rib(s), sternum and thoracic spine

1219

7624

1.65

55.07

1.8

1.7

1.55

g/l

0.04

1056

6535

Nonalcoholic fatty liver disease

380

1617

2.47

55.01

1.8

1.44

1.54

g/l

1.31

331

1400

Anxiety (asthma-related co-morbidities)

1650

8291

1.54

54.60

1.8

1.9

1.47

1.46

g/l

0.10

1455

7183

Other and unspecified local infections of skin and subcutaneous tissue

409

1806

2.39

54.58

1.9

1.8

1.68

1.50

g/l

2.92

367

1564

Other infectious diseases, including avohilmo

412

1831

2.39

54.45

2.0

1.7

1.75

1.51

g/l

4.59

358

1570

Other disorders of veins

1361

8594

1.59

54.37

1.7

1.48

1.57

g/l

3.18

1165

7340

Thrombotic microangiopathy

11.24

54.34

9.6

1.8

1.34

1.45

g/l

0.32

Other/unspecified rheumatoid arthritis

521

2541

2.16

54.33

1.5

1.7

1.64

1.56

g/l

0.92

442

2178

COPD, hospital admission 2, with asthma infections

1370

7576

1.61

54.25

1.6

1.7

1.73

1.54

g/l

11.68

1193

6441

Invasive ventilation

339

1386

2.62

54.24

2.0

1.8

1.64

1.50

g/l

1.61

293

1195

Other infectious diseases

362

1527

2.54

54.12

2.0

1.7

1.77

1.51

g/l

4.65

316

1311

COPD, hospital admissions 3, with asthma pneumonia sepsis

1205

6444

1.66

54.08

1.6

1.7

1.75

1.54

g/l

12.88

1048

5465

Unspecified jaundice

262

947

3.00

53.84

2.0

1.7

1.16

1.48

g/l

6.38

227

812

Suppurative and necrotic conditions of lower respiratory tract

294

1132

2.83

53.69

1.6

1.8

1.80

1.51

g/l

4.25

254

984

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

199

608

3.42

53.41

2.8

1.7

1.26

1.44

g/l

2.29

175

522

Benign neoplasm: Transverse colon

500

2427

2.19

53.21

1.8

1.7

1.56

g/l

0.01

442

2101

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

822

4657

1.81

53.09

1.9

1.52

1.42

g/l

2.42

711

4064

Colorectal cancer

913

5124

1.77

53.05

1.5

1.6

1.75

1.57

g/l

6.94

794

4351

Diabetic neuropathy

606

3155

2.05

52.95

1.9

1.8

1.61

1.62

g/l

0.02

549

2730

Isolated proteinuria with specified morphological lesion

172

6.81

52.73

2.6

2.1

1.67

1.57

g/l

0.33

157

Fracture of femur

1185

6686

1.65

52.66

1.7

1.55

1.58

g/l

0.61

1001

5706

Episodal and paroxysmal disorders

3465

13180

1.35

52.65

1.8

1.50

g/l

0.04

2951

11378

Hypercalcemia

244

864

3.12

52.61

2.0

1.8

1.70

1.56

g/l

1.31

215

753

Diseases of the myoneural junction and muscle

529

2628

2.12

52.48

1.7

1.66

1.54

g/l

2.13

445

2259

Other inflammatory liver diseases

285

1088

2.81

52.37

1.9

1.8

1.45

1.58

g/l

1.33

247

954

Duodenal ulcer

485

2336

2.19

52.26

1.7

1.54

1.57

g/l

0.32

426

1987

Other specified/unspecified systemic involvement of connective tissue

240

838

3.07

52.19

2.4

1.8

1.49

1.54

g/l

0.32

217

734

Other local infections of skin and subcutaneous tissue

423

1930

2.31

52.15

1.9

1.8

1.68

1.50

g/l

3.11

378

1666

Abnormal weight loss

430

1985

2.30

51.96

1.7

1.8

1.48

1.54

g/l

0.73

379

1721

Gonarthrosis

2010

7817

1.48

51.94

1.6

1.7

1.60

1.53

g/l

2.52

1696

6656

Other complications of surgical and medical care, not elsewhere classified

374

1621

2.43

51.94

1.9

1.7

1.59

1.52

g/l

0.69

315

1412

Explicit fungal Sepsis

100

9.50

51.93

2.1

1.8

1.66

1.39

g/l

1.04

Neurological diseases

2555

9180

1.42

51.85

1.8

1.48

1.49

g/l

0.12

2220

7927

Benign neoplasm: Rectum

750

4197

1.87

51.82

1.6

1.7

1.57

1.58

g/l

0.08

653

3618

COPD, early/later onset

1806

10410

1.49

51.58

1.6

1.7

1.70

1.55

g/l

10.01

1572

8890

Collagenous colitis

380

1668

2.41

51.53

1.8

1.62

1.55

g/l

0.77

335

1447

Explicit fungal Sepsis, including avohilmo

101

9.37

51.46

2.1

1.8

1.66

1.39

g/l

1.08

Other anxiety disorders

1280

6928

1.60

51.40

1.9

1.45

1.44

g/l

0.16

1127

6019

Sulfonylureas

1394

7211

1.58

51.25

1.6

1.7

1.75

1.51

g/l

18.12

1234

6090

Seropositive rheumatoid arthritis, strict definition

559

2850

2.05

51.21

1.5

1.7

1.61

1.56

g/l

0.53

485

2452

Cholangitis (primary sclerosing, PSC)

303

1208

2.70

51.20

1.9

1.8

1.43

1.50

g/l

0.58

257

1042

ILD, hospital admissions

687

3765

1.92

51.12

2.2

1.6

1.60

1.56

g/l

0.49

591

3233

Benign neoplasm: Rectum, anus and anal canal

819

4722

1.81

50.96

1.7

1.57

g/l

0.04

707

4052

Malignant neoplasm of colon

620

3281

1.97

50.90

1.4

1.6

1.76

1.56

g/l

5.92

537

2798

Other and unspecified drugs and medicaments

354

1516

2.47

50.85

2.0

1.9

1.61

1.53

g/l

0.70

312

1321

Other renal tubulo-interstitial diseases

110

229

5.28

50.80

2.9

1.8

1.60

1.36

g/l

1.58

101

199

Alcohol dependence

933

5565

1.73

50.67

1.5

1.8

1.58

1.53

g/l

1.01

803

4805

Abnormalities of gait and mobility

554

2838

2.06

50.66

1.6

1.8

1.63

1.54

g/l

1.26

496

2450

Diseases of pulp and periapical tissues, including avohilmo

3429

13368

1.34

50.63

1.7

1.8

1.53

1.50

g/l

0.87

2947

11496

In situ neoplasms

1475

9830

1.54

50.04

1.8

1.7

1.50

1.55

g/l

1.41

1297

8406

COPD, hospital admissions

1781

10351

1.49

49.72

1.6

1.7

1.70

1.55

g/l

10.07

1548

8836

Other interstitial pulmonary diseases

693

3842

1.89

49.65

2.2

1.6

1.61

1.57

g/l

0.54

597

3290

Cholangitis (primary sclerosing, PSC), with reimbursement 202

110

237

5.28

49.34

2.2

1.27

1.46

g/l

1.13

213

Injury, poisoning and certain other consequences of external causes

1576

5199

1.54

49.21

1.8

1.50

1.47

g/l

0.53

1379

4438

Interstitial lung disease endpoints

693

3853

1.89

49.20

2.2

1.6

1.61

1.57

g/l

0.51

597

3305

Interstitial lung disease

693

3853

1.89

49.20

2.2

1.6

1.61

1.57

g/l

0.51

597

3305

Injuries to the knee and lower leg

3850

16026

1.31

49.17

1.7

1.8

1.54

1.50

g/l

1.79

3349

13753

Degeneration of macula and posterior pole

1917

10343

1.46

49.11

1.6

1.7

1.54

1.59

g/l

1.28

1628

8796

Malignant neoplasm of urinary organs, including Hilmo

474

2320

2.15

48.91

1.7

1.6

1.86

1.55

g/l

8.17

405

1991

Other diseases of pancreas

380

1712

2.36

48.79

1.8

1.7

1.52

1.56

g/l

0.29

340

1487

Ulcerative colitis

781

4480

1.79

48.68

1.8

1.51

1.50

g/l

0.11

677

3880

Hernia of abdominal wall

1608

10968

1.50

48.51

1.7

1.58

1.54

g/l

0.86

1402

9442

Fracture of lower leg, including ankle

1789

12201

1.46

48.41

1.7

1.8

1.63

1.53

g/l

3.74

1550

10460

Fracture of shoulder and upper arm

1272

8252

1.58

48.41

1.8

1.7

1.52

1.55

g/l

0.65

1096

7099

Exposure to other specified factors

2542

16036

1.38

48.39

1.9

1.8

1.55

1.50

g/l

1.79

2215

13812

Transient ischemic attack

1952

10939

1.45

48.37

1.6

1.7

1.55

1.58

g/l

0.77

1660

9330

Acute upper respiratory infections

3443

15732

1.33

48.26

1.9

1.7

1.52

g/l

0.10

2972

13506

Delirium, not induced by alcohol and other psychoactive substances

613

3297

1.95

48.12

1.6

1.7

1.57

1.54

g/l

0.28

511

2849

Other diseases of hard tissues of teeth

1948

6992

1.47

47.99

1.7

1.6

1.49

1.57

g/l

2.92

1667

5973

Superficial injury of head

895

5353

1.72

47.90

1.7

1.8

1.49

1.55

g/l

1.15

777

4619

Viral and other specified intestinal infections

607

3154

1.92

47.79

2.4

1.9

1.45

1.37

g/l

1.06

532

2739

IBD patients in KELA-register

695

3878

1.84

47.54

1.8

1.45

1.48

g/l

0.39

616

3377

Other Crohn's disease

248

924

2.83

47.39

1.7

2.0

1.55

1.47

g/l

0.63

220

814

Vascular diseases of the intestine

219

777

3.10

46.93

2.2

1.8

1.59

1.49

g/l

0.77

189

667

Nonhereditary hypogammaglobulinemia

133

7.11

46.87

2.9

2.1

1.40

1.51

g/l

0.38

124

Tumor necrosis factor alpha inhibitors

478

2373

2.08

46.69

1.5

1.8

1.55

1.46

g/l

1.16

412

2062

Neurotic, stress-related and somatoform disorders

2630

13387

1.37

46.65

1.9

1.8

1.49

1.51

g/l

0.55

2288

11571

Polyuria

879

5311

1.71

45.86

1.7

1.52

1.54

g/l

0.23

740

4586

Alcohol-induced chronic pancreatitis

281

1146

2.63

45.32

1.8

1.57

1.53

g/l

0.34

246

990

Crohn's disease of small intestine

254

982

2.73

45.20

1.7

1.9

1.60

1.48

g/l

1.11

228

869

Crohn's disease NAS

245

932

2.78

45.11

1.8

1.9

1.54

1.50

g/l

0.31

215

829

Ventral hernia

867

5236

1.71

45.11

1.8

1.7

1.59

1.57

g/l

0.32

750

4486

Artificial opening status

253

984

2.77

45.08

1.8

1.7

1.81

1.56

g/l

3.14

226

851

Other disorders of lacrimal gland

1207

7878

1.57

45.00

1.8

1.7

1.51

1.55

g/l

0.86

1046

6747

Disorders of oesophagus in diseases classified elsewhere

139

386

4.12

44.98

2.0

1.9

1.75

1.63

g/l

0.60

124

338

Anxiety disorders

2654

13550

1.36

44.92

1.9

1.8

1.49

1.51

g/l

0.56

2305

11704

Barrett oesophagus

249

965

2.80

44.90

1.7

1.8

1.68

1.54

g/l

1.31

219

826

Polymyalgia rheumatica

594

3242

1.92

44.81

1.8

1.6

1.84

1.56

g/l

8.65

506

2771

Type 1 diabetes, definitions combined

258

1003

2.66

44.54

2.4

1.9

1.24

1.34

g/l

1.12

235

873

Injuries to the shoulder and upper arm

2825

16447

1.34

44.52

1.8

1.7

1.53

1.54

g/l

0.15

2449

14100

Sleep disorders (combined)

3576

14426

1.31

44.51

1.8

1.53

1.51

g/l

0.84

3072

12423

ILD, hospital admissions 1, main diag only

604

3323

1.91

44.50

2.3

1.7

1.62

1.56

g/l

0.61

523

2862

Intestinal adhesions without obstruction

346

1554

2.35

44.44

1.9

1.7

1.60

1.54

g/l

0.44

294

1332

Secondary right heart disease

229

858

2.93

44.43

2.1

1.8

1.30

1.53

g/l

3.20

201

740

Other viral diseases, not elsewhere classified

576

3091

1.91

44.34

2.3

1.7

1.47

1.46

g/l

0.07

510

2669

Intestinal malabsorption

204

715

3.07

44.22

1.8

2.0

1.43

1.55

g/l

1.05

183

626

Failed induction of labour

170

531

3.34

44.16

2.4

2.2

1.02

1.23

g/l

3.14

155

468

Type 1 diabetes, strict (exclude DM2)

256

996

2.65

44.15

2.4

1.9

1.24

1.34

g/l

1.22

233

868

Familial hypercholesterolemia

578

3136

1.92

44.00

1.7

1.6

1.68

1.56

g/l

2.16

480

2673

Abnormal findings on diagnostic imaging of other body structures

531

2803

1.97

43.93

1.9

1.7

1.64

1.56

g/l

0.95

465

2442

Other intervertebral disc disorders

2601

11509

1.36

43.92

1.6

1.8

1.57

1.51

g/l

2.72

2254

9889

Late syphilis, including avohilmo

109

258

4.89

43.90

2.0

1.65

1.50

g/l

0.87

100

233

Soft tissue disorders related to use, overuse and pressure

923

5695

1.66

43.86

1.7

1.55

1.56

g/l

0.03

806

4903

Leukaemia of unspecified cell type

159

6.50

43.60

1.7

2.1

1.58

1.46

g/l

0.39

143

Shoulder lesions

2400

10566

1.38

43.37

1.7

1.59

1.54

g/l

1.50

2068

9029

Dorsopathies

3167

12213

1.33

43.35

1.8

1.53

1.49

g/l

1.42

2737

10501

Tubulo-interstitial nephritis, not specified as acute or chronic

252

991

2.68

43.30

1.8

1.6

1.65

1.44

g/l

3.02

216

828

Inflammatory bowel disease, strict (require KELA)

695

3988

1.79

43.28

1.8

1.45

1.48

g/l

0.41

616

3480

Spondylopathies (FG)

408

1967

2.14

43.19

1.7

1.54

1.45

g/l

1.16

348

1701

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

548

2913

1.95

43.17

2.0

1.5

1.45

1.55

g/l

1.70

473

2481

Dependence on enabling machines and devices, not elsewhere classified

154

6.27

43.14

3.2

1.7

1.37

1.48

g/l

0.45

139

Psoriatic and enteropathic arthropathies

367

1702

2.24

43.08

1.5

1.7

1.59

1.48

g/l

1.40

312

1472

Other metabolic disorders

395

1885

2.17

42.97

2.0

1.7

1.46

1.50

g/l

0.38

354

1622

Visual disturbances

1629

11396

1.46

42.91

1.8

1.7

1.51

1.53

g/l

0.32

1407

9793

Intracranial injury

1966

13212

1.41

42.79

1.7

1.8

1.51

1.53

g/l

0.54

1662

11354

Disorders of lacrimal system

1438

9665

1.49

42.74

1.7

1.50

1.55

g/l

1.24

1238

8274

Special screening examination for infectious and parasitic diseases

557

2140

1.93

42.66

2.0

1.8

1.26

1.41

g/l

3.37

492

1851

Lung transplantation

110

7.83

42.48

2.3

2.1

1.49

1.50

g/l

0.03

100

All anxiety disorders

1676

9080

1.45

42.41

1.8

1.46

1.47

g/l

0.10

1474

7874

Nonorganic sleeping disorders, excluding more controls

585

3205

1.87

42.41

1.9

1.8

1.46

1.43

g/l

0.43

510

2782

Diabetes mellitus in pregnancy

627

2166

1.87

42.35

2.5

2.0

1.21

1.33

g/l

2.60

562

1898

Pruritus

422

2083

2.11

42.30

1.9

1.7

1.55

1.50

g/l

0.47

360

1799

Pyothorax

224

851

2.87

42.18

1.6

1.9

1.82

1.52

g/l

3.58

196

739

Recurrent or chronic depression

1075

4736

1.60

42.15

1.7

1.9

1.50

1.48

g/l

0.26

934

4111

Functional dyspepsia

812

4898

1.70

42.07

1.8

1.7

1.53

1.55

g/l

0.19

697

4199

Acquired absence of limb

160

6.23

41.98

1.8

1.6

1.90

1.56

g/l

1.69

146

Undetermined asthma

404

1962

2.12

41.83

1.7

1.6

1.67

1.46

g/l

4.11

356

1666

Other and unspecified immunodeficiencies with predominantly antibody defects

148

6.22

41.79

2.8

2.5

1.38

1.43

g/l

0.12

133

Asthma, hospital admissions , main diagnosis only

2572

16873

1.34

41.35

1.7

1.8

1.59

1.50

g/l

5.42

2229

14491

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

403

1980

2.14

41.27

1.7

1.6

1.86

1.55

g/l

6.56

350

1699

Sleep apnoea

2996

14463

1.32

41.21

1.8

1.7

1.59

1.53

g/l

2.69

2565

12487

Non-allergic asthma (mode), excluding more controls

507

2653

1.94

41.12

1.6

1.63

1.45

g/l

4.36

441

2247

Bipolar affective disorders

510

2705

1.93

40.99

1.8

1.53

1.43

g/l

1.61

440

2349

Late syphilis

214

5.22

40.90

2.1

1.9

1.62

1.50

g/l

0.61

193

Malignant neoplasm of urinary organs

397

1950

2.14

40.70

1.7

1.6

1.86

1.56

g/l

6.02

342

1673

Squamous cell neoplasms and carcinomas of the skin

454

2342

2.04

40.59

1.9

1.5

1.47

1.54

g/l

0.83

389

1991

Other and unspecified myopathies

393

1930

2.15

40.57

1.6

1.7

1.65

1.54

g/l

1.42

327

1652

Unspecified acute lower respiratory infection

552

3026

1.89

40.48

2.0

1.7

1.61

1.51

g/l

1.57

488

2597

Abnormal serum enzyme levels

1179

7572

1.55

40.47

1.7

1.51

1.53

g/l

0.33

1041

6492

Congenital malformations of heart and great arteries

416

2010

2.08

40.37

1.9

1.28

1.49

g/l

4.14

316

1749

Disorders of continuity of bone

337

1554

2.26

40.31

1.7

1.8

1.55

1.50

g/l

0.42

294

1360

Ulcerative colitis, NAS

446

2285

2.02

40.10

1.8

1.7

1.55

1.50

g/l

0.51

390

1978

Non-selective monoamine reuptake inhibitors

1190

7604

1.53

40.09

1.5

1.8

1.65

1.55

g/l

3.03

1016

6495

Amyloidosis

136

401

3.81

40.08

1.9

2.0

1.53

g/l

0.00

120

351

Other pulmonary heart/vessel disease

240

968

2.70

40.07

2.1

1.8

1.30

1.53

g/l

3.49

212

836

Chronic hepatitis, not elsewhere classified

156

498

3.40

39.96

1.9

2.0

1.18

1.56

g/l

5.29

139

445

Chronic myeloid leukaemia, including Hilmo

116

7.05

39.90

1.8

1.23

1.50

g/l

1.41

106

Deforming dorsopathies

881

5498

1.64

39.85

1.9

1.8

1.57

1.53

g/l

0.76

771

4745

Covid-19 suspected case

621

3536

1.80

39.72

2.0

1.8

1.54

1.44

g/l

1.98

561

3036

1642

10492

1.44

39.67

1.8

1.6

1.48

1.60

g/l

5.62

1418

8920

Spondylosis

1789

10022

1.42

39.50

1.6

1.7

1.61

1.55

g/l

1.62

1547

8578

Epilepsy

1031

6670

1.58

39.46

1.8

1.7

1.52

g/l

0.00

867

5737

Pneumonia derived septicemia

171

582

3.20

39.39

2.2

2.0

1.69

1.47

g/l

1.85

149

514

Crohn disease (strict definition, require KELA, min 2 HDR)

222

861

2.72

39.30

1.6

2.0

1.46

1.44

g/l

0.11

196

765

Personality disorders

701

4140

1.73

39.20

1.8

1.9

1.54

1.43

g/l

2.25

614

3612

Primary biliary cholangitis (PBC)

104

257

4.46

39.02

1.7

1.5

1.24

1.50

g/l

2.03

219

Other viral hepatitis

201

745

2.83

38.82

1.9

2.0

1.42

1.45

g/l

0.14

168

662

Diagnoses used for exclusion with ILD

924

5887

1.61

38.76

1.8

1.7

1.59

1.55

g/l

0.69

776

5035

COPD-related respiratory insufficiency

524

2883

1.91

38.66

1.7

1.69

1.55

g/l

3.09

464

2469

Skin changes due to chronic exposure to nonionizing radiation

1575

10107

1.45

38.63

1.8

1.6

1.47

1.60

g/l

6.10

1366

8597

Abnormal results of function studies

323

1494

2.26

38.54

1.7

1.8

1.44

1.50

g/l

0.55

262

1305

Crohn disease (strict definition, require KELA)

223

876

2.68

38.46

1.6

2.0

1.46

1.44

g/l

0.07

197

776

Other and unspecified types of non-Hodgkin lymphoma, hilmo

213

828

2.81

38.44

2.3

1.7

1.53

1.54

g/l

0.06

178

724

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

13.06

38.33

3.2

1.8

1.55

1.68

g/l

0.27

Disorders of sclera, cornea, iris and ciliary body

1731

12492

1.41

38.09

1.9

1.7

1.52

1.53

g/l

0.20

1519

10746

Actinic keratosis

1544

9949

1.45

38.08

1.8

1.6

1.46

1.60

g/l

7.19

1339

8461

Colon adenocarcinoma

482

2592

1.94

37.89

1.5

1.6

1.74

1.55

g/l

4.42

416

2219

Acute gastritis

296

1334

2.34

37.83

1.6

1.7

1.49

1.56

g/l

0.63

257

1141

Persons with potential health hazards related to communicable diseases

957

6097

1.58

37.81

2.2

1.9

1.45

1.41

g/l

0.67

833

5349

Sciatica+with lumbago

1597

10042

1.43

37.81

1.6

1.7

1.59

1.52

g/l

2.02

1394

8644

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

232

939

2.59

37.58

1.6

2.0

1.46

1.44

g/l

0.11

205

833

Arterial embolism and thrombosis

268

1165

2.45

37.53

2.0

1.7

1.76

1.50

g/l

4.11

234

984

Left bundle-branch block

267

1154

2.43

37.47

1.6

1.5

1.52

1.59

g/l

0.58

224

985

Haemorrhoids and perianal venous thrombosis

1086

7165

1.53

37.18

1.7

1.6

1.51

1.54

g/l

0.49

948

6082

Myalgia

714

4304

1.70

37.13

1.7

1.53

1.50

g/l

0.28

611

3712

Open wound of ankle and foot

375

1862

2.10

37.10

1.9

1.8

1.63

1.49

g/l

1.84

331

1621

Disorders of adult personality and behaviour

727

4399

1.69

37.09

1.8

1.9

1.52

1.42

g/l

2.01

634

3847

Irritable bowel syndrome

753

4599

1.67

37.09

1.8

1.48

1.49

g/l

0.07

651

3939

Infection of intervertebral disc (pyogenic)

100

254

4.62

37.03

1.9

2.0

1.70

1.56

g/l

0.72

228

Colorectal adenocarcinoma

739

4451

1.69

37.03

1.5

1.6

1.73

1.57

g/l

4.86

641

3785

Marginal zone B-cell lymphoma, including Hilmo

244

4.60

36.92

3.6

1.7

1.39

1.53

g/l

0.69

213

Benign neoplasm: Caecum

462

2484

1.96

36.77

1.6

1.7

1.59

1.56

g/l

0.33

416

2146

Amyloidosis, other/unspecified

115

322

4.05

36.77

2.0

2.1

1.56

1.54

g/l

0.05

105

282

Congenital malformations of the circulatory system

451

2317

1.95

36.75

2.0

1.8

1.25

1.50

g/l

6.50

353

2022

Postprocedural endocrine and metabolic disorders, not elsewhere classified

352

1710

2.12

36.61

2.1

1.8

1.47

1.50

g/l

0.25

316

1470

Suicide or other Intentional self-harm

671

3994

1.72

36.60

1.7

1.8

1.62

1.46

g/l

3.62

572

3473

Syphilis

131

398

3.63

36.59

1.9

2.0

1.50

1.52

g/l

0.08

120

357

Syphilis, including avohilmo

131

398

3.63

36.59

1.9

2.0

1.50

1.52

g/l

0.08

120

357

Gingival hyperplasia

167

586

3.09

36.38

2.9

1.9

1.53

1.51

g/l

0.07

151

519

Sequelae of other external causes

232

958

2.57

36.30

1.7

1.9

1.62

1.52

g/l

0.77

209

831

Symptoms and signs involving the nervous and musculoskeletal systems

1905

14068

1.38

36.30

1.6

1.7

1.56

1.53

g/l

0.74

1649

12070

Shock, not elsewhere classified

127

6.28

36.18

2.4

1.6

1.55

1.40

g/l

0.49

109

Other viral diseases, not elsewhere classified, including avohilmo

735

4464

1.67

36.09

2.2

1.8

1.44

1.45

g/l

0.11

646

3858

Psoriasis

904

5819

1.59

36.08

1.7

1.60

1.54

g/l

1.12

779

5028

Other viral hepatitis, including avohilmo

207

809

2.68

35.99

1.9

2.0

1.42

1.44

g/l

0.14

173

715

Adrenocortical insufficiency

157

536

3.16

35.82

1.8

1.9

1.66

1.51

g/l

0.98

137

479

Superficial injury of lower leg

812

5104

1.63

35.77

1.8

1.49

1.50

g/l

0.06

703

4392

Malignant neoplasm of kidney, except renal pelvis

356

1770

2.11

35.40

1.7

1.6

1.85

1.56

g/l

5.25

308

1523

Other diseases of the respiratory system

805

5085

1.63

35.31

1.8

1.7

1.69

1.54

g/l

3.84

681

4329

Other respiratory disorders and diseases

805

5085

1.63

35.31

1.8

1.7

1.69

1.54

g/l

3.84

681

4329

Phlebitis and thrombophlebitis (not including DVT)

749

4640

1.66

35.30

2.1

1.7

1.64

1.57

g/l

1.00

669

3982

Selective serotonin reuptake inhibitors

3099

12593

1.29

35.24

1.6

1.8

1.55

1.50

g/l

1.84

2622

10845

Injuries to unspecified part of trunk, limb or body region

390

2005

2.03

35.13

2.0

1.8

1.51

g/l

0.02

347

1733

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

306

1445

2.23

34.96

2.0

1.8

1.48

1.53

g/l

0.38

280

1257

Disorders of magnesium metabolism

118

6.63

34.90

1.5

2.4

1.56

1.54

g/l

0.05

104

Fentanyl

393

2027

2.01

34.71

1.7

1.6

1.87

1.51

g/l

7.60

329

1740

Ulcer of oesophagus

296

1391

2.26

34.42

1.6

1.7

1.61

1.55

g/l

0.46

254

1200

Type 1 diabetes, strict definition, subgroup 1

176

644

2.82

34.37

2.2

2.0

1.18

1.25

g/l

0.55

159

567

Sicca syndrome [Sjögren]

290

1347

2.25

34.34

1.9

1.7

1.64

1.56

g/l

0.63

249

1161

Chronic viral hepatitis

163

578

2.96

34.27

1.9

1.40

1.42

g/l

0.12

135

510

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

440

2362

1.91

34.25

1.7

1.9

1.59

1.44

g/l

2.55

383

2062

Benign neoplasm: Small intestine

200

800

2.73

34.15

1.9

1.8

1.57

1.55

g/l

0.11

170

704

Mucosal proctocolitis

391

2026

1.99

34.08

1.8

1.42

1.48

g/l

0.63

344

1762

Injuries to the ankle and foot

2061

13230

1.35

33.92

1.8

1.53

1.49

g/l

1.11

1797

11469

Type 1 diabetes, strict definition

184

694

2.73

33.86

2.2

1.9

1.17

1.25

g/l

0.68

167

606

Viral hepatitis

229

967

2.47

33.82

1.8

1.9

1.43

1.47

g/l

0.24

189

852

Gangrene, not elsewhere classified

118

6.50

33.77

2.2

1.8

1.85

1.59

g/l

1.08

101

Disorders of the thyroid gland

2975

15167

1.29

33.73

1.8

1.49

1.52

g/l

0.66

2538

13049

Acute nephritic syndrome

109

311

3.90

33.66

2.9

1.9

1.55

1.50

g/l

0.24

100

278

Other skin changes

731

4566

1.65

33.54

1.9

1.7

1.40

1.56

g/l

5.19

632

3927

Hypoparathyroidism

165

602

2.97

33.54

2.4

1.8

1.49

1.51

g/l

0.06

141

528

Glucagon-like peptide-1 (GLP-1) analogues

875

5687

1.57

33.34

1.8

1.7

1.78

1.49

g/l

16.32

772

4910

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

875

5687

1.57

33.34

1.8

1.7

1.78

1.49

g/l

16.32

772

4910

Other disorders of adrenal gland

176

663

2.82

33.31

1.8

1.9

1.66

1.51

g/l

1.07

154

588

Subjective visual disturbances

822

5281

1.59

33.18

1.7

1.49

1.53

g/l

0.61

719

4572

Visual impairment including blindness (binocular or monocular)

299

1432

2.20

33.02

1.8

1.7

1.60

1.54

g/l

0.50

246

1228

Other or ill-defined heart diseases

184

709

2.72

32.98

2.0

1.6

1.54

1.50

g/l

0.21

157

611

Vitamin deficiency, wide

198

796

2.64

32.89

1.7

1.9

1.40

1.50

g/l

0.86

169

706

Vitamin deficiency

198

796

2.64

32.89

1.7

1.9

1.40

1.50

g/l

0.86

169

706

Discitis, unspecified

108

314

3.91

32.75

1.6

1.9

1.73

1.54

g/l

1.03

100

277

Kela reimbursement Agammaglobulinemia (D80-84)

6.76

32.71

1.9

2.3

1.36

1.43

g/l

0.17

Infections with a predominantly sexual mode of transmission

731

4564

1.63

32.58

1.9

1.41

g/l

0.06

644

3990

Injuries to the elbow and forearm

2166

14156

1.33

32.35

1.8

1.50

1.52

g/l

0.38

1878

12174

Viral hepatitis, including avohilmo

236

1030

2.39

32.33

1.9

1.42

1.46

g/l

0.26

195

910

Other diseases of biliary tract

357

1837

2.04

32.30

1.8

1.6

1.51

1.54

g/l

0.22

309

1573

Drug-induced neutropenia

275

1286

2.26

32.30

1.9

1.8

1.66

1.56

g/l

0.71

242

1124

Etanercept

213

890

2.51

32.27

1.4

2.0

1.49

1.51

g/l

0.09

179

782

Carcinoma in situ of skin of other and unspecified parts of face

419

2285

1.94

32.23

1.9

1.6

1.41

1.55

g/l

2.61

375

1952

Human immunodeficiency virus [HIV] disease resulting in other conditions

201

4.58

32.12

1.5

1.8

1.22

1.47

g/l

1.73

186

Personal history of other diseases and conditions

276

1277

2.21

32.07

2.1

1.9

1.35

1.38

g/l

0.15

241

1104

Other symptoms and signs involving the digestive system and abdomen

520

3000

1.78

32.01

2.2

1.7

1.56

1.54

g/l

0.16

438

2594

Use of pramipexole

772

4940

1.61

32.00

1.9

1.7

1.54

1.57

g/l

0.52

670

4233

Postprocedural disorders of digestive system, not elsewhere classified

150

533

3.04

31.98

1.6

2.0

1.50

1.52

g/l

0.11

127

476

Heart failure and hypertrophic cardiomyopathy

114

350

3.71

31.87

1.9

1.50

1.54

g/l

0.13

322

Thiazolidinediones

424

2318

1.91

31.85

1.5

1.7

1.82

1.49

g/l

10.03

378

1994

Benign neoplasm: Duodenum

143

501

3.18

31.80

2.0

1.9

1.55

g/l

0.01

121

448

Asthma, including avohilmo

3685

16405

1.25

31.79

1.7

1.8

1.56

1.50

g/l

3.65

3203

14076

Maternal care for other known or suspected fetal problems

451

1519

1.89

31.77

2.7

2.1

1.16

1.33

g/l

3.45

398

1331

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

203

4.53

31.70

1.5

1.8

1.22

1.46

g/l

1.69

188

Papulosquamous disorders

1228

8637

1.45

31.62

1.7

1.55

g/l

0.07

1054

7459

Pneumococcal septicemia

159

589

2.93

31.47

2.2

2.0

1.71

1.49

g/l

1.72

137

527

Molar incisor enamel hypoplasia, with caries

9.66

31.38

6.0

1.8

0.93

1.07

g/l

0.44

Respiratory disorders in diseases classified elsewhere

220

4.49

31.36

2.2

2.0

1.86

1.49

g/l

2.00

201

Other specified/unspecified bacterial intestinal infections

260

1203

2.28

31.34

1.8

1.59

1.53

g/l

0.40

228

1047

DVT of lower extremities

661

4096

1.66

31.32

1.8

1.6

1.62

1.58

g/l

0.41

588

3519

Oesophagitis

225

982

2.43

31.27

1.9

1.8

1.56

1.53

g/l

0.18

204

839

Alcohol abuse, main dg, excluding more controls

446

2485

1.85

30.97

1.6

1.8

1.52

1.47

g/l

0.58

390

2134

Mental and behavioural disorders due to opioids

121

384

3.32

30.94

1.7

2.1

1.65

1.35

g/l

2.43

107

348

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

192

778

2.56

30.89

1.7

2.0

1.63

1.39

g/l

2.33

160

683

Mixed hyperlipidaemia

169

651

2.78

30.77

1.6

1.9

1.78

1.49

g/l

3.18

149

568

Giant cell arteritis

203

859

2.56

30.68

1.5

1.7

2.05

1.56

g/l

6.02

168

745

6-mercaptopurine

110

331

3.50

30.61

1.6

1.7

1.36

1.38

g/l

0.07

101

297

Crohn's disease of large intestine

174

679

2.70

30.57

1.8

2.0

1.54

1.46

g/l

0.52

158

602

Disorders of porphyrin and bilirubin metabolism

147

5.27

30.54

1.9

2.2

0.95

1.50

g/l

5.57

131

Familial hypercholesterolemia, with ischemic heart disease

379

2033

1.96

30.42

1.7

1.67

1.58

g/l

1.19

317

1735

Total colectomy

164

626

2.79

30.36

1.7

2.0

1.65

1.48

g/l

1.40

147

560

Total colectomy operation

164

626

2.79

30.36

1.7

2.0

1.65

1.48

g/l

1.40

147

560

Other embolism and thrombosis

451

2545

1.84

30.33

2.6

1.7

1.59

1.56

g/l

0.28

391

2171

L04AC Interleukin inhibitors

209

891

2.45

30.30

1.6

1.9

1.70

1.52

g/l

1.40

172

782

Exclusions for E4_PCOS_BROAD

514

3002

1.76

30.26

1.9

1.8

1.54

1.49

g/l

0.60

441

2609

Adalimumab

284

1371

2.14

30.22

1.5

1.9

1.56

1.50

g/l

0.35

252

1195

L01XE Protein kinase inhibitors

233

1053

2.37

30.16

2.0

1.8

1.59

1.53

g/l

0.28

206

916

Speech therapy

861

5714

1.54

30.13

1.8

1.7

1.56

g/l

0.06

799

4907

Malnutrition

114

360

3.50

30.10

1.6

1.8

1.44

1.47

g/l

0.09

324

Cardiomyopathy, Hypertrophic obstructive

243

4.09

30.05

1.9

1.8

1.62

1.48

g/l

0.63

211

Osteonecrosis due to drugs

270

4.05

29.97

2.1

2.0

1.77

1.52

g/l

1.20

243

Human immunodeficiency virus [HIV] disease

222

4.21

29.67

1.5

1.8

1.22

1.51

g/l

2.14

206

Aspergillosis

153

5.35

29.63

1.8

2.2

1.79

1.46

g/l

1.44

137

Fracture of foot, except ankle

703

4470

1.61

29.57

1.9

1.8

1.56

1.50

g/l

0.98

614

3864

Other specified/unspecified necrotizing vasculopathies

212

4.40

29.42

2.0

1.5

1.70

1.54

g/l

0.62

196

Poor fetal growth

265

1255

2.16

29.40

3.2

2.0

1.11

1.26

g/l

2.74

235

1108

Aspergillosis, including avohilmo

154

5.28

29.35

1.8

2.2

1.79

1.45

g/l

1.48

138

Other obstructive and reflux uropathy

143

515

2.92

29.34

2.4

1.8

1.73

1.40

g/l

3.47

122

447

Specific personality disorders

582

3539

1.68

29.31

1.8

1.9

1.54

1.42

g/l

2.16

514

3092

Injury of unspecified body region

288

1421

2.12

29.28

2.1

1.8

1.56

1.51

g/l

0.39

256

1232

Reactive arthropathies

277

1344

2.14

29.21

1.9

1.8

1.64

1.47

g/l

1.62

229

1169

Left ventricular outflow tract obstruction, narrow definition

180

733

2.60

29.09

2.0

1.21

1.47

g/l

2.59

123

638

Human immunodeficiency virus [HIV] disease, including avohilmo

230

4.10

29.05

1.5

1.8

1.24

1.50

g/l

1.82

214

Moderate visual impairment, binocular

156

599

2.83

28.89

2.0

1.6

1.60

1.58

g/l

0.08

133

531

Asthma/COPD (KELA code 203)

2872

15314

1.26

28.84

1.6

1.8

1.62

1.49

g/l

10.46

2496

13144

Eosinophilic disease (BM)

188

4.47

28.62

1.6

2.0

1.62

1.50

g/l

0.49

165

Persistent mood disorders

571

3483

1.68

28.62

1.8

1.7

1.55

1.50

g/l

0.57

494

2986

Small fibre neuropathy

147

552

2.91

28.52

2.7

1.9

1.53

1.54

g/l

0.05

123

490

Other diseases of oesophagus

351

1872

1.95

28.43

1.8

1.7

1.47

1.55

g/l

0.85

309

1609

Hypersplenism

8.65

28.30

3.0

1.7

0.79

1.51

g/l

5.38

Superficial injury of hip and thigh

561

3425

1.69

28.26

1.7

1.49

1.55

g/l

0.68

480

2950

Hypothyroidism, other/unspecified

2715

14189

1.27

28.20

1.8

1.50

1.51

g/l

0.13

2323

12212

Iridocyclitis

705

4543

1.59

28.19

1.9

1.8

1.53

g/l

0.04

631

3930

Allergic asthma (mode), excluding more controls

490

2802

1.73

28.06

1.7

1.8

1.55

1.36

g/l

4.52

435

2415

Other and unspecified disorders of skin and subcutaneous tissue

234

1085

2.27

28.06

1.9

1.8

1.62

1.53

g/l

0.75

199

937

Hodgkin lymphoma, hilmo

122

418

3.15

27.82

1.9

2.2

1.55

1.46

g/l

0.36

376

Amputation of thigh

163

653

2.72

27.81

2.2

1.8

1.91

1.53

g/l

4.73

142

570

Disorders of synovium and tendon

1549

9763

1.36

27.74

1.7

1.51

g/l

0.09

1339

8393

Coeliac disease

369

2011

1.89

27.73

1.7

1.8

1.47

1.52

g/l

0.43

311

1744

Retinal vascular occlusion

492

2929

1.75

27.71

1.8

1.7

1.56

1.58

g/l

0.25

423

2499

Rotator cuff syndrome

1900

9987

1.33

27.48

1.7

1.58

1.56

g/l

0.53

1631

8535

Postmenopausal osteoporosis with pathological fracture

271

1345

2.13

27.44

1.9

1.6

1.60

1.59

g/l

0.02

239

1154

Other diseases of lip and oral mucosa

1251

9059

1.40

27.23

1.8

1.51

1.54

g/l

0.53

1078

7839

Fitting and adjustment of other devices

1194

7538

1.42

27.17

1.7

1.6

1.64

1.55

g/l

2.62

995

6369

Abscess of anal and rectal regions

253

1219

2.15

27.15

1.7

1.8

1.62

1.47

g/l

1.47

215

1057

Abnormality of white blood cells, not elsewhere classified

130

5.39

27.12

2.2

1.8

1.31

1.57

g/l

1.18

116

Other and unspecified vasculitis limited to skin

113

378

3.26

27.02

1.6

2.0

1.50

1.52

g/l

0.08

337

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

978

6796

1.47

26.96

1.9

1.7

1.49

1.54

g/l

1.10

861

5869

Cholecystitis

524

3187

1.70

26.93

1.8

1.7

1.56

g/l

0.04

445

2721

Vasculitis limited to skin, not elsewhere classified

123

434

3.08

26.75

1.6

1.9

1.50

1.53

g/l

0.10

108

386

Non-allergic asthma (mode)

507

3020

1.70

26.72

1.6

1.63

1.45

g/l

4.45

441

2560

Retinal vascular disorders

496

2988

1.73

26.70

1.8

1.7

1.55

1.58

g/l

0.29

425

2550

Hypothyreosis and Thyroxine purchase for inclusion criteria

2808

14771

1.26

26.69

1.8

1.50

1.51

g/l

0.19

2405

12718

Neuromuscular dysfunction of bladder

327

1741

1.95

26.69

1.6

1.7

1.54

g/l

0.01

281

1516

Other and unspecified effects of external causes

743

4898

1.54

26.59

1.9

1.8

1.57

1.47

g/l

1.95

643

4239

Psoriatic arthropathies

302

1563

2.00

26.58

1.5

1.8

1.60

1.49

g/l

1.08

256

1356

Disorders of skin appendages

1377

10103

1.37

26.51

1.9

1.8

1.54

1.48

g/l

1.68

1240

8739

Herpesviral [herpes simplex] infections, including avohilmo

689

4472

1.57

26.50

1.8

1.44

1.48

g/l

0.46

611

3872

Paralytic ileus

156

623

2.67

26.44

1.8

1.75

1.48

g/l

3.05

140

534

Other abnormalities of plasma proteins

267

3.78

26.43

2.0

1.8

1.75

1.51

g/l

1.31

236

Clear cell adenocarcinoma of kidney

192

844

2.42

26.43

1.6

1.81

1.54

g/l

2.69

169

737

Hypoplasia of dental enamel

7.73

26.27

6.0

1.7

0.86

0.97

g/l

0.39

Sleep apnoea, including avohilmo

3012

14750

1.25

26.18

1.7

1.8

1.58

1.52

g/l

2.56

2563

12740

Benign neoplasm: Descending colon

295

1535

2.03

26.15

1.7

1.55

1.56

g/l

0.05

263

1328

Schizophrenia or delusion, excluding more controls

763

5008

1.53

26.11

1.6

1.8

1.67

1.47

g/l

6.43

652

4328

Other blood glucose lowering drugs, excl. Insulins

546

3383

1.66

26.08

1.6

1.7

1.71

1.52

g/l

4.92

474

2888

Drug-induced osteoporosis

204

4.22

25.90

2.7

2.1

1.61

1.51

g/l

0.37

181

Urticaria and erythema

992

6963

1.45

25.77

1.9

1.8

1.46

1.49

g/l

0.55

861

6034

Herpesviral [herpes simplex] infections

368

2052

1.85

25.74

1.7

1.8

1.48

1.51

g/l

0.29

326

1767

Inflammatory diseases of the central nervous system

281

1439

2.03

25.72

1.9

1.8

1.67

1.52

g/l

1.71

243

1255

Reactive arthropathies, FINNGEN

218

1016

2.23

25.61

1.9

1.8

1.68

1.45

g/l

2.18

185

880

Polyarthritis, unspecified

142

551

2.74

25.49

1.8

1.71

1.51

g/l

1.31

126

484

Pyoderma gangrenosum

113

5.59

25.43

2.6

2.2

1.48

1.45

g/l

0.07

Laparoscopic right hemicolectomy

258

1299

2.12

25.35

1.3

1.8

1.79

1.55

g/l

4.31

225

1128

Traumatic subdural haemorrhage

527

3045

1.67

25.24

1.9

1.7

1.46

1.56

g/l

1.66

446

2597

Maternal care for other conditions predominantly related to pregnancy

393

2179

1.79

25.12

2.2

1.9

1.24

1.37

g/l

2.15

349

1916

Mental and behavioural disorders due to sedatives or hypnotics

201

914

2.29

25.09

1.4

1.9

1.65

1.49

g/l

1.48

166

801

Retinal detachments and breaks

1200

8768

1.39

24.99

1.9

1.7

1.52

1.57

g/l

1.01

1050

7523

Localized swelling, mass and lump of skin and subcutaneous tissue

982

6931

1.44

24.95

1.9

1.7

1.51

1.54

g/l

0.58

848

5959

Other disorders of ear

2824

14775

1.25

24.94

1.6

1.7

1.51

1.55

g/l

1.10

2365

12781

Allergic purpura

111

383

3.09

24.87

1.7

2.2

1.63

1.48

g/l

0.75

341

Congenital malformations of aortic and mitral valves

152

617

2.61

24.84

2.0

1.18

1.48

g/l

3.32

102

539

Iron deficiency

100

324

3.25

24.79

1.9

2.2

1.36

1.24

g/l

0.61

289

Other hammer toe(s) (acquired)

528

2973

1.66

24.76

1.4

1.7

1.59

1.57

g/l

0.16

450

2518

Scoliosis

265

1347

2.03

24.64

1.8

1.9

1.56

1.46

g/l

0.85

232

1184

Organic, including symptomatic, mental disorders

1934

10593

1.31

24.64

1.6

1.7

1.60

1.58

g/l

0.51

1581

9113

Gilbert syndrome

5.97

24.55

1.8

2.0

0.94

1.45

g/l

3.43

Complications following infusion, transfusion and therapeutic injection

208

3.99

24.22

2.7

2.0

1.68

1.50

g/l

0.63

190

Psoriasis vulgaris

566

3598

1.61

24.15

1.8

1.62

1.52

g/l

1.47

487

3119

Cholecystectomy

2196

14806

1.27

24.15

1.9

1.7

1.50

1.54

g/l

1.42

1881

12704

Postpartum care and examination

253

769

2.10

24.03

2.7

1.9

1.14

1.42

g/l

6.00

230

669

Operations for atrial fibrillation

291

3.57

24.02

2.2

1.7

1.30

1.54

g/l

1.29

259

Nonorganic sleeping disorders

585

3745

1.59

24.02

1.9

1.8

1.46

1.45

g/l

0.13

510

3245

Amenorrhoea

174

757

2.37

23.97

2.5

2.0

1.23

1.34

g/l

0.82

145

672

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

764

5033

1.50

23.79

1.4

1.6

1.99

1.57

g/l

16.39

650

4298

Other and unspecified haemorrhagic conditions

225

3.82

23.75

2.0

1.8

1.60

1.46

g/l

0.52

205

Disturbances of skin sensation

741

5003

1.51

23.72

1.8

1.47

1.50

g/l

0.35

626

4346

Temporal arteritis

170

749

2.44

23.56

1.5

1.7

2.03

1.56

g/l

5.18

145

651

Autoimmune hepatitis

5.62

23.53

1.8

1.5

1.28

1.39

g/l

0.27

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

6.06

23.53

1.9

2.0

1.62

1.53

g/l

0.19

Stomatitis and related lesions

593

3832

1.58

23.50

1.9

1.8

1.43

1.51

g/l

1.36

519

3313

Acquired absence of organs, not elsewhere classified

190

4.14

23.47

2.0

1.59

1.51

g/l

0.29

168

Other degenerative diseases of the nervous system

927

4735

1.45

23.46

1.6

1.7

1.56

g/l

0.01

758

4056

Ankylosing spondylitis

270

1407

1.98

23.41

1.6

1.8

1.59

1.49

g/l

0.84

225

1220

Malignant neoplasm of bladder, including Hilmo

434

2575

1.72

23.41

1.7

1.5

1.74

1.54

g/l

4.11

383

2196

Combinations of oral blood glucose lowering drugs

903

6361

1.45

23.39

1.6

1.7

1.73

1.49

g/l

12.03

780

5439

Colitis, primary sclerosing, strict definition

116

5.09

23.37

1.9

2.2

1.14

1.49

g/l

2.14

106

Pneumonia due to Streptococcus pneumoniae

147

604

2.56

23.35

2.1

1.8

1.82

1.46

g/l

3.72

123

524

Umbilical hernia

839

5831

1.47

23.31

1.7

1.54

g/l

0.06

741

5051

Coxarthrosis, primary

2047

13452

1.28

23.27

1.6

1.7

1.61

1.57

g/l

0.80

1752

11479

Generalized skin eruption due to drugs and medicaments

148

613

2.56

23.24

2.1

1.9

1.61

1.49

g/l

0.71

129

543

Maternal care for known or suspected fetal abnormality and damage

296

1332

1.92

23.12

2.3

2.0

1.16

1.35

g/l

2.97

263

1170

Cardiac murmurs and other cardiac sounds

265

1359

1.98

23.08

1.8

1.53

1.48

g/l

0.37

232

1166

IBD (strict) with PSC

110

5.19

22.92

1.9

2.4

1.22

1.43

g/l

0.92

103

Type1 diabetes, definitions combined, early onset

148

609

2.49

22.88

2.3

2.0

1.16

1.27

g/l

0.89

136

545

Colitis, primary sclerosing

156

4.35

22.82

1.9

2.1

1.20

1.45

g/l

1.33

142

Other arterial embolism and thrombosis

125

484

2.77

22.75

1.9

2.0

1.77

1.46

g/l

2.98

108

425

Intracranial and intraspinal abscess and granuloma

191

4.09

22.58

1.8

1.9

1.94

1.47

g/l

2.80

172

Mature T/NK-cell lymphomas, hilmo

245

3.69

22.53

1.8

1.65

1.55

g/l

0.35

219

Adverse effects, not elsewhere classified

530

3370

1.61

22.49

2.0

1.8

1.58

1.48

g/l

1.47

463

2908

Hypertrophic cardiomyopathy

177

808

2.33

22.43

1.8

1.50

1.55

g/l

0.29

157

716

Extreme obesity with alveolar hypoventilation

160

699

2.43

22.39

1.4

1.8

1.77

1.53

g/l

2.12

134

613

Supplementary factors related to causes of morbidity and mortality classified elsewhere

930

6629

1.43

22.38

1.7

1.53

1.51

g/l

0.17

799

5717

Meniscus derangement

1524

7701

1.33

22.38

1.7

1.52

g/l

0.00

1300

6579

Gonarthrosis,primary

2837

14013

1.23

22.35

1.6

1.7

1.60

1.56

g/l

1.09

2431

12015

Alcohol withdrawal state with delirium

249

1290

2.02

22.28

1.6

1.7

1.53

g/l

0.03

218

1122

Infections with a predominantly sexual mode of transmission, including avohilmo

889

5729

1.44

22.28

2.1

1.9

1.37

1.40

g/l

0.34

781

5011

Dermatitis due to substances taken internally

187

870

2.25

22.26

2.0

1.8

1.67

1.50

g/l

1.33

164

765

Unspecified human immunodeficiency virus [HIV] disease

130

4.79

22.21

1.6

1.22

1.60

g/l

2.09

120

Other specified congenital malformation syndromes affecting multiple systems

163

4.17

22.20

1.8

2.3

1.26

1.27

g/l

0.02

151

Crohn disease (strict definition, all UC cases excluded)

160

698

2.39

22.18

1.6

2.0

1.47

1.46

g/l

0.07

146

620

Neovascular glaucoma

171

772

2.35

22.17

2.2

1.8

1.57

1.53

g/l

0.19

150

669

1192

7606

1.37

22.17

1.6

1.7

1.55

1.59

g/l

0.68

1002

6471

Post-traumatic stress disorder

197

932

2.17

22.09

2.1

2.0

1.35

1.28

g/l

0.46

171

825

Emotionally unstable personality disorder

280

1501

1.91

22.05

1.7

2.1

1.45

1.35

g/l

1.10

249

1307

Early onset COPD

694

4709

1.51

21.99

1.7

1.70

1.53

g/l

4.55

613

4058

Other disorders of the musculoskeletal system and connective tissue

487

3062

1.64

21.98

1.7

1.57

1.55

g/l

0.13

427

2639

Crystal arthropathies, rheuma endpoint

102

364

3.08

21.96

1.8

1.7

1.63

1.54

g/l

0.38

317

Abscess of lung

258

3.51

21.92

1.6

2.0

1.83

1.49

g/l

1.65

235

Other problems related to primary support group, including family circumstances

262

1339

1.95

21.86

2.3

1.9

1.35

1.37

g/l

0.19

232

1182

Acute generalized exanthematous pustulosis

163

724

2.37

21.85

2.0

1.8

1.58

1.51

g/l

0.41

143

632

Procreative management

761

4299

1.48

21.74

2.2

1.8

1.37

1.52

g/l

4.38

655

3751

Giant cell arteritis with polymyalgia rheumatica

170

776

2.35

21.71

1.5

1.8

2.03

1.57

g/l

4.95

145

676

Fracture of forearm

1591

11064

1.31

21.65

1.8

1.53

1.54

g/l

0.02

1382

9514

Fall on and from stairs and steps

810

5674

1.45

21.61

1.8

1.7

1.50

1.54

g/l

0.62

697

4888

Other ulcerative colitis

180

835

2.25

21.54

1.7

1.9

1.54

1.48

g/l

0.37

159

739

Thyrotoxicosis, other and/or unspecified

571

3734

1.56

21.46

1.8

1.6

1.49

1.53

g/l

0.58

492

3216

Sarcoidosis

403

2432

1.71

21.41

1.9

1.7

1.53

1.54

g/l

0.09

342

2109

Ulcerative colitis (strict) with PSC

5.71

21.40

2.0

1.26

1.44

g/l

0.61

Somatoform disorder

443

2735

1.66

21.32

1.7

1.8

1.52

1.51

g/l

0.11

375

2369

Juvenile arthritis (FINNGEN)

113

425

2.76

21.32

2.3

1.53

1.30

g/l

1.63

105

384

Hypothyroidism, strict autoimmune, 3 medication purchases required

2485

13581

1.24

21.26

1.8

1.51

g/l

0.02

2117

11689

Maternal care for known or suspected abnormality of pelvic organs

468

1942

1.65

21.18

2.7

2.0

1.15

1.43

g/l

10.36

416

1699

Alcohol-induced acute pancreatitis

145

623

2.48

21.15

1.7

1.9

1.69

1.55

g/l

0.97

128

541

Glaucoma secondary to other eye disorders

171

788

2.30

21.11

2.2

1.8

1.57

1.53

g/l

0.22

150

693

Disorders of vitreous body and globe

1637

12092

1.30

21.11

1.9

1.7

1.50

1.58

g/l

2.81

1428

10351

Viral warts

294

1629

1.86

21.09

2.3

1.8

1.50

1.48

g/l

0.18

269

1420

Bacterial, viral and other infectious agents

246

1289

1.97

21.04

1.8

1.9

1.47

1.50

g/l

0.15

213

1127

Transport accidents

1220

7592

1.35

21.01

1.9

1.8

1.49

1.50

g/l

0.08

1057

6551

Olecranon bursitis

231

1191

2.03

20.97

1.7

1.8

1.55

1.50

g/l

0.34

202

1035

Carcinoma in situ of skin

350

2058

1.78

20.92

1.6

1.7

1.50

1.54

g/l

0.43

300

1768

therapeutic use

135

567

2.55

20.82

1.7

1.69

1.54

g/l

0.87

112

500

Open wound of forearm

323

1852

1.80

20.74

1.9

1.7

1.40

1.50

g/l

1.20

271

1591

Fissure and fistula of anal and rectal regions

648

4381

1.50

20.71

1.9

1.7

1.54

1.52

g/l

0.20

553

3739

Unspecified misadventure during surgical and medical care

213

1074

2.08

20.67

1.8

1.42

1.53

g/l

0.98

181

933

Bullous disorders

230

1193

2.03

20.66

1.8

1.51

1.50

g/l

0.08

197

1031

Other crystal arthropathies

102

377

2.97

20.61

1.8

1.63

1.52

g/l

0.49

326

Malignant neoplasm of small intestine

101

371

2.94

20.48

1.4

1.6

1.68

1.53

g/l

0.81

325

Lumbar disc prolapse

1835

10752

1.28

20.44

1.6

1.8

1.61

1.52

g/l

3.34

1610

9244

Arterial embolism and thrombosis of lower extremity artery

152

677

2.39

20.41

2.0

1.8

1.73

1.47

g/l

2.45

134

584

Drug-induced hypoglycaemia without coma

264

3.36

20.40

1.7

1.9

1.59

1.49

g/l

0.40

239

Progressive vascular leukoencephalopathy

201

1006

2.14

20.31

1.5

1.7

1.61

1.55

g/l

0.41

172

868

Mantle cell lymphoma, including Hilmo

235

3.55

20.27

2.0

1.7

1.59

1.55

g/l

0.14

210

Congenital malformations of cardiac septa

192

903

2.13

20.27

2.1

2.0

1.21

1.45

g/l

3.18

159

796

Corns and callosities

223

1148

2.02

20.27

1.7

1.8

1.66

1.54

g/l

1.00

197

988

Cyst of kidney

278

1543

1.89

20.24

2.1

1.7

1.60

1.53

g/l

0.64

243

1339

Allergic bronchopulmonary aspergillosis (ABPA)

9.12

20.21

1.4

1.6

1.69

1.45

g/l

0.42

Mixed connective tissue disease

260

3.35

20.18

2.5

2.0

1.56

1.47

g/l

0.30

232

KRA_PSY_EATING, excluding more controls

172

793

2.20

20.07

2.2

1.25

1.15

g/l

0.74

152

705

Mental and behavioural disorders due to tobacco

268

1468

1.89

20.07

1.8

1.72

1.52

g/l

2.59

243

1269

Polyarteritis nodosa and related conditions

191

3.80

20.04

1.8

2.1

1.60

1.40

g/l

0.86

176

Other and unspecified psoriasis

237

1254

1.97

19.92

1.9

1.8

1.72

1.54

g/l

1.58

199

1093

Bacterial, viral and other infectious agents, including avohilmo

257

1392

1.90

19.86

1.8

1.9

1.49

g/l

0.02

224

1220

Alcohol abuse, main dg

446

2812

1.62

19.79

1.6

1.8

1.52

1.50

g/l

0.14

390

2450

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

142

4.33

19.77

1.6

1.8

1.22

1.58

g/l

2.02

132

Disorders of vitreous body

1581

11799

1.29

19.76

1.9

1.7

1.49

1.58

g/l

3.24

1376

10113

Other juvenile arthritis

103

385

2.78

19.73

2.4

1.48

1.28

g/l

1.32

353

Other disorders of bladder

423

2644

1.65

19.71

1.7

1.54

g/l

0.00

354

2278

Special screening examination for other diseases and disorders

316

1820

1.77

19.68

1.9

1.6

1.56

1.54

g/l

0.14

284

1550

Mixed and other personality disorders

198

984

2.07

19.65

1.7

1.9

1.61

1.46

g/l

1.14

168

854

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

158

4.22

19.57

2.0

2.1

1.40

1.49

g/l

0.25

142

Exclusion endpoint for clefts

207

3.55

19.52

1.8

2.3

1.29

1.31

g/l

0.05

190

Ulcerative colitis (strict definition, require KELA)

441

2780

1.62

19.52

1.9

1.8

1.45

1.47

g/l

0.20

389

2418

Other and unspecified injuries of head

264

1454

1.88

19.52

1.5

1.8

1.59

1.52

g/l

0.57

229

1259

Smoking dependency

268

1481

1.87

19.52

1.8

1.72

1.52

g/l

2.56

243

1279

Pulmonary oedema

365

2.94

19.52

2.4

1.8

1.56

1.57

g/l

0.04

328

Thyroiditis, ILD-related definition

300

1710

1.80

19.52

2.0

1.8

1.43

1.53

g/l

1.18

253

1486

Acute and subacute iridocyclitis

555

3687

1.54

19.50

1.9

1.7

1.53

g/l

0.00

497

3189

Keratitis

1015

7509

1.37

19.50

2.0

1.8

1.50

1.52

g/l

0.23

888

6468

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

429

2688

1.63

19.49

1.9

1.8

1.44

1.47

g/l

0.23

378

2338

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

118

4.75

19.44

1.9

2.0

1.62

1.42

g/l

0.64

106

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

622

4172

1.49

19.37

2.1

1.9

1.39

1.38

g/l

0.05

537

3635

Encephalopathy

154

4.18

19.33

2.0

2.3

0.97

1.46

g/l

4.30

142

Chronic hepatitis NAS

167

3.96

19.32

1.7

1.9

1.31

1.48

g/l

0.64

151

Allergic asthma (mode)

490

3084

1.57

19.32

1.7

1.8

1.55

1.37

g/l

4.10

435

2642

Single delivery by caesarean section

373

1254

1.73

19.27

2.6

2.2

1.14

1.41

g/l

7.29

337

1094

Thyrotoxicosis

710

4962

1.46

19.22

1.8

1.7

1.52

1.54

g/l

0.19

615

4262

Chronic rhinitis, nasopharyngitis and pharyngitis

884

6410

1.40

19.21

1.7

1.8

1.50

1.51

g/l

0.12

754

5548

Other peripheral vascular diseases

248

1345

1.91

19.18

2.0

1.8

1.53

1.50

g/l

0.17

212

1160

Cerebral palsy and other paralytic syndromes

342

2038

1.73

19.10

1.7

1.8

1.53

1.52

g/l

0.08

294

1760

Acute alcohol intoxication, ICD10

570

3825

1.52

19.05

1.6

1.8

1.53

1.51

g/l

0.23

491

3328

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

470

3027

1.58

18.98

1.9

1.8

1.44

1.47

g/l

0.25

417

2642

Malignant neoplasm of small intestine, including Hilmo

122

510

2.55

18.97

1.5

1.6

1.67

1.54

g/l

0.76

102

447

Bicuspidal aortic valve syndrome

130

558

2.46

18.93

1.9

1.24

1.52

g/l

2.49

490

Ankylosing spondylitis, ICD10

256

1410

1.87

18.84

1.6

1.8

1.58

1.52

g/l

0.47

216

1232

Special screening examination for neoplasms

195

981

2.05

18.80

1.8

1.6

1.45

1.60

g/l

1.22

166

837

Assault

316

1847

1.75

18.75

1.8

1.9

1.48

1.43

g/l

0.44

272

1618

Hypertension, Pulmonary Arterial

108

4.78

18.73

2.2

2.0

1.11

1.48

g/l

1.72

Carcinoma in situ of skin of upper limb, including shoulder

137

612

2.44

18.72

2.0

1.9

1.53

1.56

g/l

0.13

117

543

Other retinal artery occlusion

117

487

2.61

18.61

1.8

1.9

1.61

1.58

g/l

0.12

105

426

Other aneurysm

212

1109

2.00

18.58

1.9

1.7

1.56

1.48

g/l

0.51

188

949

Other mycoses, not elsewhere classified/unspecified

6.54

18.55

2.4

1.7

1.56

1.57

g/l

0.02

Right hemicolectomy

233

1261

1.94

18.49

1.8

1.7

1.75

1.52

g/l

3.08

203

1095

Other symptoms and signs involving the circulatory and respiratory systems

202

1036

2.01

18.46

1.8

1.7

1.60

1.54

g/l

0.33

179

891

Systemic sclerosis (FG)

306

2.99

18.38

2.0

1.7

1.51

1.49

g/l

0.06

269

Other congenital malformations

221

1168

1.94

18.37

1.7

1.9

1.34

1.44

g/l

0.95

185

1033

Anterior Iridocyclitis

584

3973

1.50

18.30

1.9

1.7

1.53

g/l

0.02

521

3423

Unspecified urinary incontinence

291

1683

1.79

18.25

1.9

1.7

1.80

1.55

g/l

3.87

239

1454

Eosinophilia

261

3.23

18.20

1.6

2.0

1.61

1.50

g/l

0.43

232

Other disorders of bone

500

3296

1.54

18.16

1.8

1.49

1.48

g/l

0.08

428

2852

Colon adenocarcinoma, helper endpoint

482

3169

1.57

18.15

1.5

1.7

1.74

1.56

g/l

4.27

416

2714

Rheumatism, unspecified

364

2234

1.67

18.09

1.7

1.62

1.61

g/l

0.07

318

1928

Common variable immunodeficiency

5.82

18.08

1.6

2.3

1.39

1.42

g/l

0.04

Gestational diabetes (for exclusion)

630

2954

1.48

18.07

2.5

2.1

1.26

1.32

g/l

0.89

561

2593

Infarction of spleen

122

4.68

18.03

2.0

1.8

1.38

1.54

g/l

0.56

110

Polycystic ovarian syndrome, consortium definition

1711

7786

1.27

17.89

1.9

1.8

1.51

1.49

g/l

0.32

1471

6731

Abnormal findings in nipple discharge synovial fluid wound secretions

211

3.46

17.85

2.0

2.3

1.45

g/l

0.01

190

Arthropathic psoriasis

328

1970

1.71

17.83

1.6

1.7

1.58

1.55

g/l

0.27

279

1709

Drug-induced adrenocortical insufficiency

258

3.18

17.79

1.9

2.0

1.75

1.48

g/l

1.15

234

Abnormal involuntary movements

425

2723

1.60

17.78

1.7

1.8

1.53

g/l

0.00

368

2348

Disorders of phosphorus metabolism and phosphatases

6.15

17.77

1.6

2.6

1.44

1.34

g/l

0.18

Acute alcohol intoxication

751

5378

1.42

17.77

1.6

1.8

1.54

1.51

g/l

0.51

652

4657

Benign neoplasm of other and unspecified endocrine glands

406

2575

1.62

17.76

1.6

1.7

1.63

1.55

g/l

0.95

358

2225

Other specified disorders of kidney and ureter

124

538

2.44

17.74

2.7

1.9

1.49

1.54

g/l

0.23

104

485

Type of accident

847

6188

1.39

17.73

1.7

1.53

1.51

g/l

0.21

728

5332

Ulcerative enterocolitis

102

403

2.66

17.73

1.6

2.1

1.33

1.45

g/l

0.68

357

Other and unspecified nonorganic psychotic disorders

444

2866

1.57

17.69

1.6

1.8

1.59

1.44

g/l

2.56

379

2502

Paracetamol or NSAID medication

453

1438

1.61

17.68

1.9

1.47

1.34

g/l

1.92

411

1226

Artificial joint operation, meniscal resection

2801

15012

1.20

17.67

1.6

1.7

1.59

1.55

g/l

1.43

2380

12903

COPD, hospital admissions 1, only main diagnosis

1235

8189

1.32

17.63

1.6

1.7

1.69

1.55

g/l

6.73

1070

6991

Other congenital malformations, including avohilmo

326

1957

1.70

17.58

1.7

1.9

1.36

1.45

g/l

1.04

272

1717

malignant neoplasm of male genital organs

914

4030

1.39

17.55

1.7

1.6

1.59

1.52

g/l

1.30

790

3425

Right bundle-branch block

129

570

2.37

17.55

1.5

1.55

g/l

0.02

107

496

Focal epilepsy

627

4358

1.47

17.54

1.9

1.7

1.49

1.51

g/l

0.28

512

3782

Diseases of male genital organs

1532

6046

1.29

17.48

1.8

1.7

1.50

1.55

g/l

1.00

1332

5198

Heartburn

325

1956

1.70

17.45

1.7

1.44

1.52

g/l

0.96

287

1690

Pneumonitis due to solids and liquids

321

1935

1.72

17.43

1.6

1.7

1.69

1.53

g/l

2.09

272

1648

Marginal zone B-cell lymphoma

142

4.10

17.35

3.4

1.6

1.50

1.55

g/l

0.11

128

Fall involving bed

150

715

2.23

17.22

1.9

1.8

1.56

1.55

g/l

0.06

130

622

Portal vein thrombosis

264

3.14

17.20

2.4

2.0

1.33

1.58

g/l

1.03

234

Other postsurgical states

198

1036

1.98

17.16

1.6

1.7

1.54

1.55

g/l

0.04

180

896

Lung diseases due to external agents

506

3400

1.53

17.11

1.7

1.64

1.54

g/l

1.46

421

2914

Other bursopathies

402

2566

1.61

17.08

1.8

1.7

1.55

1.56

g/l

0.06

356

2215

Exclusions for E4_PCOS_CONSORTIUM

1779

8913

1.26

17.06

1.8

1.53

1.48

g/l

1.25

1505

7734

Later onset COPD

1127

6931

1.33

17.03

1.6

1.7

1.71

1.54

g/l

7.91

968

5887

Lichen simplex chronicus and prurigo

208

1112

1.94

16.98

1.7

1.8

1.65

1.53

g/l

1.06

177

968

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

323

2.80

16.91

1.7

2.2

1.41

1.32

g/l

0.32

287

Rash and other nonspecific skin eruption

293

1734

1.74

16.90

1.8

1.55

1.54

g/l

0.09

258

1508

Adult respiratory distress syndrome

225

3.34

16.86

2.2

2.1

1.68

1.49

g/l

0.65

198

Hallux valgus (acquired)

842

4393

1.39

16.84

1.6

1.8

1.60

1.54

g/l

0.85

723

3741

Other general symptoms and signs

129

571

2.31

16.84

1.8

1.33

1.43

g/l

0.69

100

493

Symptoms and signs involving speech and voice

996

7522

1.34

16.84

1.8

1.7

1.54

1.55

g/l

0.16

858

6465

Other headache syndromes

1077

8181

1.33

16.83

1.7

1.8

1.47

1.50

g/l

0.54

916

7104

Deficiency of other B group vitamins

351

2.78

16.82

1.7

1.37

1.50

g/l

0.68

318

Donors of organs and tissues

139

3.91

16.74

1.5

2.2

1.69

1.30

g/l

1.27

127

malignant neoplasm of male genital organs, including Hilmo

921

4087

1.38

16.73

1.7

1.6

1.61

1.52

g/l

1.78

793

3473

Carcinoma in situ of skin of scalp and neck

149

722

2.24

16.70

2.0

1.8

1.47

1.52

g/l

0.29

127

624

Other other unspecified disorders of the circulatory system

137

636

2.27

16.70

1.7

1.9

1.45

1.51

g/l

0.21

112

563

Lung cancer and mesothelioma

578

3375

1.48

16.69

1.7

1.5

1.90

1.50

g/l

14.02

499

2837

Respiratory insufficiency

264

1519

1.79

16.67

1.6

1.67

1.49

g/l

2.15

226

1290

Speech and linguistic disorders, excluding more controls

189

915

1.98

16.66

1.9

2.1

1.51

1.31

g/l

1.88

167

792

Sensorineural hearing loss

2377

13168

1.21

16.62

1.6

1.7

1.53

1.57

g/l

1.23

1954

11367

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

463

3068

1.54

16.57

1.7

1.8

1.46

1.52

g/l

0.71

420

2654

Other disorders of eyelid

1448

10843

1.28

16.57

1.6

1.7

1.53

1.58

g/l

1.50

1263

9242

Dissection of aorta

136

635

2.27

16.44

1.5

1.8

1.48

1.47

g/l

0.05

109

554

Primary hyperparathyroidism

356

2236

1.64

16.36

2.0

1.7

1.65

1.59

g/l

0.56

313

1933

Carcinoma in situ of skin of trunk

161

807

2.14

16.35

1.8

1.47

1.53

g/l

0.36

140

706

Chronic sinusitis

1160

8963

1.31

16.29

1.8

1.7

1.55

1.52

g/l

0.57

1002

7741

Fall on same level involving ice and snow

1688

13652

1.25

16.25

1.7

1.8

1.54

1.53

g/l

0.02

1456

11725

Embolic stroke with flimmer

109

465

2.49

16.23

1.5

1.8

1.59

1.61

g/l

0.07

400

Atrial septal defect

111

472

2.44

16.21

2.5

2.2

1.18

1.45

g/l

2.45

422

Tobacco use

167

843

2.06

16.14

2.0

1.9

1.72

1.50

g/l

2.33

152

739

Myocardial infarction, with ST-elevation

636

4515

1.44

16.14

1.6

1.7

1.70

1.54

g/l

3.85

557

3852

Hyperplasia of prostate

1212

5271

1.31

16.06

1.8

1.7

1.53

1.57

g/l

0.57

1055

4524

Memory loss

339

2121

1.66

16.00

1.7

1.8

1.55

1.52

g/l

0.20

286

1843

Conotruncal defects

130

3.98

15.98

2.6

2.5

0.92

1.29

g/l

2.46

119

Other/unspecified reactive arthropathies

195

1042

1.94

15.93

1.9

1.70

1.52

g/l

1.36

163

915

Varicose veins

1819

11191

1.24

15.88

1.7

1.57

g/l

0.01

1544

9532

Benign neoplasm: Adrenal gland

257

1497

1.78

15.87

1.6

1.7

1.73

1.57

g/l

2.00

227

1292

Dermatophytosis, including avohilmo

1879

15094

1.23

15.86

1.7

1.8

1.51

1.52

g/l

0.09

1615

13010

Encephalitis

105

446

2.48

15.75

2.5

2.3

1.63

1.45

g/l

0.97

400

Psoriatic arthropathies, ICD10

297

1799

1.70

15.70

1.5

1.7

1.61

1.55

g/l

0.43

252

1554

Phobic anxiety disorders

276

1629

1.72

15.67

1.9

1.41

1.36

g/l

0.36

247

1418

Molar incisor enamel hypoplasia

320

2.69

15.64

3.8

2.2

0.92

1.20

g/l

3.66

286

Redundant prepuce, phimosis and paraphimosis

594

4111

1.45

15.61

1.6

1.7

1.56

1.53

g/l

0.44

506

3543

Striking against or struck by other objects

876

6552

1.35

15.56

1.8

1.51

1.47

g/l

0.63

757

5686

Other encephalitis

100

418

2.53

15.56

2.6

2.3

1.68

1.45

g/l

1.39

373

Malignant melanoma

461

3096

1.52

15.56

1.9

1.6

1.49

1.55

g/l

0.74

401

2646

Enteropathic arthropathies

277

2.89

15.53

1.5

2.2

1.52

1.45

g/l

0.31

250

Migraine with aura

558

3881

1.46

15.42

1.7

1.9

1.42

g/l

0.02

486

3409

Attention to artificial openings

151

750

2.11

15.41

1.5

1.6

1.66

1.44

g/l

2.26

127

665

Conductive and sensorineural hearing loss

2436

13565

1.20

15.41

1.6

1.7

1.54

1.57

g/l

0.95

2016

11723

Exposure to other and unspecified inanimate mechanical forces

220

1233

1.84

15.38

1.8

1.9

1.48

1.50

g/l

0.10

192

1079

Prurigo nodularis

416

2.54

15.34

1.7

1.9

1.54

1.53

g/l

0.02

375

Melanocytic naevi of trunk

354

2252

1.61

15.32

1.9

1.8

1.44

1.51

g/l

0.71

312

1958

Overexertion and strenuous or repetitive movements

279

1675

1.71

15.27

1.6

1.8

1.55

1.52

g/l

0.24

240

1463

Personal history of medical treatment

165

3.60

15.21

2.0

2.1

1.80

1.54

g/l

0.80

153

Unspecified contracted kidney

4.73

15.20

2.2

2.3

1.60

1.42

g/l

0.55

Malignant melanoma, including Hilmo

509

3502

1.48

15.20

1.9

1.6

1.51

1.56

g/l

0.55

443

3002

Ulcerative ileocolitis

113

502

2.34

15.17

1.9

2.0

1.40

1.48

g/l

0.45

444

Malignant neoplasm of prostate

890

3932

1.36

15.17

1.6

1.61

1.52

g/l

1.70

765

3339

Diseases of external ear

1060

8196

1.31

15.14

1.8

1.7

1.55

1.53

g/l

0.24

907

7025

Urticaria

734

5376

1.38

15.11

2.0

1.8

1.48

g/l

0.03

636

4658

Fracture of skull and facial bones

595

4213

1.44

15.10

1.8

1.50

1.53

g/l

0.32

520

3638

Other noninfective disorders of lymphatic vessels and lymph nodes

119

543

2.29

15.06

1.7

1.80

1.60

g/l

1.06

102

471

Focal epilepsy, strict definition

578

4078

1.44

15.02

1.9

1.7

1.51

1.52

g/l

0.10

468

3532

Background retinopathy and retinal vascular changes

372

2.62

15.01

2.1

1.53

1.52

g/l

0.05

336

Trochanteric bursitis

410

2708

1.55

14.95

1.8

1.7

1.58

1.59

g/l

0.05

361

2328

Erosion of teeth , including avohilmo

646

4646

1.41

14.90

2.0

1.9

1.36

1.46

g/l

2.44

563

4042

Recurrent aphthous stomatitis , including avohilmo

418

2776

1.54

14.89

1.8

1.41

1.51

g/l

1.37

370

2401

Carcinoma in situ of other and unspecified digestive organs

174

923

1.98

14.85

1.9

1.8

1.59

g/l

0.03

166

798

ILD-related respiratory insufficiency

148

745

2.11

14.81

2.5

1.8

1.63

1.54

g/l

0.50

131

649

Spondylolisthesis/Spondylolysis

508

3509

1.47

14.81

1.8

1.7

1.63

1.55

g/l

1.10

447

3028

Dermatophytosis

435

2920

1.53

14.80

1.9

1.7

1.58

1.54

g/l

0.36

374

2531

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

507

3503

1.48

14.78

1.7

1.8

1.49

1.52

g/l

0.25

459

3032

Disorders of iron metabolism

203

3.21

14.78

1.6

2.3

1.21

1.50

g/l

1.56

180

Malignant neoplasm of head and neck, including Hilmo

302

1868

1.66

14.75

1.6

1.66

1.55

g/l

1.29

255

1598

Eating disorders

225

1279

1.79

14.74

2.0

2.2

1.31

g/l

0.00

200

1129

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

175

929

1.96

14.73

1.8

1.6

1.44

1.54

g/l

0.60

143

802

Other extrapyramidal and movement disorders in other diseases

763

5667

1.37

14.60

1.6

1.7

1.51

1.56

g/l

0.89

647

4892

Other and unspecified mood [affective] disorders

163

845

1.97

14.44

1.8

1.9

1.52

1.36

g/l

1.34

139

754

Artrosis, including avohilmo

2350

10790

1.20

14.40

1.6

1.8

1.57

1.52

g/l

2.03

2004

9274

Carcinoma in situ of skin of ear and external auricular canal

384

2.62

14.35

2.0

1.9

1.46

1.48

g/l

0.06

336

Other psoriatic arthropathies

284

1742

1.67

14.34

1.6

1.8

1.60

1.55

g/l

0.42

240

1503

Migraine

1163

7088

1.29

14.30

1.9

1.40

1.45

g/l

1.26

1013

6228

Polyarteritis nodosa

100

4.41

14.29

1.7

2.0

1.46

1.48

g/l

0.04

Abnormality of red blood cells

4.88

14.27

1.5

2.3

1.37

1.49

g/l

0.27

Carcinoma in situ of colon

118

553

2.27

14.23

1.9

1.8

1.56

1.59

g/l

0.16

112

484

Systemic sclerosis

350

2.60

14.23

2.0

1.8

1.51

1.54

g/l

0.12

308

Malignant neoplasm of stomach, including Hilmo

202

1134

1.84

14.18

1.5

1.6

1.58

1.53

g/l

0.38

183

967

severe traumatic brain injury, does not include concussion

763

5704

1.36

14.06

1.8

1.7

1.48

1.53

g/l

0.99

639

4860

Disorders of muscles

290

1796

1.65

14.05

1.9

1.7

1.60

1.50

g/l

0.93

259

1553

Faecal incontinence

276

1691

1.68

14.03

1.6

1.66

1.58

g/l

0.66

235

1450

Superficial injury of thorax

454

3106

1.49

14.00

1.8

1.7

1.47

1.51

g/l

0.33

396

2659

Malignant neoplasm of head and neck

258

1557

1.71

13.95

1.7

1.6

1.68

1.55

g/l

1.33

223

1345

Superficial injury of abdomen, lower back and pelvis

438

2976

1.50

13.94

1.7

1.8

1.46

1.49

g/l

0.27

367

2591

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

873

6555

1.33

13.89

1.8

1.9

1.50

1.43

g/l

1.24

764

5697

Other disorders of nervous system

220

1277

1.78

13.82

1.8

1.66

1.54

g/l

1.15

192

1109

Other specified and unspecified personality disorders

214

1227

1.79

13.81

1.6

1.9

1.64

1.46

g/l

1.64

191

1066

Malignant neoplasm of bladder

243

1448

1.73

13.81

1.6

1.5

1.80

1.51

g/l

4.26

214

1232

Pure hyperglyceridaemia

337

2.61

13.81

1.8

2.1

1.74

1.53

g/l

1.12

298

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

183

1003

1.88

13.80

1.6

1.9

1.57

1.47

g/l

0.80

158

889

Unspecified mental disorder

985

7629

1.30

13.78

1.7

1.8

1.62

1.49

g/l

4.50

856

6593

Panic disorder

316

2002

1.60

13.78

2.0

1.9

1.50

1.40

g/l

0.91

290

1741

Schizophrenia or delusion

763

5708

1.35

13.76

1.6

1.8

1.67

1.49

g/l

5.20

652

4936

Melanocytic naevi

816

6173

1.34

13.68

2.1

1.7

1.38

1.51

g/l

4.22

724

5352

Viral warts, including avohilmo

544

3860

1.43

13.66

2.0

1.8

1.42

1.47

g/l

0.72

488

3344

Gonarthrosis, primary, with knee surgery

1874

12120

1.22

13.64

1.6

1.7

1.62

1.57

g/l

1.26

1589

10379

Carcinoma in situ of skin of lower limb, including hip

105

481

2.36

13.57

1.9

1.7

1.37

1.59

g/l

1.95

432

Septal defects

162

840

1.95

13.57

1.8

2.1

1.26

1.44

g/l

1.63

133

743

Volvulus

439

2.37

13.52

2.9

1.9

1.67

1.50

g/l

0.84

380

Adenocarcinoma and Papillary adenocarcinoma of kidney

189

3.26

13.48

2.3

1.8

1.87

1.55

g/l

1.21

170

Use of disulfiram, acamprosate or naltrexone

229

1350

1.74

13.46

1.5

1.8

1.71

1.49

g/l

2.96

199

1171

!Aliquae complicationes praecoces traumatis

145

745

2.03

13.46

1.9

1.60

1.51

g/l

0.52

130

658

Early complications of trauma

145

745

2.03

13.46

1.9

1.60

1.51

g/l

0.52

130

658

Fibromyalgia

210

1206

1.78

13.45

1.6

1.8

1.56

1.53

g/l

0.13

183

1052

Pregnancy examination and test

242

873

1.74

13.41

1.9

1.16

1.44

g/l

5.16

215

758

Cutaneous lupus erythematosus

348

2.55

13.40

2.2

1.9

1.55

1.53

g/l

0.04

307

Mental and behavioural disorders due to use of other stimulants, including caffeine

252

2.80

13.39

1.6

2.1

1.46

1.32

g/l

0.51

230

Schizophrenia, schizotypal and delusional disorders

765

5751

1.35

13.37

1.6

1.8

1.67

1.49

g/l

5.28

654

4971

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

191

1071

1.83

13.32

2.3

1.8

1.36

1.59

g/l

3.27

172

923

Excessive, frequent and irregular menstruation

901

3652

1.33

13.27

2.0

1.9

1.48

g/l

0.01

789

3134

Central retinal artery occlusion

105

485

2.32

13.26

1.8

1.56

1.51

g/l

0.22

426

Bronchiectasis

274

1707

1.66

13.22

1.6

1.64

1.55

g/l

0.86

234

1466

Other chondrocalcinosis

253

2.92

13.21

1.7

2.0

1.63

1.54

g/l

0.26

231

Intentional self-harm by unspecified means

133

3.60

13.18

1.5

2.8

1.51

1.31

g/l

0.65

120

Nonalcoholic steatohepatitis

115

3.90

13.13

2.5

2.0

1.20

1.47

g/l

1.05

103

Fibrosis of liver

116

3.97

13.11

2.4

2.3

1.33

1.54

g/l

0.77

104

Systemic sclerosis, icd10

358

2.51

13.11

2.0

1.9

1.52

1.56

g/l

0.11

314

Eating disorder

173

942

1.87

13.11

2.2

2.3

1.27

1.21

g/l

0.32

153

828

Malignant neoplasm of prostate, including Hilmo

884

3977

1.33

13.10

1.6

1.61

1.53

g/l

1.78

759

3378

Lesion of lateral popliteal nerve

159

851

1.94

13.08

1.8

1.9

1.53

g/l

0.01

138

741

Ankylosing spondylitis, strict definition

113

534

2.19

13.07

1.4

2.0

1.49

1.50

g/l

0.01

469

Postprocedural musculoskeletal disorders, not elsewhere classified

239

1444

1.71

13.02

1.8

1.68

1.56

g/l

1.07

202

1259

Other specified/unspecified inflammatory spondylopathies

119

574

2.14

13.01

1.7

2.0

1.48

g/l

0.01

103

501

Pain associated with micturition

344

2259

1.56

13.01

2.1

1.8

1.46

1.53

g/l

0.92

288

1964

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

219

1293

1.75

12.96

1.8

1.6

1.45

1.56

g/l

0.83

180

1114

Acute pharyngitis

334

2152

1.56

12.95

1.8

1.9

1.44

1.38

g/l

0.51

297

1881

Irregular menses

992

5793

1.30

12.92

2.0

1.9

1.42

1.44

g/l

0.33

860

5050

Trigger finger

385

2590

1.51

12.91

1.7

1.48

1.56

g/l

0.90

342

2245

Hyphaema and other vascular disorders of iris and ciliary body

375

2.47

12.83

1.8

2.1

1.86

1.50

g/l

2.57

336

Follow-up examination after treatment for malignant neoplasms

297

1894

1.60

12.81

1.7

1.5

1.64

1.62

g/l

0.14

252

1631

Other diseases of upper respiratory tract

3311

15008

1.16

12.77

1.8

1.53

1.52

g/l

0.24

2854

12887

Generalized anxiety disorder

341

2241

1.54

12.57

1.9

2.0

1.38

g/l

0.01

300

1965

Other disorders of optic [2nd] nerve and visual pathways

190

1087

1.80

12.56

2.0

1.9

1.47

1.52

g/l

0.25

165

952

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

168

3.21

12.55

3.7

2.1

1.28

1.32

g/l

0.10

153

Other shoulder lesions

252

1552

1.66

12.53

1.7

1.8

1.58

1.51

g/l

0.50

221

1344

Other primary thrombocytopenia

5.32

12.49

1.9

1.34

1.45

g/l

0.24

Other epidermal thickening

150

801

1.95

12.47

1.7

1.9

1.49

1.50

g/l

0.09

136

697

Assault by bodily force

172

954

1.84

12.44

1.9

2.0

1.49

1.43

g/l

0.33

153

839

Malignant neoplasm of oral cavity

115

561

2.14

12.40

1.5

1.65

1.56

g/l

0.50

494

Diseases of the ear and mastoid process

3231

14086

1.16

12.38

1.8

1.50

1.52

g/l

0.68

2760

12203

Benign neoplasm: Rectosigmoid junction

154

835

1.94

12.36

1.7

1.8

1.69

1.57

g/l

0.82

133

728

Orchitis and epididymitis

303

1962

1.59

12.32

1.7

1.66

1.53

g/l

1.67

266

1685

Other predominantly sexually transmitted diseases, not elsewhere classified

344

2280

1.53

12.31

1.8

2.0

1.41

1.42

g/l

0.08

294

1995

Neuroendocrine tumor and carcinoma of small intestine

204

3.01

12.28

1.5

1.63

1.58

g/l

0.15

181

Primary gonarthrosis, bilateral

1642

11414

1.22

12.24

1.5

1.7

1.62

1.56

g/l

1.61

1387

9777

Other surgical follow-up care

437

2.28

12.24

2.1

1.8

1.47

1.43

g/l

0.15

395

Malignant neoplasm of oral cavity, including Hilmo

141

742

1.97

12.24

1.5

1.6

1.63

1.54

g/l

0.55

122

646

Convalescence

135

698

1.99

12.23

2.1

1.7

1.57

1.51

g/l

0.25

111

614

Ulcerative colitis (strict definition, all Crohn cases excluded)

355

2376

1.52

12.23

1.8

1.41

1.48

g/l

0.75

314

2065

Supervision of high-risk pregnancy

315

1208

1.58

12.21

2.1

1.9

1.17

1.50

g/l

8.44

267

1052

Mantle cell lymphoma

163

3.34

12.17

1.6

1.63

1.54

g/l

0.22

145

Voice disturbances

739

5614

1.34

12.17

1.7

1.53

1.55

g/l

0.35

642

4829

Myositis

428

2.32

12.14

1.6

1.8

1.69

1.51

g/l

1.07

376

Visual field defects

270

1710

1.63

12.14

1.7

1.8

1.57

1.53

g/l

0.26

239

1479

Oter anti-inflammatory and antirheumatic agents, non-steroids

761

3150

1.35

12.13

1.7

1.9

1.57

1.49

g/l

1.28

646

2691

Disorders of optic nerve and visual pathways

252

1568

1.65

12.09

1.9

1.48

1.49

g/l

0.07

219

1372

Personal history of certain other diseases

166

3.14

12.07

1.7

2.0

1.45

1.31

g/l

0.51

151

Nummular dermatitis

265

1673

1.63

12.07

1.7

1.56

1.51

g/l

0.37

228

1448

Hepatocellular carcinoma, including Hilmo

113

556

2.14

12.01

1.8

1.6

1.28

1.48

g/l

1.29

479

Cardiomyopathy in other diseases

4.29

12.00

1.5

1.8

1.28

1.52

g/l

0.90

Synovial cyst of popliteal space [Baker]

223

1350

1.70

12.00

1.8

1.7

1.55

1.58

g/l

0.12

195

1158

Malignant neoplasm of stomach

173

977

1.83

11.99

1.4

1.6

1.61

1.52

g/l

0.66

156

833

Spontaneous rupture of synovium and tendon

248

1542

1.65

11.98

1.7

1.64

1.57

g/l

0.49

204

1328

Campylobacter enteritis

398

2.34

11.95

2.2

2.0

1.60

1.50

g/l

0.36

352

Coxibs

899

3641

1.31

11.84

1.7

2.0

1.53

1.44

g/l

2.05

761

3123

Other benign neoplasms of skin

1100

8820

1.26

11.81

1.9

1.7

1.51

1.56

g/l

1.10

895

7589

Lesion of ulnar nerve

381

2611

1.49

11.74

1.6

1.7

1.54

1.53

g/l

0.04

334

2257

Atrial septal defect, secundum type

306

2.51

11.69

2.1

2.2

1.18

1.37

g/l

1.10

275

Toxic liver disease

215

2.88

11.68

2.1

1.9

1.30

1.49

g/l

0.72

196

Complications of other internal prosthetic devices, implants and grafts

141

757

1.94

11.58

1.7

1.43

1.53

g/l

0.72

129

662

Wet age-related macular degeneration

670

4884

1.35

11.58

1.6

1.59

g/l

0.03

568

4168

Carpal tunnel syndrome

1706

12378

1.20

11.56

1.7

1.57

1.54

g/l

0.67

1490

10600

Other and unspecified urticaria

471

3361

1.42

11.56

2.2

1.7

1.46

1.49

g/l

0.29

403

2900

Migraine with aura and triptan purchases

320

2118

1.53

11.56

1.6

2.0

1.49

1.39

g/l

0.95

271

1871

Disorders of myoneural junction and muscle in diseases classified elsewhere

116

3.72

11.56

2.3

2.1

1.71

1.60

g/l

0.19

104

Chorioretinal inflammation

437

2.25

11.51

1.7

1.9

1.58

1.57

g/l

0.03

384

Chronic laryngitis and laryngotracheitis

402

2795

1.47

11.51

1.7

1.66

1.57

g/l

1.18

331

2416

Pemphigoid

116

588

2.09

11.48

1.9

1.8

1.53

g/l

0.01

101

522

Other and specified injuries of hip and thigh

413

2.30

11.47

1.4

2.0

1.48

1.54

g/l

0.20

376

Acute and transient psychotic disorders

270

1728

1.59

11.46

1.6

1.8

1.66

1.50

g/l

1.90

233

1509

Speech and linguistic disorders

193

1085

1.74

11.45

1.9

2.1

1.52

1.30

g/l

2.16

170

957

Other congenital malformations of the digestive system, including avohilmo

139

738

1.93

11.42

2.1

2.0

1.39

1.47

g/l

0.46

121

655

Maze procedure for atrial fibrillation

4.45

11.42

2.4

1.7

1.18

1.50

g/l

0.88

Carrier of infectious disease

324

2.46

11.38

2.6

2.2

1.56

1.41

g/l

0.59

290

Rheumatic fever incl heart disease

112

560

2.09

11.38

2.4

1.8

1.36

1.54

g/l

1.05

495

Sequelae of injuries, of poisoning and of other consequences of external causes

602

4483

1.36

11.37

1.6

1.8

1.62

1.53

g/l

1.44

514

3891

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

402

2793

1.46

11.37

2.0

1.36

1.39

g/l

0.24

343

2451

Disorders of conjunctiva

2272

15096

1.17

11.35

1.9

1.8

1.49

1.51

g/l

0.62

2001

12995

Rheumatic valve diseases

402

2.31

11.34

2.6

1.8

1.22

1.56

g/l

2.17

358

Hypopituitarism

184

1076

1.75

11.21

2.3

1.9

1.41

1.48

g/l

0.45

163

946

Acute lymphadenitis

138

742

1.91

11.13

2.1

2.0

1.50

g/l

0.00

127

651

Other specified and unspecified disorders of eye and adnexa

116

592

2.04

11.07

1.9

1.48

1.51

g/l

0.13

101

523

Open wound of abdomen, lower back and pelvis

444

2.20

11.02

2.0

2.1

1.57

1.41

g/l

0.86

396

Presence of other devices

752

5716

1.31

11.00

1.8

1.6

1.56

1.60

g/l

0.56

637

4896

Focal epilepsy, mode (most common among epilepsy diagnosis)

523

3834

1.39

10.99

1.7

1.48

1.51

g/l

0.38

423

3323

Other disorders of iris and ciliary body

101

493

2.15

10.98

1.7

2.0

1.80

1.52

g/l

2.05

445

Ulcerative proctitis

156

876

1.83

10.97

1.5

1.9

1.57

1.48

g/l

0.56

138

767

Inflammatory disease of uterus

286

1872

1.55

10.94

1.9

1.46

1.44

g/l

0.10

250

1623

Extrapyramidal and movement disorders

1207

9865

1.24

10.92

1.6

1.7

1.53

1.56

g/l

0.52

1015

8473

Periapical abscess

1219

9964

1.23

10.91

1.7

1.8

1.56

1.53

g/l

0.59

1048

8607

Malignant melanoma of skin

342

2332

1.50

10.90

1.8

1.6

1.48

1.55

g/l

0.77

300

2004

Impetigo

108

538

2.06

10.89

2.2

2.1

1.36

1.39

g/l

0.09

478

Other disorders of eye and adnexa

368

2544

1.47

10.85

1.8

1.47

1.51

g/l

0.42

331

2193

Adhesive capsulitis of shoulder

446

3194

1.42

10.82

1.7

1.63

1.57

g/l

0.61

391

2744

Manic episode

369

2.30

10.80

1.8

2.2

1.50

1.42

g/l

0.28

332

conjunctival haemorrhage

252

1618

1.60

10.79

2.2

1.7

1.45

1.54

g/l

0.86

225

1396

Other immunodeficiencies

136

3.32

10.77

2.0

2.2

1.30

1.44

g/l

0.45

127

Iridocyclitis in diseases classified elsewhere

278

2.55

10.75

1.7

2.1

1.34

1.46

g/l

0.56

249

Degeneration of nervous system due to alcohol

446

2.22

10.73

1.6

1.8

1.55

1.59

g/l

0.13

389

Degenerative macular diseases

403

2851

1.45

10.66

1.8

1.7

1.60

1.59

g/l

0.09

349

2440

Nail disorders

224

1399

1.64

10.65

2.3

1.8

1.60

1.52

g/l

0.61

200

1218

Malignant melanoma of skin, including Hilmo

402

2841

1.44

10.57

1.8

1.6

1.49

1.55

g/l

0.66

354

2428

Cushing syndrome

154

3.14

10.54

1.8

2.0

2.00

1.43

g/l

1.99

137

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

345

2.38

10.50

2.1

1.8

1.46

1.58

g/l

0.52

311

Congenital malformations of pulmonary and tricuspid valves

4.33

10.50

2.9

1.6

1.02

1.27

g/l

0.76

Other condition

380

2661

1.45

10.49

1.7

1.8

1.59

1.50

g/l

0.97

338

2303

Coxarthrosis, primary, with hip surgery

1522

11833

1.21

10.49

1.5

1.7

1.60

1.58

g/l

0.47

1295

10087

Injury of intra-abdominal organs

343

2.34

10.47

1.8

2.1

1.67

1.44

g/l

1.00

314

Marfan's syndrome

4.68

10.46

1.7

1.9

1.18

1.46

g/l

0.55

Other inflammation of eyelid, including avohilmo

1088

8829

1.24

10.41

1.8

1.45

1.49

g/l

0.68

934

7643

Status epilepticus

119

627

1.97

10.39

1.7

1.9

1.55

1.50

g/l

0.20

103

545

Other inflammation of eyelid

400

2834

1.44

10.38

1.8

1.7

1.57

1.54

g/l

0.27

341

2440

Rare circulating lymphoid malignancy

100

3.85

10.37

1.8

1.7

1.33

1.44

g/l

0.18

Other and unspecified injuries of lower leg

195

1184

1.68

10.36

1.9

2.0

1.53

1.51

g/l

0.11

172

1047

Acute suppurative otitis media

532

3671

1.36

10.27

2.0

1.9

1.42

1.37

g/l

0.73

471

3218

Degeneration of the brain due to alcohol

454

2.18

10.27

1.6

1.8

1.55

1.58

g/l

0.11

398

Infective dermatitis

319

2172

1.50

10.26

1.6

1.7

1.55

1.52

g/l

0.20

267

1884

Kela-code for severe mental illness

866

6866

1.27

10.24

1.6

1.8

1.67

1.50

g/l

5.73

748

5930

Other localized connective tissue disorders

272

2.52

10.24

2.6

2.1

1.52

1.53

g/l

0.01

242

Fracture at wrist and hand level

893

7084

1.27

10.23

1.7

1.8

1.49

1.51

g/l

0.17

764

6127

Asthma and allergy, excluding more controls

213

1304

1.63

10.22

1.6

1.9

1.54

1.30

g/l

3.79

191

1131

Benign neoplasm of mouth and pharynx

308

2086

1.51

10.21

1.6

1.7

1.54

g/l

0.00

253

1801

Biomechanical lesions, not elsewhere classified

158

914

1.79

10.19

1.6

1.8

1.46

1.53

g/l

0.41

145

802

Other symptoms and signs involving the urinary system

318

2169

1.50

10.19

1.7

1.59

1.52

g/l

0.56

274

1886

Anorexia (incl.atypical)

132

720

1.87

10.16

2.1

1.27

1.36

g/l

0.53

121

639

Other congenital malformations of the digestive system

117

612

1.96

10.13

2.1

2.0

1.37

1.43

g/l

0.29

106

543

Hypothyroidism due to medicaments and other exogenous substances

180

2.93

10.13

1.4

1.9

1.58

1.51

g/l

0.21

162

Injuries to the neck

577

4347

1.34

10.13

1.8

1.52

1.48

g/l

0.47

504

3759

Other specified and unspecified retinal disorders

122

655

1.94

10.12

2.4

1.8

1.45

1.61

g/l

0.93

108

567

Congenital malformations of great arteries

232

2.61

10.09

1.7

2.3

1.29

1.32

g/l

0.07

208

Other and unspecified iridocyclitis

135

747

1.87

10.07

2.1

1.9

1.50

1.48

g/l

0.07

127

657

Malignant neoplasm of rectum, including Hilmo

352

2454

1.46

10.04

1.7

1.6

1.71

1.55

g/l

2.46

309

2086

Macular pucker

526

3928

1.37

10.03

1.5

1.7

1.53

1.59

g/l

0.78

449

3378

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

226

2.64

10.00

1.9

2.4

1.58

1.41

g/l

0.61

205

Inflammatory diseases of female pelvic organs

1415

8056

1.21

10.00

1.8

1.9

1.47

1.50

g/l

0.54

1201

6991

Diseases of salivary glands

846

6715

1.27

9.97

1.9

1.7

1.56

1.53

g/l

0.32

728

5793

Other and unspecified vascular occlusions

324

2233

1.49

9.94

1.8

1.7

1.54

1.57

g/l

0.25

275

1910

Other abnormal immunological findings in serum

245

2.56

9.91

1.7

2.0

1.56

1.44

g/l

0.49

217

Other misadventures during surgical and medical care

392

2.23

9.88

1.8

2.1

1.65

1.50

g/l

0.64

355

Follow-up care involving plastic surgery

464

2.09

9.81

1.5

1.7

1.70

1.50

g/l

1.07

408

Seborrhoeic keratosis

727

5684

1.30

9.79

1.8

1.7

1.48

1.58

g/l

2.17

651

4885

Other secondary gonarthrosis

168

1001

1.73

9.77

1.6

1.8

1.77

1.57

g/l

1.91

144

875

Diplopia

375

2658

1.44

9.77

1.7

1.60

1.54

g/l

0.48

313

2299

Internal derangement of knee

908

7204

1.26

9.77

1.7

1.8

1.52

1.49

g/l

0.38

764

6178

Menorrhagia

778

3379

1.30

9.76

1.8

1.50

1.52

g/l

0.17

666

2885

Emphysema

256

1690

1.56

9.72

1.6

1.7

1.68

1.53

g/l

1.77

222

1454

Ingrowing nail

141

800

1.81

9.67

1.9

2.0

1.67

1.49

g/l

1.38

126

707

Personal history of malignant neoplasm

191

1175

1.66

9.65

1.7

1.50

1.59

g/l

0.57

167

1016

Migraine without aura

382

2713

1.42

9.63

1.9

2.0

1.31

1.37

g/l

0.72

329

2382

Post-traumatic wound infection, not elsewhere classified

422

2.15

9.62

1.7

2.1

1.60

1.46

g/l

0.81

382

Intrahepatic Cholestasis of Pregnancy (ICP)

123

668

1.88

9.61

2.2

1.9

1.09

1.34

g/l

2.11

106

582

Disorders of psychological development

236

1411

1.57

9.60

1.9

2.1

1.50

1.30

g/l

2.24

211

1244

Other mycoses, not elsewhere classified/unspecified, including avohilmo

256

2.51

9.57

2.1

2.0

1.47

1.44

g/l

0.10

229

Malignant neoplasm, without specification of site, including Hilmo

150

870

1.78

9.56

1.6

1.79

1.53

g/l

1.78

121

744

Abnormal findings on antenatal screening of mother

131

726

1.83

9.55

2.1

1.12

1.19

g/l

0.43

114

642

Postzoster neuralgia

295

2.42

9.55

1.7

1.40

1.60

g/l

0.84

265

Erythema nodosum

410

2.16

9.52

1.9

1.50

1.53

g/l

0.09

364

Hydrocele

383

2740

1.43

9.51

2.1

1.6

1.45

1.53

g/l

1.16

327

2355

Conjunctivitis (acute, non atopic)

693

5375

1.30

9.51

2.0

1.7

1.51

1.50

g/l

0.06

625

4644

Symptoms and signs involving emotional state

383

2.19

9.50

1.9

2.2

1.52

1.48

g/l

0.11

338

Haemorrhagic disorder due to circulating anticoagulants

297

2.43

9.49

1.6

1.5

1.59

1.62

g/l

0.08

270

Otitis externa

597

4566

1.32

9.48

1.9

1.8

1.54

1.51

g/l

0.28

525

3939

Complications of genitourinary prosthetic devices, implants and grafts

385

2.20

9.45

2.1

1.8

1.73

1.51

g/l

1.18

339

Blindness, monocular

159

3.00

9.45

2.0

2.2

1.73

1.52

g/l

0.44

147

Other disorders of amino-acid metabolism

4.45

9.41

7.0

2.5

0.97

1.53

g/l

2.11

Pain in thoracic spine

377

2689

1.42

9.40

2.0

1.7

1.46

1.51

g/l

0.45

325

2314

Selective deficiency of immunoglobulin G [IgG] subclasses

3.82

9.39

2.6

2.0

1.46

1.51

g/l

0.09

Hypertrophic disorders of skin

132

740

1.83

9.39

1.9

2.1

1.43

1.46

g/l

0.13

113

656

Other/unspecified synovitis and tenosynovitis

296

2022

1.49

9.37

1.9

1.7

1.49

1.54

g/l

0.44

259

1745

Contact with heat and hot substances

140

801

1.80

9.34

2.0

1.35

1.49

g/l

0.93

114

709

802

5961

1.28

9.32

1.7

1.6

1.52

1.59

g/l

1.55

673

5075

Cervicalgia

544

4118

1.34

9.30

1.8

1.7

1.52

1.53

g/l

0.06

464

3548

Malignant neoplasm of breast, including Hilmo

833

4229

1.27

9.28

1.5

1.7

1.67

1.59

g/l

1.08

697

3625

Other follicular disorders

184

1135

1.66

9.25

1.8

1.9

1.73

1.47

g/l

3.16

168

992

Congenital iodine-deficiency syndrome/hypothyroidism

477

2.06

9.23

2.0

1.7

1.60

1.49

g/l

0.49

413

Senility

165

2.88

9.23

1.4

1.45

1.59

g/l

0.42

146

Malignant neoplasm of breast, HER2-negative, including Hilmo

832

4229

1.27

9.19

1.5

1.7

1.67

1.59

g/l

1.09

696

3625

Mental and behavioural disorders due to cannabinoids

253

2.44

9.17

1.3

2.3

1.65

1.35

g/l

1.39

232

Focal brain injury

193

1209

1.64

9.16

1.7

1.8

1.49

1.50

g/l

0.09

162

1041

Ectropion of eyelid

162

978

1.72

9.10

2.0

1.7

1.59

1.51

g/l

0.54

138

831

Other eating disorders

504

1.98

9.05

2.0

2.3

1.17

1.21

g/l

0.17

447

Fibroblastic disorders

676

5292

1.29

9.04

1.6

1.7

1.47

1.56

g/l

1.77

586

4510

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

162

977

1.71

9.02

1.8

1.6

1.48

1.54

g/l

0.36

134

838

Malignant neoplasm of tongue

302

2.33

8.98

1.5

1.68

1.54

g/l

0.60

265

Intentional self-harm by sharp object

250

2.44

8.96

1.5

2.5

1.31

1.33

g/l

0.04

228

Follicular lymphoma, hilmo

145

853

1.77

8.96

1.6

1.9

1.73

1.55

g/l

0.95

111

748

Abnormal findings on diagnostic imaging of central nervous system

131

745

1.81

8.95

2.0

1.54

1.52

g/l

0.09

108

656

Other hearing loss

960

7586

1.24

8.94

1.9

1.7

1.51

1.59

g/l

2.01

809

6542

Other congenital malformations of skin

100

523

1.97

8.92

1.5

2.2

1.31

1.50

g/l

1.33

467

CR(E)ST syndrome

210

2.62

8.90

2.1

2.0

1.47

1.58

g/l

0.38

184

Abdominal aortic aneurysm (AAA)

351

2485

1.43

8.89

1.9

1.7

1.66

1.51

g/l

2.12

301

2101

Restless leg syndrome

390

2835

1.40

8.80

1.7

1.48

1.55

g/l

0.92

333

2445

Retinal haemorrhage

508

2.00

8.79

2.0

1.8

1.38

1.58

g/l

1.56

449

Corneal scars and opacities

472

2.03

8.79

2.2

2.0

1.56

1.51

g/l

0.14

424

Mental disorders, not otherwise specified

178

1103

1.64

8.78

2.0

1.39

1.41

g/l

0.17

160

964

Organ-limited amyloidosis

3.72

8.78

1.7

2.4

1.33

1.61

g/l

0.84

Myocardial infarction, unclassifiable

780

5567

1.27

8.77

1.6

1.63

1.55

g/l

1.82

664

4708

Disorders of vestibular function (Vertigo)

1363

11207

1.19

8.77

1.6

1.7

1.54

1.56

g/l

0.29

1157

9593

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

115

635

1.88

8.76

2.8

1.8

1.52

1.53

g/l

0.02

565

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

123

689

1.82

8.74

2.2

2.0

1.09

1.25

g/l

1.12

106

602

Orthopaedic devices associated with adverse incidents

360

2.22

8.73

1.4

1.8

1.69

1.53

g/l

0.72

320

Other bullous disorders

446

2.06

8.71

1.9

1.45

1.46

g/l

0.02

404

Other erythematous conditions

108

586

1.91

8.69

1.8

2.0

1.32

1.51

g/l

1.47

517

Disorders of tooth development and eruption

367

2138

1.41

8.68

1.8

1.7

1.49

1.47

g/l

0.11

331

1844

Oesophageal obstruction

122

689

1.84

8.68

1.7

1.8

1.58

1.55

g/l

0.16

107

597

Social phobias

159

959

1.68

8.65

2.1

1.9

1.36

1.32

g/l

0.17

140

841

Surgical ablation of atrial fibrillation

3.61

8.65

2.4

1.8

1.28

1.62

g/l

0.91

Other bacterial agents as the cause of diseases classified to other chapters

161

2.87

8.64

2.1

2.0

1.62

1.49

g/l

0.41

143

Malignant neoplasm of breast

814

4188

1.26

8.62

1.5

1.7

1.65

1.60

g/l

0.73

679

3589

Ventricular septal defect, a heart condition

242

2.44

8.62

1.6

2.5

1.20

1.29

g/l

0.27

217

Leisure time condition

494

3737

1.34

8.57

1.7

1.49

1.51

g/l

0.17

414

3235

Malignant neoplasm of breast, HER2-negative

812

4181

1.26

8.56

1.5

1.7

1.65

1.60

g/l

0.69

677

3582

Primary adrenocortical insufficiency

156

2.88

8.54

1.9

2.3

1.37

1.42

g/l

0.15

140

Impacted cerumen

360

2601

1.41

8.52

1.5

1.7

1.51

1.54

g/l

0.28

289

2253

Other disorders of conjunctiva

422

3127

1.37

8.50

2.1

1.7

1.46

1.57

g/l

1.61

371

2698

Caries of enamel

2554

14744

1.14

8.46

1.9

1.8

1.43

1.53

g/l

7.34

2259

12703

Other maltreatment syndromes

354

2.16

8.46

1.9

1.41

1.45

g/l

0.12

316

Psychotic depression

148

886

1.71

8.39

1.7

1.9

1.58

1.46

g/l

0.81

129

772

Other keratitis

282

1952

1.47

8.39

2.1

1.8

1.57

1.49

g/l

0.68

250

1691

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1274

10268

1.20

8.39

1.7

1.8

1.50

g/l

0.02

1116

8875

Traumatic subarachnoid haemorrhage

122

695

1.82

8.39

1.8

1.7

1.44

1.54

g/l

0.58

100

599

Viral infections of the central nervous system

177

1110

1.63

8.39

1.7

1.9

1.48

1.51

g/l

0.16

149

979

Preterm labour and delivery

459

3440

1.35

8.38

2.5

1.8

1.26

1.53

g/l

8.68

396

2997

Somnolence, stupor and coma

126

724

1.79

8.37

1.8

1.9

1.61

1.54

g/l

0.39

114

629

Disorders of ocular muscles, binocular movement, accommodation and refraction

1172

9717

1.20

8.34

1.9

1.8

1.50

1.48

g/l

0.20

1010

8427

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

156

947

1.68

8.34

2.1

1.9

1.15

1.43

g/l

3.38

136

822

Traction detachment of retina

136

3.03

8.34

3.2

2.1

1.66

1.50

g/l

0.47

121

Superficial injury of wrist and hand

484

3664

1.34

8.30

1.6

1.9

1.51

1.47

g/l

0.44

422

3186

Varicella [chickenpox], including avohilmo

116

650

1.82

8.30

2.8

2.0

1.44

1.39

g/l

0.20

106

565

Dementia in Alzheimer disease

431

4793

0.74

8.29

1.5

1.7

1.62

1.55

g/l

0.80

321

4104

Ptosis of eyelid

343

2471

1.42

8.28

1.5

1.7

1.51

1.57

g/l

0.62

296

2117

Colonic or urogenital fistula

704

5601

1.27

8.27

1.9

1.7

1.55

1.54

g/l

0.15

601

4828

Artificial joint re-operation

224

1492

1.55

8.27

1.5

1.7

1.72

1.57

g/l

1.26

186

1297

Sacroiliitis, not elsewhere classified

101

543

1.90

8.25

1.8

2.1

1.60

1.39

g/l

1.07

474

Behavioural syndromes associated with physiological disturbances and physical factors

2567

15363

1.14

8.24

1.8

1.47

1.52

g/l

1.47

2211

13259

Other and unspecified erythematous conditions

525

1.94

8.24

1.8

2.0

1.34

1.51

g/l

1.14

466

Event of undetermined intent

158

968

1.67

8.23

1.6

2.0

1.54

1.49

g/l

0.24

131

845

Necrosis of pulp, including avohilmo

1436

12092

1.18

8.21

1.8

1.49

1.51

g/l

0.28

1232

10494

Calculus of kidney and ureter

884

7221

1.24

8.21

1.8

1.7

1.56

1.53

g/l

0.28

773

6197

Secondary parkinsonism, excluding more controls

421

2.05

8.20

1.4

1.7

1.60

1.54

g/l

0.22

357

Urolithiasis

970

8002

1.23

8.17

1.8

1.7

1.55

1.53

g/l

0.27

844

6880

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

683

4449

1.28

8.16

1.7

1.6

1.88

1.56

g/l

11.74

586

3786

Disease of hard tissues of teeth, NOS

1496

6653

1.19

8.16

1.7

1.6

1.47

1.57

g/l

3.78

1263

5711

Speech disturbances, not elsewhere classified

283

1977

1.46

8.15

1.9

1.8

1.58

1.53

g/l

0.36

238

1700

Other abnormal uterine and vaginal bleeding

545

3003

1.32

8.14

1.8

1.56

g/l

0.02

457

2558

All dysplastic lesions of the vulva

101

547

1.90

8.13

2.4

1.9

1.64

1.54

g/l

0.42

480

Atopic dermatitis

1339

9018

1.19

8.13

1.9

1.8

1.47

1.46

g/l

0.21

1148

7855

Conjunctivitis

1920

13445

1.16

8.13

1.8

1.49

1.51

g/l

0.25

1693

11586

Other bursitis of hip

328

2.20

8.13

1.6

1.7

1.57

1.53

g/l

0.15

294

Superficial injury of shoulder and upper arm

319

2274

1.43

8.11

1.6

1.8

1.53

1.51

g/l

0.09

264

1967

Carbimazole or st.post thyroidectomy, condition for graves disease

494

3767

1.33

8.09

1.9

1.7

1.51

1.54

g/l

0.33

428

3246

Malignant neoplasm of tongue, including Hilmo

417

2.05

8.06

1.5

1.65

1.53

g/l

0.64

369

Vitamin D deficiency

232

2.43

8.06

1.8

2.3

1.50

1.45

g/l

0.14

208

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

197

2.59

8.02

2.1

1.60

1.45

g/l

0.56

178

Autoimmune hyperthyroidism

128

746

1.75

8.01

1.9

1.5

1.45

1.53

g/l

0.44

108

644

Nonsuppurative otitis media

520

3458

1.32

7.99

2.4

1.9

1.49

1.39

g/l

1.57

462

3032

Embolic stroke

169

1065

1.64

7.98

1.5

1.7

1.55

1.54

g/l

0.05

151

917

Other injuries of lower limb, level unspecified

139

2.93

7.97

2.3

2.0

1.40

1.44

g/l

0.09

123

Alcohol induced polyneuropathy

181

2.69

7.92

1.9

1.5

1.61

1.52

g/l

0.25

161

Other acute viral hepatitis

162

2.74

7.92

1.7

2.2

1.62

1.41

g/l

0.59

147

Hypertrophic scar

116

661

1.79

7.88

1.9

2.1

1.45

1.46

g/l

0.05

587

Benign neoplasm of urinary organs

150

921

1.68

7.88

2.1

1.8

1.59

1.52

g/l

0.37

129

807

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

156

962

1.65

7.87

2.1

1.9

1.15

1.35

g/l

1.99

136

836

Other secondary coxarthrosis

105

584

1.86

7.87

1.6

1.9

1.63

1.54

g/l

0.40

513

Complications of the puerperium, not elsewhere classified

370

2.07

7.87

3.4

2.0

1.00

1.33

g/l

3.75

323

Other symptoms and signs involving general sensations and perceptions

127

746

1.76

7.86

1.6

1.9

1.54

1.56

g/l

0.10

104

651

Panniculitis affecting regions of neck and back

101

554

1.88

7.86

2.1

1.9

1.56

1.54

g/l

0.10

483

Fracture of neck

199

1307

1.57

7.86

1.9

1.8

1.51

1.54

g/l

0.21

175

1132

Benign neoplasm: Other and unspecified parts of small intestine

275

2.32

7.84

1.6

1.9

1.61

1.51

g/l

0.41

244

Injuries to the wrist and hand

2840

16809

1.12

7.82

1.7

1.8

1.52

1.51

g/l

0.05

2457

14478

Specific development disorders of speech and language

132

752

1.73

7.82

1.7

2.1

1.62

1.37

g/l

1.89

114

669

Agoraphobia

298

2.20

7.81

1.9

2.2

1.44

1.31

g/l

0.45

265

Anogenital herpesviral [herpes simplex] infection

127

744

1.74

7.80

2.0

2.1

1.35

1.37

g/l

0.09

116

659

Cervical disc disorders

950

7854

1.22

7.79

1.7

1.57

1.55

g/l

0.24

793

6745

Use of donepezil

494

6084

0.76

7.77

1.5

1.6

1.63

1.56

g/l

0.90

403

5170

Diseases of inner ear

1569

12947

1.17

7.76

1.5

1.7

1.55

1.56

g/l

0.21

1329

11111

Allergic conjunctivitis

1324

10834

1.18

7.74

1.7

1.8

1.49

g/l

0.05

1157

9392

Arthropathy in ulcerative colitis

164

2.70

7.73

1.6

2.2

1.59

1.42

g/l

0.62

143

Infection due to other mycobacteria

225

2.43

7.70

2.2

1.7

1.61

1.51

g/l

0.35

197

Dislocation of lens

290

2.26

7.70

1.9

1.6

1.51

1.65

g/l

0.50

258

Unspecified visual impairment (binocular)

238

2.39

7.69

1.5

2.2

1.40

1.50

g/l

0.30

219

Primary coxarthrosis, bilateral

909

7504

1.23

7.68

1.6

1.7

1.59

1.58

g/l

0.04

770

6417

Cerebral cysts

145

887

1.67

7.65

2.0

1.24

1.45

g/l

2.03

123

778

Diseases of tongue

166

1050

1.62

7.64

1.7

1.6

1.58

1.53

g/l

0.26

142

897

malignant neoplasm of female genital organs, including Hilmo

399

2834

1.36

7.63

1.8

1.6

1.77

1.65

g/l

1.23

322

2419

Disorders of orbit

113

647

1.80

7.63

1.8

1.9

1.58

1.55

g/l

0.10

570

Acne

193

1254

1.55

7.59

2.3

2.2

1.25

1.24

g/l

0.04

177

1106

Other disorders of patella

342

2492

1.39

7.57

1.6

1.8

1.64

1.44

g/l

2.88

292

2151

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

184

1196

1.58

7.57

1.7

1.6

1.89

1.53

g/l

3.87

166

1037

Varicella [chickenpox]

105

590

1.82

7.52

2.9

2.0

1.38

1.40

g/l

0.07

516

Infection due to other mycobacteria, including avohilmo

240

2.36

7.52

2.2

1.7

1.64

1.51

g/l

0.47

211

Golimumab

398

2.01

7.51

1.5

1.9

1.59

1.46

g/l

0.50

357

Viral infections of the central nervous system, including avohilmo

186

1213

1.56

7.49

1.7

1.9

1.49

1.51

g/l

0.17

158

1069

Other sleep disorders

294

2098

1.42

7.47

1.5

1.8

1.48

1.50

g/l

0.18

251

1833

Malignant neoplasm, without specification of site

103

579

1.84

7.46

1.8

1.6

1.66

1.54

g/l

0.48

492

Seborrhoeic dermatitis

273

1926

1.44

7.44

1.6

1.7

1.66

1.52

g/l

1.47

231

1672

Burns and corrosions

324

2351

1.40

7.43

1.6

1.8

1.48

1.47

g/l

0.02

270

2042

Atopic dermatitis, strict definition with reimbursement

591

4475

1.28

7.41

2.3

1.9

1.48

1.39

g/l

1.64

513

3918

Nontraumatic intracranial haemmorrhage

616

4895

1.27

7.41

1.6

1.7

1.52

1.56

g/l

0.43

526

4164

Palmar fascial fibromatosis [Dupuytren]

478

3684

1.32

7.39

1.6

1.43

1.56

g/l

2.87

409

3130

Asthma and opportunity respiratory infection

153

962

1.64

7.37

1.5

1.7

1.82

1.53

g/l

2.97

129

831

Anorexia

186

2.53

7.36

1.3

2.1

1.37

1.40

g/l

0.10

162

Juvenile rheumatoid arthirtis

185

2.51

7.35

1.4

2.1

1.63

1.29

g/l

1.32

170

Other orthopaedic follow-up care

136

828

1.68

7.32

1.7

1.65

1.52

g/l

0.81

121

722

Asthma and allergy

213

1413

1.50

7.30

1.6

1.9

1.54

1.32

g/l

3.39

191

1222

Other puerperal infections

134

812

1.68

7.27

2.9

2.1

1.17

1.23

g/l

0.39

124

707

Sequelae of injuries of lower limb

224

1529

1.49

7.26

1.7

1.8

1.62

1.52

g/l

0.74

189

1329

Other prurigo

164

2.65

7.24

1.5

1.8

1.55

1.47

g/l

0.26

147

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

497

3859

1.31

7.23

1.4

1.6

1.93

1.57

g/l

8.87

420

3302

Corneal ulcer

449

3437

1.32

7.22

1.9

1.8

1.48

1.50

g/l

0.14

391

2993

Other nonthrombocytopenic purpura

147

2.77

7.21

1.6

1.7

1.54

1.50

g/l

0.11

131

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

324

2.13

7.21

1.5

2.0

1.64

1.49

g/l

0.61

293

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

454

1.92

7.20

1.7

2.1

1.59

1.48

g/l

0.50

407

Malignant neoplasm of floor of mouth, including Hilmo

113

3.04

7.19

1.4

1.5

1.74

1.54

g/l

0.51

104

Inguinal hernia

1665

9608

1.16

7.19

1.7

1.43

1.55

g/l

5.77

1423

8244

Follicular cysts of skin and subcutaneous tissue

469

3619

1.31

7.14

1.7

1.8

1.59

1.51

g/l

0.88

420

3130

Other and unspecified follicular disorders

108

624

1.78

7.10

1.8

2.0

1.74

1.48

g/l

1.84

546

All dysplastic lesions of the vagina

311

2.12

7.10

2.2

2.0

1.39

1.54

g/l

0.64

272

Other specified/unspecified soft tissue disorders

133

813

1.68

7.10

1.6

1.7

1.58

1.59

g/l

0.05

112

710

Lactose intolerance

372

2.02

7.10

2.0

1.40

1.46

g/l

0.19

333

Monoarthritis, not elsewhere classified

108

624

1.78

7.09

1.6

1.9

1.80

1.48

g/l

1.73

546

Pediculosis, acariasis and other infestations

146

913

1.63

7.08

1.8

1.9

1.44

1.49

g/l

0.36

122

804

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

351

2.04

7.08

2.7

2.1

1.29

g/l

0.02

312

Viral encephalitis, not elsewhere classified/unspecified

313

2.14

7.06

1.5

2.0

1.63

1.49

g/l

0.53

283

Superficial injury of ankle and foot

270

1916

1.43

7.06

1.8

1.9

1.49

1.43

g/l

0.51

243

1663

Left hemicolectomy

440

1.95

7.01

1.7

1.9

1.66

1.56

g/l

0.46

394

D07AA Corticosteroids, weak (group I)

339

2497

1.37

7.01

1.6

1.9

1.53

1.44

g/l

1.04

303

2157

Disorders of speech understanding and production

103

577

1.79

7.00

1.8

2.1

1.63

1.39

g/l

1.49

511

Other and unspecified mononeuropathies, also in other diseases

490

1.88

6.95

1.7

1.9

1.66

1.58

g/l

0.40

425

Malignant neoplasm of other connective and soft tissue, including Hilmo

117

697

1.73

6.93

1.8

1.7

1.82

1.53

g/l

1.83

105

603

Hidradenitis suppurativa

396

1.96

6.91

1.7

2.3

1.73

1.40

g/l

2.76

354

Other disorders of penis

281

2020

1.42

6.88

1.6

1.7

1.59

1.52

g/l

0.55

241

1739

Hyperaldosteronism

478

1.89

6.86

1.7

1.8

1.56

g/l

0.00

420

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

282

2032

1.41

6.85

1.7

1.6

1.71

1.56

g/l

1.71

246

1733

Malignant neoplasm of other and unspecified parts of tongue

212

2.38

6.84

1.5

1.50

1.55

g/l

0.14

185

Twin gestation

133

818

1.65

6.82

2.5

1.9

1.09

1.43

g/l

5.08

120

715

Benign neoplasm: Kidney

110

649

1.75

6.80

2.3

1.9

1.60

1.53

g/l

0.30

577

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

135

820

1.64

6.79

2.3

2.0

1.36

1.31

g/l

0.26

116

723

Scleritis and episcleritis

141

884

1.63

6.78

2.2

1.9

1.54

1.52

g/l

0.09

126

773

Other noninflammatory disorders of uterus, except cervix

526

2747

1.29

6.78

1.7

1.8

1.68

1.61

g/l

0.91

443

2327

Dissociative [conversion] disorders

427

1.92

6.78

1.5

2.0

1.53

1.36

g/l

0.92

377

Alzheimer disease, excluding more controls

569

2911

1.28

6.77

1.5

1.7

1.60

1.59

g/l

0.07

460

2477

280

2023

1.41

6.76

1.7

1.19

1.54

g/l

9.33

234

1738

Specific development disorders of scholastic skills

390

1.94

6.75

2.2

1.31

1.26

g/l

0.21

353

Ovarian cyst

758

3527

1.24

6.75

1.7

1.9

1.55

1.49

g/l

0.84

657

3027

LSIL lesion of the vagina

163

2.56

6.74

2.6

2.2

1.49

1.43

g/l

0.15

139

Hyperosmolality and hypernatraemia

233

2.31

6.74

1.5

1.9

1.60

1.50

g/l

0.31

210

Erythema multiforme

346

2.04

6.73

1.9

1.8

1.53

1.50

g/l

0.07

306

LSIL lesion of the vulva

311

2.09

6.71

2.8

2.1

1.49

1.50

g/l

0.03

277

Malignant neoplasm of liver and intrahepatic bile ducts

102

592

1.78

6.70

1.9

1.6

1.34

1.49

g/l

0.89

503

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1369

11402

1.16

6.69

1.8

1.7

1.56

1.53

g/l

0.57

1166

9858

Acne vulgaris

147

930

1.60

6.68

2.2

2.1

1.26

1.23

g/l

0.14

134

818

Other congenital malformations of skin, including avohilmo

185

1238

1.52

6.65

1.7

1.9

1.35

1.50

g/l

1.33

153

1089

Metatarsalgia

228

1590

1.46

6.63

1.6

1.7

1.60

1.55

g/l

0.33

194

1376

Disorders of optic nerve, not elsewhere classified

363

2.02

6.63

2.3

2.0

1.48

1.52

g/l

0.12

333

Parkinson's disease, excluding more controls

404

2839

1.33

6.62

1.5

1.7

1.58

1.59

g/l

0.08

341

2420

Viral agents as the cause of diseases classified to other chapters

314

2.09

6.61

1.7

2.1

1.39

1.48

g/l

0.33

278

Acetic acid derivatives and related substances

844

3594

1.22

6.58

1.8

2.0

1.47

1.44

g/l

0.40

720

3083

Dislocation, sprain and strain of joint and ligaments of hip

118

716

1.70

6.58

1.7

1.9

1.45

1.54

g/l

0.50

635

Other and unspecified glaucoma

238

1682

1.45

6.58

1.6

1.7

1.66

1.54

g/l

1.10

201

1457

Other disorders of peripheral nervous system

3.13

6.56

1.7

2.3

1.49

1.53

g/l

0.07

Hyperhidrosis

313

2.06

6.56

1.8

2.0

1.23

1.42

g/l

0.90

273

Malignant neoplasm of breast, HER-positive

640

3837

1.25

6.55

1.5

1.6

1.66

1.62

g/l

0.45

526

3289

Nonsuppurative otitis media, including avohilmo

698

4919

1.24

6.50

2.4

1.9

1.46

1.42

g/l

0.63

622

4292

Sleep disorders, other/unspecified

412

1.91

6.50

1.4

2.1

1.43

1.42

g/l

0.03

365

Malignant neoplasm of breast, ER-positive, including Hilmo

641

3843

1.25

6.49

1.5

1.6

1.66

1.62

g/l

0.48

527

3295

Other mental disorders due to brain damage and dysfunction and to physical disease

391

2992

1.33

6.49

1.5

1.7

1.54

1.55

g/l

0.08

323

2597

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

242

1718

1.44

6.46

1.6

1.8

1.54

1.56

g/l

0.11

212

1497

Suppurative and unspecified otitis media

765

5580

1.22

6.44

1.9

1.43

1.41

g/l

0.29

672

4865

Other and unspecified rosacea

220

1535

1.46

6.42

1.7

1.8

1.46

1.54

g/l

0.63

199

1331

Guillain-Barre syndrome

251

2.22

6.41

1.8

2.1

1.58

1.54

g/l

0.12

227

Optic neuritis

479

1.84

6.40

1.4

2.1

1.55

1.44

g/l

0.49

426

Malignant neoplasm of rectum

270

1955

1.41

6.40

1.7

1.6

1.69

1.56

g/l

1.50

236

1679

Unspecified event, undetermined intent

345

2.01

6.40

1.7

2.1

1.52

1.41

g/l

0.35

314

Cramp and spasm

122

751

1.67

6.39

1.9

1.46

1.51

g/l

0.23

103

662

Complications peculiar to reattachment and amputation

110

2.95

6.37

2.5

1.8

2.08

1.53

g/l

1.39

100

Parkinson's disease, strict definition, excluding more controls

380

2702

1.33

6.36

1.5

1.7

1.55

1.59

g/l

0.33

320

2303

Idiopathic pulmonary fibrosis

265

1921

1.41

6.36

1.9

1.7

1.61

1.53

g/l

0.75

220

1640

Adenocarcinoma and papilloma adenocarcinoma of rectum

268

1942

1.40

6.33

1.7

1.5

1.71

1.56

g/l

1.66

234

1663

Radiculopathy

438

3408

1.30

6.33

1.9

1.7

1.59

1.56

g/l

0.31

379

2925

Multiple gestation

135

850

1.61

6.32

2.5

1.9

1.10

1.44

g/l

5.20

122

743

Other infective otitis externa

160

1052

1.55

6.32

2.2

1.9

1.61

1.51

g/l

0.69

144

918

Dissocial personality disorder

181

2.42

6.30

1.7

2.1

1.93

1.43

g/l

1.94

167

Hepatocellular carcinoma

427

1.90

6.28

1.7

1.6

1.26

1.47

g/l

1.00

366

Gastrojejunal ulcer

195

2.38

6.26

1.6

1.8

1.52

1.51

g/l

0.01

176

Other specified/unspecified dorsopathies

528

1.79

6.25

1.6

1.8

1.49

1.58

g/l

0.38

457

Conjunctivitis (acute, non atopic), including avohilmo

2817

15371

1.11

6.24

1.8

1.51

1.53

g/l

0.43

2480

13181

Other and unspecified visual disturbances

274

1998

1.39

6.23

1.9

1.7

1.51

1.55

g/l

0.28

243

1730

Otitis externa, unspecified

271

1971

1.39

6.23

2.0

1.8

1.45

1.51

g/l

0.51

247

1710

Maternal care for known or suspected malpresentation of fetus

264

1349

1.41

6.20

2.1

1.16

1.33

g/l

2.85

236

1180

Bullous pemphigoid

452

1.88

6.19

1.4

2.0

1.61

1.55

g/l

0.22

405

Other/unspecified crystal arthropathies

118

2.87

6.19

1.7

1.8

1.60

1.57

g/l

0.04

104

Labour and delivery complicated by fetal stress [distress]

333

1609

1.35

6.17

2.1

1.14

1.28

g/l

2.40

289

1409

Other enthesopathy of foot (+metatarsalgia)

240

1713

1.42

6.16

1.6

1.7

1.59

1.55

g/l

0.23

206

1480

Unknown and unspecified causes of morbidity

145

936

1.57

6.16

1.6

1.60

1.51

g/l

0.42

130

804

Sequelae of injuries of head

134

852

1.61

6.15

1.7

1.9

1.67

1.54

g/l

0.72

111

743

Allergic urticaria

182

1235

1.50

6.14

1.8

1.9

1.55

1.49

g/l

0.40

162

1090

Other operation for atrial fibrillation

108

3.02

6.13

1.7

1.8

1.44

1.52

g/l

0.13

Paraplegia, diplegia of upper limbs

359

1.97

6.11

1.8

1.9

1.76

1.49

g/l

1.25

322

Systemic sclerosis,strict definition

112

2.84

6.10

2.0

1.77

1.60

g/l

0.41

Injuries involving multiple body regions

547

1.76

6.08

1.5

2.1

1.73

1.47

g/l

1.72

489

Schizoaffective disorder

155

1019

1.55

6.08

1.4

1.9

1.74

1.48

g/l

2.53

124

892

Retinal detachment with retinal break

365

2791

1.33

6.08

2.0

1.7

1.50

1.58

g/l

0.89

328

2399

Hyperfunction of pituitary gland

576

1.74

6.08

1.6

2.0

1.42

1.44

g/l

0.05

513

Cerebral palsy

147

2.53

6.05

1.9

3.0

1.27

1.22

g/l

0.13

133

Benign paroxysmal vertigo

808

6758

1.21

6.03

1.6

1.7

1.51

1.58

g/l

1.19

690

5822

Blepharochalasis

818

6854

1.21

5.99

1.5

1.7

1.54

1.60

g/l

1.04

710

5864

Burns and corrosions of external body surface, specified by site

255

1850

1.40

5.97

1.6

1.8

1.47

1.48

g/l

0.05

212

1616

Open wound of hip and thigh

476

1.81

5.97

1.8

2.2

1.45

1.44

g/l

0.04

426

Lack of expected normal physiological development

117

2.60

5.95

2.7

2.6

0.98

1.11

g/l

0.44

Ulcerative rectosigmoiditis

186

1278

1.48

5.92

1.8

1.50

1.51

g/l

0.05

168

1124

Malignant neoplasm of tonsil and base of tongue

314

2.02

5.91

2.1

1.5

1.56

1.53

g/l

0.10

276

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

328

2.00

5.90

1.5

1.56

1.54

g/l

0.07

292

Other enthesopathies

677

5576

1.22

5.86

1.6

1.7

1.59

1.53

g/l

0.92

582

4816

Strabismus

612

4982

1.24

5.83

1.9

1.8

1.51

1.49

g/l

0.16

531

4318

Malignant neoplasm of endocrine gland, including Hilmo

175

1192

1.49

5.82

2.0

1.6

1.62

1.57

g/l

0.22

151

1028

Erythema intertrigo

430

1.86

5.82

1.8

1.9

1.62

1.49

g/l

0.58

384

UC patients in KELA-register (code 208), prior to 1994

115

717

1.65

5.79

2.0

1.9

1.56

1.57

g/l

0.03

109

631

Ocular pain

194

1350

1.46

5.78

1.9

1.46

1.51

g/l

0.39

175

1180

Arthropathy in Crohn disease

127

2.65

5.78

1.2

2.4

1.45

1.39

g/l

0.13

114

Raynaud syndrome

203

1425

1.45

5.78

2.1

1.9

1.35

1.52

g/l

1.76

171

1246

Malignant neoplasm of larynx

262

2.12

5.77

1.6

1.7

1.85

1.53

g/l

1.56

230

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

739

6153

1.21

5.77

1.8

1.52

g/l

0.00

643

5319

Hemiplegia

131

842

1.59

5.77

1.8

2.0

1.51

1.52

g/l

0.08

111

747

Use of anticholinesterases

957

8643

0.85

5.76

1.4

1.7

1.61

1.57

g/l

0.59

777

7371

N06DA Anticholinesterases

957

8643

0.85

5.76

1.4

1.7

1.61

1.57

g/l

0.59

777

7371

Antepartum haemorrhage, not elsewhere classified

124

784

1.60

5.75

2.7

1.9

1.24

1.37

g/l

0.92

113

695

Diseases of middle ear and mastoid

1380

9839

1.15

5.75

2.1

1.8

1.45

1.47

g/l

0.26

1204

8519

Behavioural disorders, excluding more controls

156

2.42

5.75

1.8

2.3

1.72

1.17

g/l

2.09

142

Migraine without aura and triptan purchases

286

2123

1.36

5.74

1.9

2.0

1.34

1.38

g/l

0.34

243

1869

Malignant neoplasm of renal pelvis, including Hilmo

190

2.33

5.74

2.6

1.7

1.79

1.60

g/l

0.55

164

Contusion of other and unspecified parts of foot

107

655

1.66

5.71

2.1

1.50

1.42

g/l

0.40

579

Acute laryngitis and tracheitis

213

1484

1.43

5.70

1.8

2.0

1.53

1.36

g/l

1.45

188

1302

Viral agents as the cause of diseases classified to other chapters, including avohilmo

360

1.92

5.69

1.7

2.1

1.47

g/l

0.01

321

Other maternal disorders predominantly related to pregnancy

1020

5435

1.18

5.69

2.0

1.8

1.36

1.50

g/l

5.07

885

4724

Car occupant injured in other and unspecified transport accidents

416

3261

1.29

5.68

2.1

1.8

1.56

1.47

g/l

1.11

360

2826

Testicular dysfunction

101

612

1.69

5.67

1.6

1.7

1.50

1.52

g/l

0.07

533

Meningitis

119

751

1.62

5.66

1.6

1.9

1.61

1.54

g/l

0.32

106

666

Outcome of delivery

217

934

1.44

5.66

1.8

1.9

1.17

1.47

g/l

5.42

190

806

Benign neoplasm: Oesophagus

185

2.34

5.64

2.0

1.7

1.37

1.49

g/l

0.41

166

Alzheimer’s disease (Late onset), excluding more controls

494

2557

1.27

5.63

1.5

1.7

1.60

1.59

g/l

0.08

401

2175

Chondrocostal junction syndrome [Tietze]

560

1.72

5.63

1.8

2.0

1.49

g/l

0.01

497

Impotence

178

1231

1.48

5.60

1.7

1.44

1.53

g/l

0.72

155

1061

Disorders of lysine and hydroxylysine metabolism

+∞

5.59

25.0

0.0

0.46

—

g/l

—

Hallux rigidus

326

2483

1.33

5.58

1.5

1.7

1.52

1.57

g/l

0.35

278

2134

Other specified/unspecified disorders of bone/cartilage

399

1.86

5.56

1.7

1.9

1.51

1.56

g/l

0.20

355

Generalized epilepsy

516

1.74

5.55

1.7

2.1

1.25

1.39

g/l

0.69

466

Malignant neoplasm of larynx, including Hilmo

350

1.93

5.55

1.5

1.6

1.80

1.52

g/l

1.49

301

Other salmonella infections, including avohilmo

103

631

1.67

5.54

1.7

1.9

1.69

1.50

g/l

0.92

553

Granulomatous disorders of skin and subcutaneous tissue

349

1.92

5.53

2.5

2.0

1.37

1.49

g/l

0.44

313

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

212

1513

1.43

5.53

1.5

1.7

1.57

1.54

g/l

0.15

190

1294

Neuralgia and neuritis, unspecified

125

803

1.59

5.52

1.7

1.8

1.64

1.54

g/l

0.54

107

699

Hyperkinetic disorders, excluding more controls

186

1204

1.45

5.50

1.8

2.3

1.22

1.13

g/l

0.75

161

1064

Medical treatment for female infertility

302

2253

1.34

5.50

2.2

2.0

1.07

1.31

g/l

6.38

279

1957

139

913

1.54

5.47

2.2

2.0

1.25

1.20

g/l

0.23

122

809

Respiratory tuberculosis, confirmed, including avohilmo

352

1.93

5.47

1.6

1.9

1.58

1.54

g/l

0.12

316

HSIL lesion of the vulva

233

2.14

5.47

1.7

2.2

1.74

1.51

g/l

0.79

209

Exfoliative dermatitis

175

2.36

5.45

1.6

2.2

1.60

1.43

g/l

0.48

159

Other salmonella infections

543

1.72

5.44

1.7

2.0

1.75

1.51

g/l

1.04

479

Coarctation of the aorta

113

2.69

5.42

1.6

1.9

1.31

g/l

0.00

102

Melanocytic naevi of upper limb, including shoulder

352

1.91

5.42

1.8

2.0

1.41

1.50

g/l

0.37

317

Other protozoal intestinal diseases

181

2.30

5.42

1.6

2.3

1.29

1.37

g/l

0.21

164

Gastrointestinal stromal tumor and sarcoma

195

2.27

5.42

1.3

1.7

1.68

1.56

g/l

0.32

175

Pneumothorax

204

1456

1.43

5.39

1.7

1.63

1.50

g/l

1.01

180

1252

Papilloedema, unspecified

310

1.96

5.38

2.5

2.2

1.41

g/l

0.00

283

Blood alcohol or alcohol intoxication level

289

1.99

5.36

2.0

2.1

1.35

1.44

g/l

0.40

263

Bronchitis, not specified as acute or chronic

216

1556

1.41

5.35

1.8

1.7

1.38

1.52

g/l

1.74

183

1316

Toxic effects of substances chiefly nonmedicinal as to source

262

1948

1.36

5.31

1.7

1.9

1.54

1.48

g/l

0.54

226

1706

Enthesopathies of lower limb, excluding foot

520

4221

1.24

5.28

1.7

1.8

1.54

1.52

g/l

0.20

442

3648

Superficial injury of forearm

233

1703

1.39

5.27

1.8

1.9

1.40

1.47

g/l

0.60

205

1484

Poisoning by narcotics and psychodysleptics [hallucinogens]

170

2.31

5.27

1.4

2.3

1.88

1.33

g/l

2.42

155

Prepatellar bursitis

119

766

1.59

5.26

1.7

1.63

1.49

g/l

0.79

104

659

Other specified/unspecified hearing loss

259

1930

1.37

5.24

1.8

1.7

1.44

1.55

g/l

1.29

239

1669

Dislocation, sprain and strain of joints and ligaments of thorax

534

1.71

5.22

2.7

2.0

1.48

1.52

g/l

0.22

469

Postpartum haemorrhage

376

2418

1.29

5.21

2.4

2.0

1.12

1.40

g/l

9.40

328

2124

Other bursitis of elbow

147

2.46

5.20

3.0

2.0

1.40

1.52

g/l

0.30

133

Other female pelvic inflammatory diseases

331

2553

1.31

5.18

1.6

1.7

1.60

1.57

g/l

0.19

270

2202

malignant neoplasm of female genital organs

341

2582

1.31

5.18

1.8

1.6

1.76

1.65

g/l

0.89

277

2208

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

159

2.36

5.17

1.3

2.5

1.83

1.43

g/l

1.44

146

Viral meningitis, including avohilmo

437

1.78

5.17

2.1

1.39

1.40

g/l

0.03

388

Separation of retinal layers (serosa)

108

683

1.62

5.16

2.3

1.8

1.49

1.58

g/l

0.44

591

Other disorders of pigmentation

115

738

1.59

5.16

1.9

1.50

1.53

g/l

0.10

102

643

HSIL lesion of the vagina

166

2.32

5.13

1.9

2.3

1.39

1.52

g/l

0.33

147

Glaucoma

1726

13097

1.13

5.13

1.6

1.7

1.53

1.58

g/l

1.53

1449

11193

Glucosamine medication

1417

9988

1.14

5.12

1.7

1.57

1.59

g/l

0.34

1208

8530

Malignant neoplasm of endocrine gland

149

1011

1.50

5.11

2.0

1.6

1.58

1.54

g/l

0.19

128

876

Injury of other and unspecified intrathoracic organs

181

1278

1.45

5.10

1.7

1.8

1.64

1.51

g/l

0.91

162

1106

Panniculitis, unspecified

148

2.41

5.09

1.5

1.7

1.42

1.52

g/l

0.31

132

Protein-energy malnutrition of moderate and mild degree

168

2.34

5.08

1.4

2.1

1.36

1.53

g/l

0.50

151

Urethritis and urethral syndrome

281

1.98

5.07

1.6

2.0

1.59

1.47

g/l

0.27

245

Other and unspecified abdominal hernia

116

750

1.59

5.07

1.5

1.8

1.61

1.57

g/l

0.18

106

658

Inflammatory disorders of male genital organs, not elsewhere classified

241

2.09

5.07

1.6

1.9

1.52

1.51

g/l

0.02

213

Lifestyle-related condition

174

2.29

5.07

2.1

2.2

1.80

1.46

g/l

1.09

153

Alcoholic gastritis

241

2.08

5.06

1.5

1.8

1.54

1.53

g/l

0.03

213

Contact with other hot metals

227

2.11

5.06

1.9

1.7

1.45

1.40

g/l

0.11

202

Atopic dermatitis, strict definition

552

4426

1.23

5.04

2.3

1.9

1.47

1.39

g/l

1.19

482

3877

Scabies

103

647

1.62

5.03

1.8

2.0

1.49

1.48

g/l

0.02

570

Psoriasis (vulgaris), strict definition

494

1.72

5.03

1.7

2.1

1.55

1.53

g/l

0.06

439

Malignant neoplasm of tonsil and base of tongue, including Hilmo

391

1.83

5.02

2.0

1.5

1.56

1.53

g/l

0.11

344

Vulvovaginal ulceration/inflammation in other diseases

127

836

1.54

5.02

1.8

2.1

1.30

1.40

g/l

0.62

110

728

Anankastic personality disorder

434

1.76

4.99

2.3

2.1

1.41

1.39

g/l

0.06

386

Childhood asthma (age<16), excluding more controls

181

991

1.44

4.98

2.4

2.3

1.21

1.09

g/l

1.24

162

883

Respiratory tuberculosis, confirmed

342

1.89

4.96

1.6

2.0

1.57

1.55

g/l

0.04

307

Other disorders of the genitourinary system

324

2512

1.31

4.96

1.8

1.7

1.58

1.59

g/l

0.08

270

2173

Urethral stricture

182

1295

1.44

4.95

1.5

1.7

1.63

1.49

g/l

1.23

153

1121

Bulimia nervosa (incl. atypical)

318

1.89

4.95

2.5

2.1

1.42

1.18

g/l

1.18

279

Car occupant injured in noncollision transport accident

489

1.72

4.93

2.3

2.1

1.40

1.43

g/l

0.10

433

Algoneurodystrophy

348

1.85

4.91

2.0

2.1

1.37

1.43

g/l

0.28

311

Thyrotoxicosis with toxic multinodular goitre

163

1138

1.46

4.91

1.6

1.7

1.69

1.59

g/l

0.86

146

983

Excessive attrition of teeth

1458

12807

1.13

4.90

1.7

1.8

1.41

1.50

g/l

3.52

1255

11124

Viral meningitis

422

1.77

4.90

2.1

1.41

1.40

g/l

0.04

379

Benign neoplasm: Skin of other and unspecified parts of face

288

2203

1.33

4.89

2.3

1.7

1.53

1.55

g/l

0.12

219

1899

Isolated patent ductus arteriosus

2.74

4.89

1.3

2.0

1.56

1.14

g/l

0.73

Combined immunodeficiencies

151

2.37

4.88

2.0

1.64

1.47

g/l

0.41

137

Eustachian salpingitis and obstruction

143

971

1.49

4.88

2.2

1.9

1.48

1.40

g/l

0.45

119

846

Family history of certain disabilities and chronic diseases leading to disablement

512

1.69

4.88

2.1

2.0

1.23

1.43

g/l

1.40

447

Demyelinating diseases of the central nervous system

163

1137

1.45

4.85

1.9

1.39

1.48

g/l

0.74

140

995

Other and unspecified epidermal thickening

410

1.78

4.84

1.6

2.2

1.56

1.50

g/l

0.26

371

Malignant neoplasm of other connective and soft tissue

388

1.81

4.83

1.9

1.7

1.81

1.55

g/l

0.83

344

Achalasia of cardia

280

1.97

4.83

1.5

2.0

1.71

1.55

g/l

0.55

250

Postmenopausal bleeding

632

2741

1.22

4.82

1.6

1.7

1.60

1.63

g/l

0.21

540

2320

Paralytic strabismus

194

1402

1.41

4.81

1.7

1.8

1.63

1.53

g/l

0.72

168

1208

Benign thyroid growths and nodules

824

6546

1.18

4.79

1.6

1.7

1.62

1.58

g/l

0.48

724

5610

Sleep disorders

2388

14972

1.10

4.77

1.8

1.48

1.52

g/l

1.27

2056

12918

Herpesviral keratitis and keratoconjunctivitis

113

737

1.57

4.76

1.9

1.49

1.50

g/l

0.01

101

643

Other factor of the environment

192

2.18

4.76

2.1

2.0

1.80

1.43

g/l

1.37

170

Crushed, pushed or stepped on by crowd or human stampede

145

993

1.48

4.76

1.9

2.0

1.45

1.43

g/l

0.09

117

887

Respiratory tuberculosis, bacteriologically and histologically confirmed

354

1.85

4.76

1.6

1.9

1.58

1.54

g/l

0.12

316

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

5.55

4.75

1.6

1.7

1.44

1.82

g/l

0.53

Other menopausal disorders

380

2670

0.79

4.74

1.8

1.44

1.58

g/l

2.12

327

2282

Dronedarone medication

466

1.73

4.73

1.7

1.6

1.30

1.56

g/l

2.06

403

Other and unspecified paralytic syndromes

199

2.14

4.73

1.8

2.3

1.19

1.47

g/l

1.23

183

Other intracranial haemorrhages

109

709

1.59

4.72

1.8

1.45

1.54

g/l

0.43

623

Other symptoms and signs involving the nervous and musculoskeletal systems

1059

9241

1.15

4.70

1.6

1.8

1.52

g/l

0.01

901

7973

Other noninflammatory disorders of vulva and perineum

204

1489

1.39

4.69

1.9

1.8

1.50

1.51

g/l

0.07

175

1281

Aneurysms, operations, SAH

421

3392

1.26

4.69

1.8

1.7

1.57

1.58

g/l

0.07

371

2913

Maltreatment syndromes

580

1.63

4.68

1.6

2.0

1.53

1.38

g/l

0.85

512

Other diseases of spinal cord

475

1.71

4.67

1.6

2.1

1.73

1.55

g/l

0.67

423

Female infertility, associated with anovulation

119

785

1.53

4.66

2.4

2.1

1.16

1.22

g/l

0.37

110

694

Anuria and oliguria

117

2.56

4.65

1.7

1.9

1.59

1.47

g/l

0.20

106

Alzheimer’s disease (Early onset)

1014

0.56

4.64

1.4

1.7

1.57

1.54

g/l

0.07

871

Exophthalmic conditions

148

2.34

4.64

1.8

2.2

1.63

1.45

g/l

0.37

135

Polyhydramnios

399

1.75

4.61

2.0

1.19

1.33

g/l

0.61

353

Other endocrine disorders

102

625

1.59

4.60

2.5

2.1

1.31

1.41

g/l

0.49

559

Other disorders starting during childhood or adolecense, excluding more controls

394

1.74

4.59

2.1

2.0

1.27

1.09

g/l

1.01

340

Premature separation of placenta [abruptio placentae]

180

2.16

4.59

2.0

1.21

1.42

g/l

0.65

157

Episcleritis

111

726

1.56

4.59

1.9

1.45

1.50

g/l

0.20

101

635

Toxic effect of other and unspecified substances

129

2.41

4.59

1.5

2.0

1.80

1.37

g/l

1.90

116

Obsessive-compulsive disorder

115

756

1.54

4.59

1.8

2.0

1.36

1.28

g/l

0.46

670

Procedures for purposes other than remedying health state

263

1.95

4.57

1.5

1.7

1.33

1.48

g/l

0.60

234

Measles

2.73

4.56

1.5

2.2

1.54

1.42

g/l

0.25

Thyrotoxicosis with diffuse goitre

291

2248

1.31

4.56

2.0

1.7

1.46

1.53

g/l

0.64

249

1955

Testicular hypofunction

547

1.65

4.56

1.6

1.7

1.49

1.51

g/l

0.05

473

Chronic Coagulation defects

285

1.91

4.55

1.5

2.0

1.36

1.46

g/l

0.42

251

Oligomenorrhoea

424

1.73

4.54

2.2

1.9

1.26

1.39

g/l

0.65

374

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

131

2.44

4.54

1.5

1.6

1.98

1.59

g/l

1.14

118

Scar conditions and fibrosis of skin

524

1.65

4.52

1.6

1.9

1.47

1.49

g/l

0.06

462

Tuberculosis, IBD comorbidity

205

1512

1.38

4.51

1.7

1.51

1.53

g/l

0.11

177

1286

Pyoderma

265

1.95

4.51

1.8

2.0

1.66

1.47

g/l

0.63

240

Single spontaneous delivery

696

4344

0.84

4.51

1.7

1.8

1.48

1.58

g/l

2.19

608

3747

Rosacea

288

2228

1.31

4.49

1.6

1.8

1.42

1.52

g/l

1.03

257

1929

Open wound of thorax

203

2.09

4.49

2.0

2.4

1.44

1.47

g/l

0.10

185

Infective bursitis

504

1.67

4.48

2.1

1.8

1.48

1.55

g/l

0.31

447

Chondropathies

333

2624

1.28

4.48

1.6

1.8

1.51

1.49

g/l

0.16

284

2292

Malignant neoplasm of rectosigmoid junction, including Hilmo

512

1.67

4.48

1.7

1.6

1.79

1.54

g/l

1.39

445

Measles, including avohilmo

2.70

4.47

1.5

2.1

1.54

1.41

g/l

0.26

Thyroiditis

150

1050

1.45

4.44

1.7

1.8

1.52

g/l

0.01

129

920

Dermatopolymyositis, unspecified

2.98

4.44

1.5

1.28

1.56

g/l

0.82

Acne, including avohilmo

388

2513

1.26

4.39

2.0

2.2

1.33

1.23

g/l

1.20

355

2217

Renal cell carcinoma of kidney

569

1.62

4.39

1.6

1.84

1.53

g/l

2.26

485

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

340

2691

1.27

4.38

1.9

1.35

1.44

g/l

1.01

294

2342

Burns and corrosions of multiple and unspecified body regions

326

1.83

4.36

1.7

1.8

1.48

1.49

g/l

0.03

296

Benign neoplasm of other and unspecified intrathoracic organs

159

2.24

4.35

2.3

1.8

1.80

1.45

g/l

0.96

144

Other fall from one level to another

537

4467

1.21

4.35

1.8

1.45

1.49

g/l

0.56

482

3871

Benign neoplasm: Liver/bile ducts

356

1.79

4.33

1.9

2.0

1.47

g/l

0.00

313

Other and unspecified acute skin changes due to ultraviolet radiation

448

1.71

4.32

1.7

1.63

1.58

g/l

0.19

399

Other and unspecified tonsillitis

632

4424

1.19

4.32

1.8

1.9

1.41

1.40

g/l

0.13

553

3876

Recurrent dislocation and subluxation of joint

120

808

1.50

4.32

2.3

1.9

1.74

1.43

g/l

2.10

107

711

Epiphora

365

1.78

4.30

1.7

1.8

1.47

1.53

g/l

0.17

326

Other and unspecified nerve root and plexus disorders, also in other diseases

481

3966

1.22

4.30

1.6

1.7

1.55

1.54

g/l

0.06

423

3429

Autonomic disorders

358

1.78

4.26

2.1

2.0

1.40

1.49

g/l

0.35

322

Childhood asthma (age<16)

181

1022

1.39

4.25

2.4

2.3

1.21

1.10

g/l

1.05

162

910

Astigmatism

139

967

1.46

4.25

1.7

1.9

1.51

1.45

g/l

0.36

116

851

Other proliferative retinopathy

2.83

4.23

1.3

2.4

1.61

1.55

g/l

0.13

Alzheimer’s disease (Atypical or mixed)

258

3278

0.77

4.23

1.6

1.59

1.53

g/l

0.46

199

2794

Intracerebral haemorrhage

390

3158

1.25

4.22

1.6

1.7

1.51

1.56

g/l

0.37

330

2702

Other demyelinating diseases of the central nervous system

388

1.73

4.21

2.1

1.9

1.37

1.41

g/l

0.13

344

Causalgia

167

2.16

4.21

1.4

2.1

1.29

1.47

g/l

0.57

148

Excessive vomiting in pregnancy

128

878

1.47

4.20

2.8

1.9

1.18

1.45

g/l

2.99

110

764

Monoamine oxidase A inhibitors

265

2048

1.31

4.20

1.5

1.8

1.51

1.55

g/l

0.32

225

1775

Other abnormal findings in urine

295

1.87

4.19

2.4

2.0

1.55

1.50

g/l

0.13

268

Hypothermia

324

1.82

4.18

1.5

1.9

1.56

1.52

g/l

0.11

286

Polyp of the female genital tract

652

3116

1.19

4.17

1.6

1.8

1.55

1.56

g/l

0.13

562

2656

Emotional disorders starting during childhood or adolecense, excluding more controls

354

1.74

4.16

2.3

2.2

1.22

1.05

g/l

0.80

314

Otalgia

188

1385

1.38

4.15

1.6

1.9

1.39

1.52

g/l

1.09

153

1213

Abnormal blood-pressure reading, without diagnosis

102

671

1.55

4.15

2.6

1.7

1.44

1.54

g/l

0.54

578

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

138

964

1.45

4.13

2.2

1.9

1.72

1.43

g/l

2.34

123

848

Short stature, not elsewhere classified

155

2.14

4.11

4.1

2.0

0.94

1.16

g/l

0.77

141

Other specific arthropathies, wide

274

1.87

4.09

1.6

1.7

1.41

1.48

g/l

0.22

240

Perforation of tympanic membrane

244

1875

1.32

4.07

1.9

1.8

1.49

1.52

g/l

0.23

211

1632

Malignant neoplasm of respiratory system and intrathoracic organs

576

4022

1.20

4.06

1.6

1.91

1.55

g/l

11.82

493

3422

Benign neoplasm: Liver

304

1.82

4.05

1.9

2.0

1.44

1.45

g/l

0.04

267

HSIL lesion of the cervix uteri, vagina or vulva

322

2559

1.27

4.04

2.3

1.9

1.44

1.37

g/l

0.52

278

2239

Benign neoplasm of middle ear and respiratory system

208

1566

1.35

4.04

1.7

1.67

1.53

g/l

1.27

173

1359

Evidence of alcohol involvement determined by blood alcohol level

184

2.08

4.03

2.0

2.5

1.45

1.49

g/l

0.13

166

Haemophilus septicemia

4.52

4.03

2.9

1.8

1.37

1.65

g/l

0.53

Other diseases of gallbladder

119

816

1.49

4.02

1.9

1.7

1.34

1.51

g/l

1.31

104

717

Other acute skin changes due to ultraviolet radiation

574

1.59

4.02

1.7

1.8

1.61

1.56

g/l

0.19

515

Malignant neoplasm of oropharynx

255

1.91

4.01

2.3

1.5

1.40

1.49

g/l

0.26

221

Malignant neoplasm of bronchus and lung, including Hilmo

572

4022

1.20

3.98

1.7

1.5

1.88

1.56

g/l

9.71

493

3419

Benign neoplasm: Skin of eyelid, including canthus

407

3333

1.23

3.98

1.5

1.7

1.55

1.57

g/l

0.22

342

2875

Secondary parkinsonism

529

1.62

3.98

1.4

2.0

1.60

1.55

g/l

0.20

472

Conduct disorder

205

1.99

3.97

1.8

2.5

1.76

1.28

g/l

1.84

188

Fistulae involving female genital tract

220

1.97

3.97

1.7

2.0

1.86

1.57

g/l

0.61

202

Brain meningioma, including Hilmo

116

793

1.49

3.96

1.8

1.6

1.68

1.58

g/l

0.43

100

684

Tuberculosis, wide, including avohilmo

214

1626

1.34

3.92

1.7

1.52

1.53

g/l

0.06

186

1390

Convergent concomitant strabismus

103

688

1.52

3.91

2.3

2.0

1.40

1.42

g/l

0.09

616

Insomnia

2302

14707

1.09

3.90

1.8

1.47

1.51

g/l

1.09

1978

12691

Benign neoplasm: Other and unspecified parts of mouth

571

1.58

3.89

1.8

1.9

1.48

1.53

g/l

0.23

509

Anogenital herpesviral [herpes simplex] infection, including avohilmo

195

1459

1.35

3.89

2.3

2.1

1.27

1.36

g/l

0.75

174

1282

Flat foot [pes planus] (acquired)

200

1504

1.35

3.88

1.8

1.53

g/l

0.01

169

1300

Exposure to other and unspecified animate mechanical forces

360

1.73

3.88

2.8

2.1

1.55

1.43

g/l

0.44

323

Behavioural disorders

186

2.03

3.88

1.8

2.5

1.72

1.30

g/l

1.43

171

Lesion of radial nerve

603

1.56

3.86

1.7

1.9

1.49

1.54

g/l

0.25

524

Corticotropin deficiency

121

2.34

3.86

1.5

2.3

1.51

1.49

g/l

0.03

107

Other/unspecified enthesopathies, not elsewhere classified

203

1533

1.34

3.85

1.7

1.56

g/l

0.00

176

1315

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

338

2364

1.25

3.84

1.8

2.3

1.33

1.21

g/l

1.60

296

2094

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

202

1514

1.34

3.83

2.3

1.9

1.33

1.41

g/l

0.73

173

1315

Schizophrenia

320

2562

1.26

3.82

1.5

1.8

1.84

1.50

g/l

7.14

277

2241

Other protozoal intestinal diseases, including avohilmo

259

1.86

3.79

1.7

2.3

1.23

1.41

g/l

0.64

233

Benign neoplasm: Skin of trunk

104

703

1.51

3.79

2.0

1.47

1.53

g/l

0.26

624

Cauda equina syndrome

189

2.03

3.78

1.5

2.4

1.57

1.38

g/l

0.74

173

Melanocytic naevi, other sites/unspecified

185

1382

1.36

3.78

2.3

1.9

1.33

1.52

g/l

2.46

174

1206

Family history of malignant neoplasm

190

1423

1.35

3.78

1.7

1.45

1.53

g/l

0.61

162

1224

Postpartum hemorraghe, all women as controls

376

2991

1.23

3.74

2.4

2.1

1.12

1.32

g/l

5.66

328

2632

Scleritis

169

2.08

3.74

3.3

2.1

1.80

1.50

g/l

0.60

148

Malignant neoplasm of bone and articular cartilage, including Hilmo

254

1.86

3.72

2.0

1.6

1.39

1.54

g/l

0.62

230

Lagophthalmos

241

1.91

3.71

1.6

1.9

1.71

1.47

g/l

0.72

214

Acute bronchiolitis

597

1.51

3.70

2.2

1.37

1.27

g/l

0.51

521

Poisoning by medicine, drug-induced

156

2.12

3.70

1.4

2.1

1.38

1.45

g/l

0.16

140

Other disorders of bone density and structure

321

1.75

3.67

1.7

2.3

1.60

1.41

g/l

0.88

285

Rheumatoid lung disease

2.58

3.67

1.5

2.1

1.98

1.63

g/l

0.60

Ganglion

431

3576

1.21

3.67

1.5

1.8

1.45

1.50

g/l

0.52

368

3088

Open wound of wrist and hand

1118

9626

1.13

3.65

1.7

1.8

1.54

1.50

g/l

0.65

964

8334

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

227

1.91

3.64

1.6

2.10

1.59

g/l

1.90

201

All dysplastic lesions of the cervix uteri, vagina or vulva

478

3904

1.20

3.64

2.1

1.9

1.45

1.40

g/l

0.55

413

3401

Carcinoma in situ of skin, other sites/unspecified

363

1.73

3.64

2.0

1.8

1.52

1.59

g/l

0.22

328

Benign neoplasm: Anus and anal canal

517

1.59

3.63

1.8

2.0

1.69

1.51

g/l

0.84

464

Disorders of refraction and accommodation

588

4998

1.18

3.63

2.0

1.8

1.46

1.47

g/l

0.15

506

4340

Other disorders of cornea

240

1873

1.30

3.61

1.6

1.8

1.51

1.54

g/l

0.19

214

1627

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

125

2.26

3.59

1.6

2.0

1.39

1.50

g/l

0.27

113

Malignant neoplasm of ovary, including Hilmo

127

901

1.43

3.58

1.6

1.93

1.62

g/l

1.84

103

778

Infectious mononucleosis, including avohilmo

130

925

1.42

3.56

2.1

1.36

1.30

g/l

0.32

112

821

Infectious mononucleosis

130

925

1.42

3.56

2.1

1.36

1.30

g/l

0.32

112

821

Lichen simplex chronicus

535

1.57

3.55

1.8

1.9

1.80

1.52

g/l

1.96

479

Monoplegia

244

1.87

3.55

1.8

1.9

1.47

1.56

g/l

0.25

222

Burn and corrosion of trunk

456

1.62

3.55

1.5

2.1

1.55

1.50

g/l

0.16

405

Other peripheral vertigo

237

1853

1.30

3.54

1.5

1.8

1.51

1.54

g/l

0.24

196

1598

Secondary polycythaemia

379

1.68

3.54

1.7

1.9

1.34

1.54

g/l

1.09

333

Secondary parkinsonism+Parkinsonism in other disease

553

1.56

3.53

1.4

1.9

1.61

1.55

g/l

0.23

495

Foreign body in alimentary tract

134

964

1.41

3.52

1.9

2.0

1.52

g/l

0.00

111

848

Erectile dysfunction

250

1975

1.29

3.50

1.9

1.7

1.51

1.54

g/l

0.18

211

1712

Other/unspecified disorders of vestibular function

112

783

1.46

3.48

1.6

1.9

1.55

1.56

g/l

0.02

691

Malignant neoplasm of tonsil

231

1.88

3.48

2.5

1.5

1.27

1.50

g/l

1.06

198

Malignant neoplasm of rectosigmoid junction

268

1.81

3.46

1.4

1.5

1.85

1.58

g/l

1.12

234

Hordeolum and other deep inflammation of eyelid

129

924

1.42

3.46

2.1

1.9

1.28

1.51

g/l

2.37

103

810

Other noninflammatory disorders of vagina

166

1238

1.36

3.46

2.2

1.8

1.39

1.54

g/l

1.43

145

1076

Brain meningioma

109

758

1.46

3.46

1.9

1.6

1.68

1.57

g/l

0.43

654

Cervicocranial syndrome

243

1911

1.28

3.44

1.7

1.56

1.54

g/l

0.07

211

1644

Contusion of ankle

506

1.57

3.44

1.8

2.1

1.56

1.47

g/l

0.35

453

Malignant neoplasm of oropharynx, including Hilmo

321

1.73

3.44

2.2

1.5

1.43

1.55

g/l

0.39

281

Congenital malformations of uterus and cervix

195

1.94

3.44

1.6

2.3

1.19

1.30

g/l

0.31

171

Tuberculosis of other organs

391

1.66

3.43

1.6

1.7

1.55

1.59

g/l

0.11

352

Panhypopituitarism

284

1.78

3.42

1.4

2.0

1.40

1.45

g/l

0.13

259

Tuberculosis, wide

208

1608

1.31

3.42

1.7

1.51

1.53

g/l

0.09

180

1375

Certain conditions originating in the perinatal period

125

788

1.42

3.42

2.9

2.2

1.21

g/l

0.01

115

697

Bacterial meningitis

508

1.57

3.42

1.6

2.1

1.75

1.50

g/l

1.26

451

Other nonscarring hair loss

114

2.26

3.42

2.0

2.2

1.52

1.38

g/l

0.38

Other and unspecified injuries of shoulder and upper arm

508

1.57

3.42

1.5

2.1

1.58

1.52

g/l

0.27

452

Chromosomal abnormalities, not elsewhere classified

195

1.93

3.41

2.1

2.3

1.43

1.31

g/l

0.22

167

Other specified/unspecified spondylopathies

454

1.61

3.40

1.5

1.7

1.52

g/l

0.01

397

Malignant neoplasm of oesophagus, including Hilmo

655

1.50

3.40

1.3

1.6

1.69

1.53

g/l

1.17

565

Malignant neoplasm of breast, ER-negative, including Hilmo

419

3269

1.21

3.38

1.6

1.65

g/l

0.01

353

2796

Myasthenia gravis

293

1.77

3.38

1.8

1.9

1.49

1.50

g/l

0.03

261

Disorders of brain, other and unspecified

135

2.16

3.37

2.8

1.8

1.52

1.44

g/l

0.13

126

Suggestive for eosinophilic asthma

227

1777

1.29

3.37

1.5

1.7

1.71

1.52

g/l

2.20

197

1534

Toxic effect of ethanol

517

1.55

3.37

1.6

2.1

1.50

1.49

g/l

0.03

460

Malignant neoplasm of thyroid gland, including Hilmo

141

1030

1.39

3.36

2.0

1.6

1.60

1.56

g/l

0.14

124

894

Pulmonary eosinophilia, not elsewhere classified

191

1.96

3.35

1.6

1.8

1.66

1.44

g/l

0.54

170

Pedestrian injured in collision with car, pick-up truck or van

369

1.67

3.35

1.8

2.0

1.71

1.50

g/l

0.99

335

Optic atrophy

241

1.84

3.35

1.7

2.1

1.63

1.47

g/l

0.48

218

Other disorders of choroid

249

1.83

3.35

1.8

1.63

1.59

g/l

0.09

225

Papillary adenocarcinoma of thyroid gland

680

1.48

3.35

1.9

1.7

1.36

1.54

g/l

0.98

596

Melanocytic naevi of lower limb, including hip

100

689

1.48

3.34

2.6

1.9

1.23

1.47

g/l

1.99

610

False labour

394

2016

1.22

3.34

2.1

1.12

1.38

g/l

9.48

343

1765

Helminthiases, including avohilmo

534

1.54

3.34

2.9

2.2

1.14

1.39

g/l

2.19

478

Hereditary deficiency of other clotting factors

2.38

3.34

1.4

2.1

1.24

1.48

g/l

0.69

Ulcer of vagina/vulva

369

1.66

3.34

1.6

2.1

1.45

1.46

g/l

0.03

320

Ovarian dysfunction

118

837

1.42

3.32

2.3

2.2

1.49

1.26

g/l

1.66

108

728

Thyroiditis, unspecified

184

1.96

3.31

2.1

1.9

1.75

1.43

g/l

0.98

164

MS-disease / Multiple Sclerosis

127

914

1.41

3.31

1.8

1.9

1.33

1.47

g/l

1.12

108

801

Embedded teeth, including avohilmo

152

1126

1.36

3.30

2.0

2.1

1.33

1.31

g/l

0.09

138

998

Contact with other hot fluids

410

1.62

3.27

1.7

2.1

1.25

1.41

g/l

0.85

367

Other sexually transmitted chlamydial diseases

674

1.47

3.27

1.9

2.1

1.14

1.24

g/l

0.73

603

Other and unspecified injuries of wrist and hand

513

1.55

3.26

2.1

2.3

1.59

1.45

g/l

0.67

457

Other deformities of toe(s)

546

1.53

3.26

1.6

1.9

1.45

1.53

g/l

0.34

483

Inguinal or femoral hernia, bilateral

310

2529

1.24

3.25

1.6

1.7

1.45

1.55

g/l

1.04

260

2183

Perioral dermatitis

250

1.80

3.25

1.7

2.4

1.30

1.37

g/l

0.28

223

Unspecified parasitic disease

131

2.17

3.24

1.9

1.8

1.45

1.60

g/l

0.42

117

Haemangioma and lymphangioma, any site

200

1549

1.31

3.23

1.7

1.9

1.50

1.54

g/l

0.22

182

1355

Inguinal hernia, bilateral

305

2486

1.24

3.23

1.5

1.7

1.45

1.55

g/l

1.14

256

2145

Prolonged pregnancy

112

1339

0.71

3.23

1.6

2.1

1.15

1.34

g/l

1.68

1174

Respiratory conditions due to other external agents

374

1.65

3.23

2.2

1.8

1.58

1.54

g/l

0.13

337

Tongue abnormality

151

1126

1.36

3.22

1.7

1.8

1.60

1.56

g/l

0.20

130

979

Other/unspecified soft tissue disorders related to use, overuse and pressure

404

1.62

3.22

1.5

1.8

1.28

1.60

g/l

2.56

354

Benign neoplasm: Tongue

477

1.57

3.20

1.9

1.62

1.51

g/l

0.42

422

Other and unspecified trigeminal disorders

201

1.89

3.19

1.4

2.3

1.50

1.47

g/l

0.09

180

Transient global amnesia

149

1980

0.74

3.19

1.8

1.7

1.41

1.56

g/l

1.21

119

1720

Vascular dementia (subcortical)

123

892

1.41

3.18

1.6

1.7

1.53

1.54

g/l

0.03

106

779

Infliximab

215

1.85

3.18

1.6

2.2

1.54

1.34

g/l

0.53

195

Pustular psoriasis

101

705

1.46

3.17

1.3

1.9

1.82

1.57

g/l

1.65

623

Presbycusis

484

4076

1.19

3.15

1.9

1.6

1.53

1.57

g/l

0.55

384

3501

Other specified disorders of muscle

454

1.57

3.15

2.0

1.7

1.45

1.54

g/l

0.40

395

Disorders of eyelid in diseases classified elsewhere

494

1.55

3.15

1.8

1.9

1.68

1.53

g/l

0.53

437

Other and unspecified nonscarring hair loss

2.41

3.14

1.8

2.4

1.57

1.40

g/l

0.37

Pustulosis palmaris et plantaris

624

1.48

3.14

1.3

1.9

1.83

1.59

g/l

1.29

551

Other contact dermatitis

168

1276

1.33

3.13

1.6

1.8

1.65

1.51

g/l

1.01

140

1116

Additional codes for the location of defect, injury or illness

137

1011

1.38

3.13

1.8

1.9

1.46

1.53

g/l

0.37

122

894

Macular cyst

652

1.48

3.12

1.8

1.58

1.62

g/l

0.16

570

Mental retardation, wide definition

522

1.52

3.12

1.6

2.2

1.55

1.41

g/l

0.64

462

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

609

5281

1.16

3.12

1.6

1.9

1.50

1.49

g/l

0.10

531

4579

Optic atrophy, wide definition

255

1.77

3.09

1.7

2.0

1.64

1.46

g/l

0.56

232

Malignant neoplasm of tonsil, including Hilmo

263

1.76

3.08

2.4

1.5

1.30

1.52

g/l

1.07

229

Adenocarcinoma and papillary adenocarcinoma of stomach

489

1.55

3.08

1.4

1.6

1.58

1.54

g/l

0.12

423

Nonspecific lymphadenitis

108

767

1.43

3.08

1.6

1.9

1.52

1.57

g/l

0.20

667

Haemangioma, any site

189

1464

1.31

3.07

1.7

1.9

1.52

1.54

g/l

0.13

171

1280

Use of biperiden

115

827

1.41

3.07

1.6

1.9

1.83

1.55

g/l

2.09

724

Vascular dementia

334

2664

1.22

3.07

1.5

1.6

1.61

1.53

g/l

0.87

281

2268

Unspecified parasitic disease, including avohilmo

134

2.11

3.07

1.9

1.8

1.46

1.58

g/l

0.36

120

Myopia

239

1905

1.26

3.05

2.0

1.9

1.40

1.45

g/l

0.31

209

1670

2.33

3.04

1.3

2.4

1.72

1.46

g/l

0.42

Other neurotic disorders

110

787

1.42

3.04

1.8

1.48

1.56

g/l

0.44

100

686

Dermatitis herpetiformis

287

1.72

3.04

1.6

1.9

1.41

1.46

g/l

0.13

260

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

101

711

1.44

3.03

1.9

1.44

1.53

g/l

0.45

625

Oxicams

678

3357

1.15

3.02

1.6

1.9

1.56

1.47

g/l

1.62

565

2871

Hypotension due to drugs

304

1.71

3.01

1.4

1.8

1.64

1.57

g/l

0.16

279

Other superficial mycoses, including avohilmo

214

1688

1.28

3.00

1.8

1.9

1.52

1.44

g/l

0.63

180

1468

LSIL lesion of the cervix uteri, vagina or vulva

220

1740

1.27

3.00

2.2

1.8

1.44

g/l

0.00

196

1515

Other strabismus

443

3749

1.18

2.98

2.0

1.8

1.45

1.47

g/l

0.27

383

3243

HSIL lesion of the cervix uteri

274

2224

1.24

2.97

2.3

2.0

1.39

1.35

g/l

0.27

240

1949

Other congenital malformations of heart

2.47

2.96

2.4

2.0

1.04

1.33

g/l

0.97

Entropion and trichiasis of eyelid

261

2116

1.25

2.96

1.7

1.49

1.54

g/l

0.37

234

1807

Pathological resorption of teeth

600

1.48

2.95

1.7

2.0

1.49

g/l

0.01

529

Inflammatory disorders of breast

113

816

1.40

2.94

1.8

2.0

1.36

1.42

g/l

0.34

102

719

Carcinoma in situ of skin of lip

2.79

2.93

2.7

2.0

1.76

1.63

g/l

0.26

Superficial injuries involving multiple body regions

375

1.61

2.92

1.6

2.2

1.62

1.43

g/l

0.76

339

Sequelae of injuries of neck and trunk

455

1.55

2.91

1.4

2.2

1.52

g/l

0.01

398

Malignant neoplasm of corpus uteri, including Hilmo

200

1573

1.29

2.91

1.9

1.6

1.75

1.66

g/l

0.47

155

1352

Sudden idiopathic hearing loss

257

2083

1.25

2.90

1.7

1.8

1.55

1.56

g/l

0.01

223

1815

Gonococcal infection

423

1.56

2.90

1.5

1.9

1.55

g/l

0.01

377

Dependent personality disorder

260

1.73

2.90

2.0

2.1

1.57

1.48

g/l

0.28

233

Use of galantamine

169

2173

0.77

2.89

1.5

1.7

1.67

1.54

g/l

1.00

139

1843

Burns and corrosions confined to eye and internal organs

329

1.64

2.88

1.3

2.2

1.50

1.45

g/l

0.11

296

Disorders of globe

449

1.55

2.88

1.8

1.9

1.63

1.56

g/l

0.27

401

Sequelae of other and unspecified infectious and parasitic diseases

702

1.43

2.87

1.9

1.43

1.52

g/l

0.42

616

Congenital dyserythropoietic anaemia

9.91

2.87

2.4

1.8

1.89

1.93

g/l

—

Dislocation, sprain and strain of joints and ligaments at neck level

296

2434

1.22

2.87

1.7

1.9

1.50

1.44

g/l

0.51

258

2116

Impingement syndrome of shoulder

545

4725

1.16

2.86

1.8

1.7

1.57

1.56

g/l

0.04

460

4088

Other, unspecified and serous retinal detachments

606

1.47

2.84

1.9

1.8

1.49

1.60

g/l

0.51

527

Rhabdomyosarcoma

9.44

2.84

1.2

1.5

0.94

1.02

g/l

—

Other otitis externa (chronic)

151

1149

1.33

2.84

1.7

1.9

1.62

1.51

g/l

0.62

130

1003

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

166

1.93

2.84

2.4

1.6

1.34

1.52

g/l

0.61

149

Carcinoma in situ of other and unspecified genital organs

262

1.72

2.83

1.8

2.1

1.54

1.57

g/l

0.05

227

Parapsoriasis

270

1.71

2.81

1.7

2.1

1.49

g/l

0.01

244

Postpartum hemorraghe, parous women as controls

376

2642

1.20

2.81

2.4

2.1

1.12

1.30

g/l

4.49

328

2334

Patent foramen ovale

293

1.68

2.81

1.6

2.3

1.38

1.39

g/l

0.03

267

Other disorders of binocular movement

247

1.73

2.80

1.7

2.2

1.35

1.32

g/l

0.07

221

Malignant neoplasm of thyroid gland

125

926

1.37

2.80

2.1

1.6

1.56

1.55

g/l

0.04

108

806

Pedestrian injured in transport accident

157

1204

1.32

2.79

1.8

1.9

1.52

g/l

0.01

133

1057

Other acquired deformities of musculoskeletal system and connective tissue

100

716

1.42

2.78

1.6

1.8

1.50

1.56

g/l

0.22

630

Pediculosis, acariasis and other infestations, including avohilmo

332

2770

1.21

2.77

1.7

1.9

1.44

1.43

g/l

0.12

276

2414

Cryptococcosis, including avohilmo

9.93

2.77

2.0

4.1

1.10

1.95

g/l

—

Cryptococcosis

9.93

2.77

2.0

4.1

1.10

1.95

g/l

—

Bell's palsy

271

2221

1.23

2.75

1.8

1.7

1.58

1.52

g/l

0.46

234

1916

Persistent delusional disorders

172

1339

1.30

2.74

1.4

1.8

1.76

1.54

g/l

2.08

156

1161

Idiopathic hypoparathyroidism

2.77

2.74

2.1

2.7

1.42

1.41

g/l

0.01

Other and unspecified injuries of ankle and foot

526

1.48

2.74

1.6

2.1

1.37

1.46

g/l

0.40

470

Juvenile osteochondrosis

373

1.58

2.73

1.8

2.1

1.47

1.40

g/l

0.20

340

Deviated nasal septum

823

7344

1.13

2.73

1.6

1.7

1.52

1.54

g/l

0.21

698

6337

Pilonidal cyst

145

1102

1.33

2.73

1.8

1.9

1.50

1.41

g/l

0.60

126

966

Universal erythroderma, KELA reimbursement

220

1.78

2.73

1.7

1.54

1.50

g/l

0.08

199

Other bursitis, not elsewhere classified

140

2.00

2.73

1.3

1.6

1.74

1.52

g/l

0.64

130

Atypical facial pain

109

795

1.39

2.72

1.6

1.9

1.40

1.55

g/l

1.14

692

Injury of nerves and spinal cord at neck level

383

1.58

2.72

1.6

1.9

1.49

1.53

g/l

0.12

342

Cluster headache, strict

446

1.52

2.71

1.5

2.0

1.39

1.49

g/l

0.49

393

Other disorders of Eustachian tube

455

1.52

2.71

1.8

2.0

1.49

1.54

g/l

0.14

403

Asthma mixed form (mode), excluding more controls

601

1.45

2.71

1.6

1.7

1.52

1.45

g/l

0.30

514

Sequelae of infectious and parasitic diseases, including avohilmo

163

1264

1.30

2.68

1.9

1.8

1.51

1.54

g/l

0.11

141

1088

Viral haemorrhagic fevers, not elsewhere classified/unspecified

179

1406

1.29

2.68

1.7

1.8

1.46

1.52

g/l

0.31

161

1226

All dysplastic lesions of the cervix uteri

394

3294

1.18

2.67

2.2

2.0

1.39

1.36

g/l

0.20

343

2876

Melanoma in situ

128

963

1.36

2.67

2.4

1.8

1.45

1.53

g/l

0.47

109

834

Use of rivastigmine

400

4661

0.85

2.67

1.4

1.6

1.56

g/l

0.01

325

3957

Fourth [trochlear] nerve palsy

385

1.57

2.67

1.7

1.9

1.61

1.47

g/l

0.64

348

Any dementia, excluding more controls

1189

7432

1.10

2.66

1.5

1.7

1.63

1.56

g/l

1.55

974

6341

Congenital malformations and deformations of the musculoskeletal system

146

1109

1.32

2.66

2.5

2.0

1.35

1.39

g/l

0.24

126

973

Tooth agenesis EXCLUDE clefts and syndromes

367

1.57

2.65

1.9

2.5

1.09

1.25

g/l

0.89

334

Non-small cell lung cancer, squamous, helper endpoint

1215

0.70

2.65

1.6

1.7

1.95

1.52

g/l

3.48

1033

Use of antiglaucoma preparations and miotics

233

1892

1.25

2.64

1.7

1.55

g/l

0.02

200

1629

509

1.49

2.63

1.5

1.9

1.80

1.53

g/l

1.77

451

Open wound of shoulder and upper arm

291

1.65

2.63

1.4

2.6

1.20

1.48

g/l

1.11

265

Delayed milestone in childhood

126

1.96

2.62

2.6

2.2

1.13

1.11

g/l

0.03

109

Burn and corrosion of wrist and hand

507

1.48

2.62

1.4

2.2

1.40

1.45

g/l

0.17

453

Spinal instabilities

394

1.55

2.61

1.5

1.9

1.68

1.50

g/l

0.70

342

Abnormal spermatozoa

266

3210

0.82

2.59

1.5

1.7

1.60

1.54

g/l

0.48

219

2767

Cerebral aneurysm, nonruptured

193

1537

1.27

2.58

1.8

1.61

1.56

g/l

0.29

173

1330

Other drug-induced secondary parkinsonism

165

1.89

2.58

1.5

2.1

1.60

1.57

g/l

0.06

148

Assault by blunt object

179

1.83

2.57

2.5

2.0

1.46

1.42

g/l

0.07

163

Atrophic disorders of skin

323

2714

1.20

2.55

1.7

1.57

g/l

0.00

270

2336

Gonococcal infection, including avohilmo

461

1.50

2.55

1.4

2.0

1.53

1.52

g/l

0.04

411

Endometriosis

676

3471

1.14

2.53

1.7

1.9

1.46

1.49

g/l

0.37

574

2978

Bruxism

187

1.80

2.53

1.8

2.3

1.42

1.38

g/l

0.08

164

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

195

1.79

2.53

1.4

1.8

1.71

1.55

g/l

0.45

174

Malignant neoplasm of breast, HER-negative

383

3137

1.18

2.51

1.7

1.6

1.61

1.65

g/l

0.32

320

2679

Malignant neoplasm of mesothelium and soft tissue

714

1.40

2.51

1.7

1.98

1.53

g/l

2.66

622

Flatulence and related conditions

130

1.98

2.51

2.0

2.1

1.63

1.46

g/l

0.31

117

Spinal osteochondrosis

130

1.98

2.51

1.5

2.8

1.24

1.39

g/l

0.43

118

Malignant neoplasm of other and ill-defined sites, including Hilmo

241

1.70

2.50

1.8

1.5

1.92

1.59

g/l

0.89

213

Other and unspecified injuries of thorax

264

1.67

2.50

1.7

2.2

1.44

g/l

0.01

238

Varicose veins of other sites

145

1120

1.31

2.49

1.8

1.30

1.54

g/l

2.41

125

973

Salpingitis and oophoritis

320

2693

1.20

2.48

1.8

1.7

1.56

1.58

g/l

0.19

279

2325

Other and unspecified hypertrophic disorders of skin

2.25

2.47

1.7

2.6

1.41

1.34

g/l

0.10

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

559

1.43

2.46

2.1

2.4

1.26

1.20

g/l

0.27

496

Malignant neoplasm of ovary

665

1.40

2.46

1.5

1.6

2.05

1.62

g/l

2.28

572

Small kidney of unknown cause

3.09

2.45

1.5

1.38

1.51

g/l

0.22

Atypical mycobacterium lung infection

213

1.75

2.44

1.9

1.8

1.82

1.52

g/l

1.11

191

Tooth eruption problems

227

1786

1.23

2.44

2.0

2.2

1.31

1.26

g/l

0.38

210

1591

Female infertility

510

2658

1.15

2.43

2.3

2.0

1.30

1.44

g/l

2.88

464

2303

Digestive system disorders of fetus and newborn

6.81

2.43

1.8

1.5

0.93

1.38

g/l

—

Polycystic ovarian syndrome, broad definition

156

1219

1.29

2.42

2.5

2.2

1.27

1.18

g/l

0.66

141

1079

Non-small cell lung cancer, including Hilmo

385

3096

1.18

2.41

1.6

1.5

1.90

1.56

g/l

7.70

332

2633

Tuberculosis of other organs, strict, including avohilmo

469

1.48

2.40

1.7

1.54

1.57

g/l

0.11

420

Tuberculosis of other organs, strict

461

1.49

2.39

1.7

1.55

1.57

g/l

0.06

414

Other inflammation of vagina/vulva

410

1.51

2.39

1.8

2.1

1.43

1.40

g/l

0.09

358

Acute nasopharyngitis (common cold)

210

1690

1.24

2.38

1.7

1.8

1.56

1.53

g/l

0.16

187

1461

Nocardiosis

4.51

2.38

2.6

1.87

1.68

g/l

—

Nocardiosis, including avohilmo

4.51

2.38

2.6

1.87

1.68

g/l

—

Disorder of external ear, unspecified

552

1.44

2.38

2.0

1.71

1.54

g/l

0.72

491

Benign neoplasm: Skin of scalp and neck

420

1.51

2.38

2.8

2.0

1.39

1.51

g/l

0.68

377

Vascular dementia (other)

163

1.87

2.38

1.3

1.7

1.57

1.63

g/l

0.17

152

Other/unspecified enthesopathies of lower limb, excluding foot

141

1092

1.30

2.38

1.6

1.9

1.67

1.54

g/l

0.75

119

948

Nontoxic multinodular goitre

458

3985

1.16

2.37

1.6

1.67

1.60

g/l

0.83

403

3438

Radial styloid tenosynovitis [de Quervain]

102

754

1.37

2.37

1.4

1.8

1.45

1.53

g/l

0.47

665

Mixed conductive and sensorineural hearing loss

324

2747

1.19

2.37

1.8

1.7

1.58

1.56

g/l

0.10

262

2389

Subacute thyroiditis

502

1.46

2.37

1.6

2.0

1.44

1.51

g/l

0.24

439

Chronic diseases of tonsils and adenoids

1606

10913

0.93

2.36

1.9

1.8

1.48

1.50

g/l

0.21

1404

9457

Habitual aborter

169

1.80

2.35

2.1

2.0

1.28

1.21

g/l

0.15

148

Chronic suppurative otitis media, including avohilmo

172

1369

1.27

2.35

1.8

1.9

1.53

1.48

g/l

0.29

151

1199

Haemorrhage in early pregnancy

431

3626

1.16

2.33

1.9

1.8

1.36

1.48

g/l

1.91

374

3146

Cysts of oral region, not elsewhere classified

132

1018

1.31

2.33

1.7

1.9

1.44

1.54

g/l

0.54

116

887

Abscess of external ear

178

1.79

2.31

1.7

2.2

1.50

1.39

g/l

0.29

163

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

366

1.54

2.31

1.5

1.6

1.55

1.54

g/l

0.04

315

Subarachnoid haemorrhage

258

2149

1.21

2.30

1.7

1.52

1.54

g/l

0.10

224

1837

Diffuse brain injury

530

1.43

2.30

1.7

1.8

1.46

1.51

g/l

0.17

456

Hyperprolactinaemia

341

1.54

2.29

1.7

2.0

1.32

1.39

g/l

0.22

300

Peroneal tendinitis

201

1.73

2.28

1.5

2.0

1.32

1.38

g/l

0.20

175

Meretoja disease

2.57

2.28

1.7

2.1

1.34

1.55

g/l

0.57

Hirsprung

6.13

2.28

1.4

2.0

2.18

1.13

g/l

—

Contact with sharp glass

481

1.45

2.27

1.6

2.2

1.54

1.42

g/l

0.42

434

Intermittent heterotropia

724

1.36

2.27

1.8

2.0

1.36

1.38

g/l

0.07

642

Recurrent dislocation of patella

522

1.43

2.27

2.1

2.3

1.50

1.28

g/l

0.94

472

Malignant neoplasm of eye and adnexa, including Hilmo

233

1.67

2.26

1.9

1.7

1.48

1.55

g/l

0.17

207

Other disorders starting during childhood or adolescence

493

1.44

2.24

2.1

2.3

1.27

1.20

g/l

0.28

443

Other melanin hyperpigmentation

369

1.52

2.23

1.9

1.44

1.53

g/l

0.28

332

Complications predominantly related to the puerperium

415

3602

1.16

2.22

2.3

1.9

1.36

1.44

g/l

0.82

379

3128

Other and unspecified corneal deformities and disorders

476

1.45

2.22

1.6

1.9

1.68

1.48

g/l

0.90

420

Sequelae of infectious and parasitic diseases

156

1237

1.27

2.22

1.9

1.8

1.48

1.54

g/l

0.30

136

1068

Delivery

743

4355

0.89

2.19

1.8

1.47

1.58

g/l

2.74

648

3755

Meralgia paraesthetica

511

1.43

2.18

1.9

1.45

1.57

g/l

0.42

445

Foreign body or object entering through skin

125

966

1.31

2.18

1.5

1.9

1.49

1.51

g/l

0.07

850

Non-small cell lung cancer, adenocarcinoma

157

1250

1.27

2.18

1.8

1.6

1.83

1.54

g/l

2.66

138

1080

Injury of muscle and tendon at wrist and hand level

297

2518

1.19

2.18

1.6

1.8

1.58

1.53

g/l

0.40

270

2184

Unspecified/other endometriosis

144

1108

1.28

2.18

2.0

1.37

1.40

g/l

0.12

126

954

Emotional disorders starting during childhood or adolescence

447

1.45

2.17

2.3

1.24

1.18

g/l

0.24

404

Use of memantine

816

7238

0.90

2.17

1.5

1.7

1.58

1.57

g/l

0.17

629

6183

Use of other anti-dementia drugs

816

7238

0.90

2.17

1.5

1.7

1.58

1.57

g/l

0.17

629

6183

L02BX Other hormone antagonists and related agents

186

1514

1.25

2.17

1.4

1.7

1.89

1.51

g/l

3.89

150

1314

Malignant neoplasm of floor of mouth

2.31

2.17

1.5

1.6

1.94

1.53

g/l

—

Burns and corrosions of multiple body regions

123

1.93

2.17

2.0

1.8

1.55

1.51

g/l

0.06

110

Sixth [abducent] nerve palsy

631

1.39

2.17

1.8

1.9

1.68

1.51

g/l

0.78

571

Exposure to unspecified smoke, fire and flames

145

1.85

2.17

1.5

1.9

1.45

1.56

g/l

0.19

127

Somnolence

167

1.78

2.16

1.8

2.1

1.53

1.43

g/l

0.17

154

Third [oculomotor] nerve palsy

332

1.54

2.15

1.9

1.61

1.45

g/l

0.51

301

Other congenital malformations of intestine, including avohilmo

160

1.80

2.15

1.5

2.2

1.68

1.44

g/l

0.48

144

Other diseases of peritoneum

743

1.35

2.15

1.6

1.8

1.39

1.54

g/l

0.82

660

Androgenic alopecia

102

2.02

2.15

1.5

2.4

1.47

1.33

g/l

0.26

Major anomalies of jaw size

307

1.56

2.14

1.5

2.2

1.28

1.40

g/l

0.32

271

Injury of eye and orbit

293

2485

1.19

2.14

1.6

1.8

1.43

1.49

g/l

0.58

254

2151

Benign neoplasm: Tonsil

183

1.74

2.14

1.2

2.0

1.39

1.43

g/l

0.12

162

Disorders of synovium and tendon in diseases classified elsewhere

324

1.54

2.13

1.5

1.7

1.60

g/l

0.00

284

Allergic colitis

197

1.70

2.13

2.4

2.5

1.12

1.18

g/l

0.12

178

Malignant neoplasm of cervix uteri, including Hilmo

268

1.59

2.12

1.9

1.8

1.43

1.54

g/l

0.42

236

Unspecified abortion

513

1.42

2.12

2.4

1.7

1.42

1.59

g/l

0.79

446

Viral conjunctivitis, including avohilmo

497

1.43

2.11

1.9

2.1

1.51

1.47

g/l

0.11

447

Benign neoplasm: Appendix

184

1.74

2.11

1.5

1.9

1.41

1.51

g/l

0.28

168

Mastocytosis

2.27

2.10

1.5

2.5

1.12

1.56

g/l

1.42

Bursitis of shoulder

374

1.50

2.10

1.5

1.7

1.96

1.56

g/l

1.91

330

Malignant neoplasm of corpus uteri

177

1435

1.25

2.09

1.9

1.6

1.67

1.65

g/l

0.07

137

1239

Problems related to social environment

457

1.44

2.09

1.5

1.9

1.70

1.51

g/l

0.64

415

Burn and corrosion of shoulder and upper limb, except wrist and hand

302

1.55

2.07

1.6

1.9

1.54

1.45

g/l

0.23

274

Chronic iridocyclitis

104

791

1.33

2.06

1.6

1.8

1.53

g/l

0.01

699

Injury of muscle and tendon at ankle and foot level

343

1.51

2.05

1.5

2.1

1.40

1.51

g/l

0.30

302

Heterophoria

149

1187

1.27

2.05

2.1

1.9

1.45

1.48

g/l

0.16

126

1052

Residual foreign body in soft tissue

101

766

1.33

2.04

1.4

1.8

1.53

1.51

g/l

0.07

668

Hypersensitivity pneumonitis due to organic dust

264

1.59

2.04

1.8

2.1

1.70

1.46

g/l

0.65

241

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

451

1.44

2.03

1.5

2.2

1.61

1.46

g/l

0.69

403

Postpartum haemorrhage due to anatomy

159

1278

1.25

2.02

2.5

2.3

1.06

1.13

g/l

0.52

143

1143

Placenta praevia

393

1.46

2.01

3.2

1.8

1.14

1.34

g/l

1.14

341

Malignant neoplasm of other and unspecified parts of biliary tract

249

1.60

2.01

1.6

1.69

1.58

g/l

0.27

219

Sexual dysfunction

257

1.59

1.99

1.6

2.1

1.53

1.47

g/l

0.15

235

Fall on and from ladder

197

1627

1.22

1.99

2.1

1.7

1.45

1.53

g/l

0.57

167

1418

Benign neoplasm: Skin of upper limb, including shoulder

306

1.53

1.97

3.2

1.9

1.44

1.51

g/l

0.20

274

Postprocedural disorders of nervous system

110

848

1.31

1.97

1.8

2.0

1.51

1.41

g/l

0.51

751

Arthropod-borne viral fevers and viral haemorrhagic fevers

210

1746

1.21

1.97

1.7

1.8

1.51

1.52

g/l

0.06

187

1507

Carcinoma in situ of vulva

113

1.92

1.96

1.6

2.7

1.96

1.49

g/l

0.70

100

Acute drug-induced interstitial lung disorder

143

1.82

1.96

3.1

1.9

1.46

1.52

g/l

0.13

128

Unspecified lump in breast

308

2647

1.17

1.95

1.7

1.49

1.58

g/l

0.97

270

2270

Carcinoma in situ, bladder

116

907

1.30

1.95

1.6

1.8

1.64

1.52

g/l

0.70

107

780

Sacrococcygeal disorders, not elsewhere classified

380

1.47

1.95

1.8

2.0

1.42

1.52

g/l

0.39

329

Female infertility, cervical, vaginal, other or unspecified origin

461

2595

1.14

1.94

2.3

2.0

1.28

1.43

g/l

3.20

417

2255

Carcinoma in situ of other and unspecified sites

124

978

1.29

1.94

1.6

1.8

1.68

1.53

g/l

1.04

115

838

Alzheimer’s disease (Early onset), excluding more controls

771

0.70

1.94

1.4

1.6

1.57

1.55

g/l

0.05

656

L02BB Anti-androgens

301

2591

1.17

1.93

1.4

1.7

1.76

1.53

g/l

3.04

260

2211

Other and unspecified injuries of abdomen, lower back and pelvis

220

1.63

1.92

1.8

2.3

1.30

1.39

g/l

0.21

201

Cluster headache, wide

507

1.40

1.91

1.5

2.0

1.36

1.48

g/l

0.63

445

Bitten or struck by other mammals

213

1777

1.21

1.91

2.0

1.9

1.53

1.46

g/l

0.51

191

1549

Benign neoplasm: Larynx

577

1.38

1.91

1.5

1.9

1.64

1.50

g/l

0.65

516

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

140

1119

1.26

1.91

1.8

1.7

1.67

1.53

g/l

0.80

123

964

Benign neoplasm of ovary

345

2997

1.16

1.90

1.9

1.7

1.57

1.61

g/l

0.36

304

2570

Leiomyoma of uterus

1276

6639

1.08

1.88

1.7

1.56

g/l

0.05

1076

5722

Hyperkinetic disorders (excl. ADHD)

164

1.71

1.87

1.7

2.6

1.20

1.27

g/l

0.16

150

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

173

1420

1.23

1.87

1.6

1.8

1.34

1.56

g/l

2.78

146

1239

Other specified and unspecified disorders of conjunctiva

145

1.77

1.86

2.5

1.8

1.30

1.53

g/l

0.85

131

Benign neoplasm: Skin of lower limb, including hip

435

1.43

1.85

1.3

1.9

1.48

1.49

g/l

0.03

387

Appendectomy

1479

13164

1.07

1.85

1.8

1.54

1.50

g/l

0.86

1273

11416

Alzheimer disease

980

7596

0.92

1.85

1.5

1.7

1.59

1.57

g/l

0.30

792

6476

Noninflammatory disorders of female genital tract

802

3661

1.10

1.84

2.0

1.9

1.45

1.48

g/l

0.39

694

3142

Sequelae of injuries of upper limb

199

1660

1.21

1.82

1.6

1.8

1.65

1.54

g/l

0.90

177

1451

Open bite

546

1.37

1.81

1.7

2.4

1.19

1.30

g/l

0.43

490

Maternal care for cervical incompetence

513

1.38

1.81

1.8

1.9

1.33

1.51

g/l

0.88

456

Hereditary motor and sensory neuropathy

124

1.83

1.81

1.6

1.7

1.31

1.50

g/l

0.40

111

Uterine polyps

577

3024

1.12

1.80

1.6

1.8

1.57

g/l

0.01

494

2574

Injury of cranial nerves

2.00

1.80

1.4

2.6

2.35

1.39

g/l

1.44

Other specified and unspecified disorders of lens

186

1.67

1.79

2.4

1.7

1.59

1.70

g/l

0.26

167

Benign neoplasm: salivary glands, exclude unknown (D119)

206

1729

1.20

1.78

1.5

1.7

1.66

1.54

g/l

0.94

178

1494

Acute alcohol intoxication ICD-9

584

1.36

1.78

1.7

1.8

1.54

1.56

g/l

0.10

505

Achilles tendinitis

219

1847

1.19

1.78

1.9

1.8

1.56

1.53

g/l

0.21

186

1609

Other and unspecified mononeuropathies of lower limb

439

1.41

1.77

1.7

1.8

1.64

1.58

g/l

0.18

384

Trigeminal neuralgia

119

943

1.27

1.77

1.5

1.8

1.60

1.56

g/l

0.18

100

818

Excessive earwax

1759

15016

1.06

1.77

1.7

1.48

1.56

g/l

3.12

1491

12899

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

724

1.32

1.77

2.1

1.8

1.70

1.56

g/l

0.67

640

Dyshidrosis [pompholyx]

178

1.66

1.76

1.9

1.61

1.37

g/l

0.60

158

Other abnormal products of conception

458

2665

1.13

1.75

2.0

2.1

1.31

1.35

g/l

0.43

412

2339

Congenital malformations of genital organs

138

1106

1.25

1.75

1.9

2.0

1.25

1.39

g/l

1.01

121

966

Ovarian dysfunction, other/unspecified

2.13

1.74

1.7

2.7

1.78

1.36

g/l

0.57

Emotional disorders and disorders of social functioning with onset specific to childhood

480

1.38

1.73

2.4

1.19

1.10

g/l

0.43

427

Dislocation, sprain and strain of joints and ligaments of head

500

1.37

1.73

1.6

2.1

1.51

1.42

g/l

0.38

445

Stenosis and insufficiency of lacrimal passages

214

1808

1.19

1.72

1.4

1.8

1.50

1.54

g/l

0.21

176

1553

Carcinoma in situ of skin of eyelid, including canthus

2.44

1.72

2.0

2.1

1.19

1.39

g/l

0.56

Dermatographic urticaria

115

912

1.27

1.70

1.8

1.9

1.44

1.50

g/l

0.34

799

Benign neoplasm of major salivary glands

228

1940

1.19

1.70

1.6

1.7

1.68

1.54

g/l

1.38

199

1669

Alopecia areata

317

1.47

1.69

1.9

2.1

1.55

1.47

g/l

0.23

281

Hypogonadotropic hypogonadism

418

1.41

1.68

1.9

1.56

1.50

g/l

0.19

371

Hypermetropia

137

1111

1.24

1.67

1.5

1.8

1.47

1.48

g/l

0.04

115

968

Chronic suppurative otitis media

143

1167

1.24

1.66

1.8

1.54

1.48

g/l

0.35

125

1023

Exposure to smoke, fire and flames

394

1.42

1.66

1.3

2.0

1.51

1.52

g/l

0.02

351

Fenamates

384

2306

1.14

1.66

1.7

2.1

1.52

1.43

g/l

1.19

339

1998

Other sexually transmitted chlamydial diseases, including avohilmo

136

1103

1.24

1.65

2.0

2.2

1.13

1.22

g/l

0.69

124

981

Acute appendicitis, with complications

437

3899

1.13

1.65

1.9

1.8

1.58

1.54

g/l

0.35

382

3360

Lichen planus

297

2586

1.16

1.65

1.7

1.43

1.58

g/l

2.16

255

2231

Benign neoplasm: Skin of ear and external auricular canal

100

786

1.29

1.64

1.9

1.28

1.52

g/l

2.35

697

Injury of muscle and tendon at hip and thigh level

209

1771

1.19

1.64

2.0

1.8

1.60

1.52

g/l

0.55

190

1531

Certain zoonotic bacterial diseases, including avohilmo

489

1.37

1.63

2.2

2.0

1.41

1.47

g/l

0.24

439

Inflammatory diseases of prostate (prostatitis)

333

2926

1.15

1.63

1.5

1.6

1.54

1.55

g/l

0.08

273

2504

Other specified/unspecified deforming dorsopathies

206

1.58

1.62

1.7

1.9

1.68

1.49

g/l

0.42

179

Use of glatiramer acetate

151

1.68

1.62

2.6

2.1

1.49

1.39

g/l

0.26

133

Perichondritis of external ear

313

1.47

1.61

1.7

1.9

1.46

1.59

g/l

0.32

285

Hypermobility syndrome

516

1.35

1.59

1.6

2.1

1.25

1.38

g/l

0.62

452

Mixed disorders of conduct and emotions, excluding more controls

183

1.60

1.58

1.8

2.3

1.59

1.11

g/l

1.02

161

Hyperkinetic disorders

187

1533

1.19

1.58

1.8

2.2

1.22

1.19

g/l

0.19

162

1357

Oral leukoplakia, including avohilmo

458

1.38

1.58

1.8

2.0

1.70

1.54

g/l

0.67

410

Amblyopia ex anopsia

552

1.34

1.58

2.3

2.1

1.30

1.49

g/l

0.91

502

Vascular dementia (mixed)

494

1.37

1.57

2.0

1.8

1.57

1.52

g/l

0.17

438

Injury of muscle and tendon at lower leg level

328

2887

1.14

1.56

1.8

1.62

1.52

g/l

0.95

287

2493

Graves disease, strict definition

176

1477

1.20

1.55

1.8

1.45

1.50

g/l

0.34

147

1285

Tonsillectomy and adenotomy

877

6596

0.92

1.55

2.3

1.9

1.36

1.41

g/l

0.81

771

5751

Other disorders of amniotic fluid and membranes

165

1327

1.21

1.55

1.9

2.0

1.24

1.36

g/l

1.38

143

1159

Perineal laceration during delivery

216

1485

1.18

1.55

2.1

1.11

1.29

g/l

2.57

188

1307

Granuloma annulare

201

1.57

1.54

2.6

2.1

1.23

1.50

g/l

0.86

178

Laparoscopic left hemicolectomy

308

1.46

1.54

1.4

1.9

1.73

1.56

g/l

0.64

275

Toxic effect of contact with venomous animals

651

1.31

1.54

1.5

2.0

1.52

1.46

g/l

0.28

582

Benign neoplasm: Pituitary gland, craniopharyngeal duct

106

846

1.27

1.53

1.5

1.9

1.37

1.50

g/l

0.70

743

Other and/or unspecified nontoxic goitre

174

1462

1.20

1.53

1.6

1.7

1.54

1.59

g/l

0.36

159

1266

Ophthalmic devices associated with adverse incidents

2.60

1.53

1.4

3.5

1.84

1.53

g/l

—

Malignant neoplasm of ureter, including Hilmo

155

1.67

1.52

2.5

1.8

1.60

1.58

g/l

0.05

135

Postmenopausal atrophic vaginitis

444

2700

0.89

1.52

1.6

1.8

1.51

1.61

g/l

1.47

387

2293

Scabies, including avohilmo

258

2238

1.16

1.51

1.7

1.9

1.45

1.42

g/l

0.20

212

1962

Assault by sharp object

202

1.56

1.51

1.5

2.0

1.55

1.40

g/l

0.35

186

Cervical polyps

183

1547

1.19

1.50

1.7

1.8

1.40

1.57

g/l

1.89

158

1331

Toxic effect of other noxious substances eaten as food

2.31

1.50

2.3

2.1

1.60

1.68

g/l

—

Other specified transport accidents

1.90

1.49

1.6

1.8

1.40

1.44

g/l

0.06

Disorders of lacrimal system and orbit in diseases classified elsewhere

326

1.43

1.49

1.7

1.39

1.47

g/l

0.25

287

Infections of genitourinary tract in pregnancy

143

1182

1.22

1.49

1.8

1.9

1.49

1.47

g/l

0.11

125

1024

Dislocation, sprain and strain of joints and ligaments of elbow

111

894

1.25

1.48

1.6

2.0

1.45

1.44

g/l

0.03

787

Anisometropia and aniseikonia

472

1.35

1.47

3.1

1.9

1.43

1.52

g/l

0.31

426

Other bursitis of knee

204

1.55

1.46

1.5

1.7

1.48

1.47

g/l

0.02

181

Examination and encounter for administrative purposes

177

1497

1.19

1.46

1.5

1.6

1.53

1.57

g/l

0.27

154

1282

Other disorders affecting eyelid function

149

1.65

1.45

1.3

1.9

1.44

1.49

g/l

0.16

136

Cerebral atherosclerosis

270

1.47

1.44

1.5

1.8

1.62

1.60

g/l

0.05

244

Chronic inflammatory disorders of orbit

2.37

1.44

1.4

2.3

1.91

1.45

g/l

—

Congenital malformations of breast, including avohilmo

157

1.61

1.42

2.1

1.26

1.27

g/l

0.02

139

Crossbite

105

777

1.25

1.42

1.5

2.2

1.41

1.36

g/l

0.20

681

Vertigo of central origin

297

1.44

1.41

1.2

2.0

1.63

1.49

g/l

0.48

267

Benign neoplasm: Bronchus and lung

206

1.54

1.41

1.2

2.0

1.64

1.45

g/l

0.48

187

Male infertility

527

1.32

1.41

1.7

1.8

1.28

1.47

g/l

1.19

463

Cervicobrachial syndrome

444

4006

1.11

1.41

1.7

1.8

1.47

1.53

g/l

0.61

374

3447

Polycystic ovarian syndrome

588

1.30

1.41

2.6

2.2

1.41

1.18

g/l

1.39

518

Allergic contact dermatitis

240

2085

1.16

1.41

1.8

1.59

1.52

g/l

0.52

213

1808

Lyme disease

654

7108

0.92

1.41

1.7

1.35

1.56

g/l

8.78

550

6152

Lyme disease, including avohilmo

654

7108

0.92

1.41

1.7

1.35

1.56

g/l

8.78

550

6152

Hypersomnia

182

1.57

1.40

1.5

1.9

1.80

1.40

g/l

1.07

161

Alzheimer disease, including avohilmo

1132

8344

0.93

1.39

1.5

1.7

1.61

1.57

g/l

0.68

920

7125

Motorcycle rider injured in noncollision transport accidents

382

1.38

1.39

2.2

2.3

1.57

1.41

g/l

0.57

339

Non-small cell lung cancer

257

2222

1.15

1.39

1.7

1.5

1.94

1.54

g/l

6.56

223

1886

Vascular syndromes of brain in cerebrovascular disorders

121

995

1.23

1.39

1.4

1.8

1.51

1.54

g/l

0.14

111

868

Other congenital malformations of circulatory system

383

1.38

1.5

2.1

1.26

1.48

g/l

1.04

341

Disturbance of activity and attention

175

1449

1.18

1.38

1.8

2.3

1.23

1.17

g/l

0.42

152

1279

Foreign body in respiratory tract

101

814

1.25

1.37

1.6

2.1

1.56

1.47

g/l

0.37

720

Biological medicines for asthma

248

1.47

1.37

1.3

2.0

1.72

1.47

g/l

0.70

220

Malignant neoplasm of oesophagus

470

1.34

1.37

1.4

1.6

1.75

1.52

g/l

1.51

414

Melanoma in situ of upper limb, including shoulder

144

1.65

1.37

1.4

2.1

1.22

1.50

g/l

0.66

128

Pleural plaque

291

2574

1.14

1.36

1.6

1.7

1.50

1.53

g/l

0.28

245

2200

Endocrine disorders, other/unspecified

249

1.47

1.35

1.7

2.1

1.50

1.46

g/l

0.11

224

Antenatal screening

262

1278

1.15

1.35

2.1

1.9

1.26

1.48

g/l

3.36

228

1114

Other osteochondropathies

129

1069

1.22

1.35

1.6

1.9

1.54

1.52

g/l

0.08

113

937

Adenomyosis (Endometriosis of uterus)

264

2314

1.14

1.35

1.6

1.8

1.48

1.58

g/l

1.07

223

1968

Contraceptive management

567

4331

0.91

1.35

2.1

1.8

1.38

1.54

g/l

3.70

492

3773

Nasal polyp

453

4107

1.11

1.34

1.6

1.7

1.55

1.53

g/l

0.18

389

3555

Congenital deformities of feet, including avohilmo

454

1.33

2.3

2.2

1.27

1.44

g/l

0.77

410

Deep endometriosis

122

1470

0.82

1.31

1.6

1.7

1.43

1.50

g/l

0.38

1258

Tuberculosis

160

1358

1.19

1.31

1.7

1.50

1.54

g/l

0.21

137

1156

Malignant neoplasm of bronchus and lung

469

3563

1.11

1.31

1.6

1.5

1.92

1.56

g/l

9.99

402

3024

Contracture of muscle

2.07

1.30

1.3

1.7

1.32

1.55

g/l

0.35

Inguinal hernia, unilateral

466

1.33

1.29

1.5

1.9

1.55

1.59

g/l

0.13

414

Femoral hernia, unilateral

466

1.33

1.29

1.5

1.9

1.55

1.59

g/l

0.13

414

Inguinal of femoral hernia, unilateral

466

1.33

1.29

1.5

1.9

1.55

1.59

g/l

0.13

414

Medial epicondylitis

510

1.31

1.28

1.5

1.8

1.56

1.61

g/l

0.16

443

Dementia, including avohilmo

1510

9769

1.06

1.28

1.5

1.7

1.61

1.58

g/l

0.75

1217

8379

Endometriosis diagnosis and infertility diagnosis occurring together

141

1185

1.20

1.27

2.3

1.9

1.26

1.42

g/l

1.55

127

1024

Temporomandibular joint disorders, including avohilmo

873

7894

1.07

1.27

1.6

1.9

1.44

1.45

g/l

0.16

753

6882

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

398

1.35

1.26

2.0

1.6

1.94

1.61

g/l

1.15

348

Foreign body entering into or through eye or natural orifice

161

1373

1.18

1.25

2.0

1.9

1.47

1.50

g/l

0.15

139

1194

Spirochaetal infections, other/unspecified, including avohilmo

663

7157

0.92

1.25

1.7

1.35

1.56

g/l

8.82

558

6192

Alzheimer’s disease, strict definition

757

6560

0.93

1.24

1.5

1.7

1.60

1.57

g/l

0.47

614

5604

147

1.58

1.24

3.5

2.0

1.28

1.13

g/l

0.30

134

Tinnitus

547

5027

1.09

1.24

1.7

1.53

1.56

g/l

0.39

467

4357

Cluster headache, strict, including avohilmo

619

1.27

1.23

1.5

2.0

1.44

1.47

g/l

0.12

544

Congenital ovarian cysts

425

1.33

1.23

1.8

2.1

1.32

1.36

g/l

0.12

371

Benign neoplasm: Parotid gland

179

1543

1.17

1.23

1.6

1.8

1.66

1.54

g/l

0.89

154

1346

Generalized epilepsy, mode (most common among epilepsy diagnosis)

366

1.35

1.21

1.9

2.3

1.31

1.38

g/l

0.16

331

Respiratory tuberculosis

134

1130

1.20

1.21

1.8

1.7

1.49

1.55

g/l

0.30

116

966

Other conjunctival vascular disorders and cysts

376

1.35

1.20

1.7

1.8

1.60

1.51

g/l

0.28

342

Respiratory tuberculosis, confirmed and not-confirmed

134

1131

1.20

1.8

1.7

1.49

1.55

g/l

0.31

116

967

Endometriosis of rectovaginal septum and vagina

104

1258

0.82

1.20

1.4

1.8

1.47

1.55

g/l

0.34

1080

Benign neoplasm: Lip

368

1.35

1.19

1.5

1.9

1.41

1.49

g/l

0.29

329

Oral lichen planus and hypothyroidism or thyroxine medication

282

1.40

1.19

2.5

1.9

1.45

1.56

g/l

0.26

245

Burn and corrosion of hip and lower limb, except ankle and foot

342

1.36

1.18

1.5

2.0

1.48

1.44

g/l

0.11

308

LSIL lesion of the cervix uteri

155

1324

1.18

1.9

1.37

1.39

g/l

0.12

138

1152

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

258

1.43

1.17

1.4

1.9

1.39

1.58

g/l

0.68

230

Benign neoplasm: other/unspecified salivary gland

474

1.31

1.17

1.6

1.8

1.81

1.55

g/l

1.13

425

Hereditary corneal dystrophies

634

1.26

1.17

1.4

1.8

1.46

1.54

g/l

0.36

550

Other degenerative diseases of the basal ganglia

405

1.33

1.17

1.3

2.0

1.47

1.51

g/l

0.15

364

Serous carcinoma of ovary, including Hilmo

465

1.30

1.16

1.6

1.96

1.63

g/l

1.03

404

Atopic conjunctivitis

580

1.27

1.16

2.0

1.9

1.39

1.48

g/l

0.37

520

Graves ophthalmopathy

327

1.36

1.14

1.7

1.8

1.41

1.48

g/l

0.19

289

Injury of nerves at wrist and hand level

564

1.27

1.14

2.0

1.59

1.46

g/l

0.45

490

Melanoma in situ of other and unspecified parts of face

277

1.41

1.14

3.3

1.9

1.47

1.55

g/l

0.18

254

Benign neoplasm of meninges

233

2060

1.14

1.13

1.8

1.7

1.58

1.57

g/l

0.03

201

1764

Lordosis

2.35

1.13

1.3

2.7

1.20

1.26

g/l

—

Spermatocele

196

1715

1.15

1.12

1.5

1.6

1.49

1.54

g/l

0.25

166

1473

Abnormal findings in secretions and smears from cervix uteri vagina vulva

860

5930

1.07

1.12

2.1

1.9

1.39

1.46

g/l

1.25

751

5170

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

637

1.25

1.12

1.6

1.8

1.38

1.54

g/l

0.87

561

Graves ophthalmopathy, strict

294

1.38

1.12

1.7

1.8

1.39

1.50

g/l

0.36

258

Pregnancy with abortive outcome

1370

6774

1.06

1.11

1.8

1.53

1.50

g/l

0.36

1176

5847

Spirochaetal infections, other/unspecified

196

1717

1.15

1.10

1.7

1.8

1.40

1.55

g/l

1.51

166

1493

Asthma mixed form (mode)

701

1.23

1.10

1.6

1.7

1.52

1.47

g/l

0.22

598

Disorders of male genital organs in diseases classified elsewhere

1.73

1.10

1.3

2.1

1.51

1.53

g/l

0.05

Other spirochaetal diseases

670

7177

0.93

1.07

1.7

1.35

1.56

g/l

8.69

564

6209

Dislocation, sprain and strain of joints and ligaments of knee

1302

11196

1.05

1.8

1.49

1.48

g/l

0.13

1123

9703

Abrasion of teeth

772

7249

1.07

1.03

1.7

1.51

1.54

g/l

0.47

667

6271

Injury of muscle and tendon at forearm level

256

1.39

1.02

1.8

1.9

1.53

1.46

g/l

0.21

233

Effects of foreign body entering through natural orifice

514

4760

1.08

1.02

1.7

1.8

1.58

1.50

g/l

1.12

429

4148

Deep bite that required surgery

108

0.46

1.02

1.0

2.6

0.97

1.34

g/l

—

Morphin

387

1.31

1.01

1.4

1.7

1.85

1.51

g/l

1.68

337

Retinal breaks without detachment

354

3228

1.10

1.01

1.7

1.49

1.60

g/l

1.32

305

2778

Deep bite

179

1376

1.15

1.01

2.1

1.9

1.23

1.46

g/l

3.34

154

1196

Periodontal disease, other/unspecified

405

1.30

1.01

1.4

2.0

1.48

1.52

g/l

0.09

352

Severe visual impairment, monocular

173

1.47

1.00

1.9

2.1

1.65

1.51

g/l

0.34

157

Normal-pressure hydrocephalus

1143

0.83

1.00

1.4

1.7

1.68

1.52

g/l

1.16

987

Lichen planus, including avohilmo

430

3958

1.09

1.00

1.7

1.43

1.58

g/l

3.05

372

3422

Embedded and impacted teeth

428

3190

1.09

1.00

2.3

2.1

1.29

1.30

g/l

0.06

382

2815

Schizoid personality disorder

232

1.40

0.99

1.5

2.4

1.88

1.45

g/l

1.31

208

Pituitary-dependent Cushing's disease

1.87

0.99

1.7

2.3

2.07

1.57

g/l

—

Dentofacial anomalies [including malocclusion]

1375

11259

0.95

0.99

1.8

1.9

1.44

1.49

g/l

1.26

1183

9787

Benign neoplasm: Skin, unspecified

667

1.23

0.98

1.6

1.9

1.53

1.52

g/l

0.03

591

Melanocytic naevi of other and unspecified parts of face

109

923

1.19

0.98

2.8

1.9

1.30

1.53

g/l

2.21

815

Foreign body in ear

267

1.36

0.98

2.0

2.1

1.60

1.39

g/l

0.54

244

Bicipital tendinitis

795

1.20

0.98

2.0

1.7

1.52

1.56

g/l

0.19

693

Other spirochaetal diseases, including avohilmo

682

7271

0.94

0.97

1.7

1.35

1.56

g/l

8.57

572

6291

Inflammation of lacrimal passages (acute and unspecified)

259

1.37

0.97

2.1

1.8

1.26

1.43

g/l

0.64

227

Benign neoplasm: Cerebral meninges

209

1860

1.13

0.96

1.9

1.7

1.56

1.58

g/l

0.12

180

1597

Benign neoplasm: Pharynx, unspecified

117

1.57

0.96

1.2

2.5

1.88

1.40

g/l

0.84

105

Otitis media, unspecified

182

1477

1.14

0.95

1.7

2.0

1.36

1.39

g/l

0.16

160

1304

Dysplasia of cervi uteri

401

2590

1.09

0.94

2.1

1.9

1.43

1.44

g/l

0.11

346

2239

Delivery, wide proxy

657

3723

0.93

0.94

1.9

1.8

1.46

1.59

g/l

2.76

568

3194

Ankle and foot

135

1.51

0.91

2.4

2.1

1.39

1.47

g/l

0.17

120

Personality and behavioural disorders due to brain disease, damage and dysfunction

236

1.38

0.91

2.6

1.8

1.63

1.48

g/l

0.36

214

Unspecific neurodegenerative disorder

1284

9191

0.95

0.91

1.5

1.7

1.60

1.57

g/l

0.53

1030

7865

Dementia

1406

9203

1.05

0.91

1.5

1.7

1.62

1.58

g/l

0.99

1131

7890

Anti-inflammatory and antirheumatic products, non-steroids

782

3705

1.06

0.90

1.8

2.0

1.51

1.43

g/l

1.66

685

3183

Increased muscle tone

1.61

0.89

1.4

2.2

1.45

1.46

g/l

0.02

Hypertrophy of breast

217

2418

0.89

1.7

1.50

1.54

g/l

0.23

186

2075

Cluster headache, wide,, including avohilmo

675

1.21

0.88

1.5

1.9

1.41

1.48

g/l

0.28

593

Other complications of labour and delivery, not elsewhere classified

134

1030

1.16

0.88

2.2

1.13

1.19

g/l

0.33

118

911

Allergic contact dermatitis due to drugs in contact with skin

325

1.31

0.88

1.7

2.0

1.72

1.49

g/l

0.73

291

Peritonsillar abscess

383

3533

1.09

0.87

1.8

1.56

1.47

g/l

1.18

337

3077

Non-allergic asthma

175

1551

1.13

0.87

1.7

1.8

1.47

1.52

g/l

0.31

155

1354

Other and unspecified intracranial injuries

532

1.23

0.86

1.7

2.0

1.75

1.53

g/l

1.21

476

Pedestrian injured in collision with pedal cycle

478

1.25

0.86

1.9

2.1

1.37

1.54

g/l

0.69

433

Dementia in other diseases classified elsewhere

122

1058

1.16

0.86

1.5

1.8

1.53

1.50

g/l

0.14

914

Acute poliomyelitis

188

1.40

0.85

1.6

2.2

1.66

1.49

g/l

0.36

171

Acute poliomyelitis, including avohilmo

188

1.40

0.85

1.6

2.2

1.66

1.49

g/l

0.36

171

Cerebral amyloid angiopathy

105

1.57

0.85

1.6

2.4

1.52

g/l

0.01

Other and unspecified disorders of vitreous body

1048

9773

1.05

0.85

1.8

1.7

1.48

1.59

g/l

3.68

904

8385

Vasomotor and allergic rhinitis

741

6841

1.06

0.84

1.8

1.44

1.47

g/l

0.39

636

5946

Congenital hypothyroidism without goiter

1.73

0.84

1.6

1.9

1.13

1.45

g/l

0.65

Aphakia

231

1.36

0.84

1.7

1.8

1.54

1.51

g/l

0.06

205

Calculus of lower urinary tract

140

1229

1.15

0.84

1.5

1.7

1.54

1.52

g/l

0.11

119

1057

Pain and other conditions associated with female genital organs and menstrual cycle

335

2571

1.09

0.83

2.1

2.0

1.47

1.41

g/l

0.52

282

2239

Obstructed labour due to maternal pelvic abnormality

189

2112

0.89

0.83

2.0

1.7

1.69

1.59

g/l

0.63

164

1832

Impacted teeth

296

2320

1.10

0.83

2.6

2.2

1.25

g/l

0.00

264

2062

Muscle strain

471

1.24

0.83

2.4

1.9

1.80

1.54

g/l

0.88

415

Moderate mental retardation

1.64

0.83

1.5

1.9

1.43

1.29

g/l

0.27

Disturbances of smell and taste

672

1.20

0.83

1.7

1.9

1.55

1.57

g/l

0.06

591

Pollen allergy

281

2528

1.10

0.82

1.9

2.0

1.36

1.37

g/l

0.06

243

2196

Juvenile cataract

1.74

0.82

1.6

1.5

1.11

1.49

g/l

—

Retinoschisis and retinal cysts

464

1.24

0.82

1.4

1.9

1.56

1.57

g/l

0.05

409

Vertical strabismus

518

1.23

0.81

2.0

1.27

1.47

g/l

1.22

465

Disorder of the sleep-wake schedule

224

1.35

0.81

2.0

1.58

1.37

g/l

0.56

194

Kissing spine

1.89

0.81

1.3

1.7

1.69

1.45

g/l

—

Benign neoplasm: Prostate

148

1.46

0.81

1.4

1.88

1.53

g/l

0.67

135

Drowning and submersion while in natural water

0.51

0.81

1.2

1.9

1.61

1.56

g/l

—

Benign neoplasm of brain and other parts of central nervous system

128

1120

1.15

0.80

1.6

1.9

1.60

1.53

g/l

0.40

111

978

Acute appendicitis

1625

14530

1.04

0.80

1.8

1.52

1.51

g/l

0.21

1424

12543

Use of amantadine

251

1.33

0.80

1.6

2.0

1.48

g/l

0.01

224

Oral lichen planus

438

1.25

0.80

2.2

2.0

1.36

1.54

g/l

0.91

385

Pedal cyclist injured in other and unspecified transport accidents

220

1990

1.11

0.79

1.6

1.8

1.43

1.49

g/l

0.43

193

1727

Retained placenta and membranes, without haemorrhage

177

1582

1.12

0.79

1.8

1.7

1.42

1.56

g/l

1.21

154

1372

Propionic acid derivatives

778

3705

1.06

0.79

1.8

2.0

1.51

1.43

g/l

1.74

679

3183

Aggressive periodontitis

358

1.27

0.79

1.8

2.0

1.62

1.52

g/l

0.28

316

L02BA Anti-estrogens

257

2812

0.91

0.77

1.5

1.7

1.68

1.59

g/l

0.62

216

2405

Mixed disorders of conduct and emotions

217

1.35

0.77

1.8

2.7

1.59

1.19

g/l

0.80

200

Schizotypal disorder

244

1.32

0.76

1.6

2.2

1.76

1.41

g/l

1.15

218

Hydrocephalus

151

1692

0.89

0.74

1.4

1.8

1.67

1.53

g/l

1.05

129

1463

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

732

0.83

0.74

1.4

2.0

1.45

1.57

g/l

0.55

646

Calcific tendinitis of shoulder

101

875

1.16

0.74

1.9

1.7

1.71

1.58

g/l

0.69

761

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

116

1016

1.15

0.74

1.9

1.8

1.36

1.59

g/l

1.94

890

Explosion of other materials

1.84

0.74

4.3

2.3

1.55

1.76

g/l

—

Burn and corrosion confined to eye and adnexa

281

1.29

0.73

1.3

2.2

1.54

1.44

g/l

0.21

253

Gluteal tendinitis

644

1.19

0.73

1.5

1.8

1.50

1.56

g/l

0.27

563

Lumbosacral plexus disorders

1.62

0.73

1.4

1.8

2.15

1.63

g/l

—

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

168

1.38

0.72

2.1

2.3

1.64

1.29

g/l

0.85

148

Other acute disseminated demyelination

109

1.49

0.72

1.9

2.2

1.51

1.37

g/l

0.30

Ménière disease

206

1871

1.11

0.72

1.6

1.7

1.63

1.55

g/l

0.53

178

1608

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

101

1.51

0.71

1.5

1.6

2.22

1.57

g/l

—

Traumatic amputation of wrist and hand

804

0.84

0.71

1.8

1.9

1.59

1.53

g/l

0.21

699

Diseases of appendix

1765

15270

1.03

0.70

1.7

1.8

1.52

1.51

g/l

0.23

1538

13172

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

109

1241

0.87

0.70

1.7

1.8

1.56

1.54

g/l

0.10

1083

Single delivery by forceps and vacuum extractor

147

984

0.89

0.70

1.6

2.3

1.16

1.37

g/l

2.13

129

853

Sequelae of tuberculosis, including avohilmo

374

1.24

0.69

1.9

1.7

1.45

1.53

g/l

0.22

339

Appendicitis, broad definition

1747

15172

1.03

0.69

1.8

1.52

1.51

g/l

0.25

1523

13090

Premature rupture of membranes

258

1684

1.09

0.69

1.8

2.0

1.21

1.39

g/l

3.10

220

1472

Undefined dementia

304

3024

0.92

0.68

1.6

1.71

1.54

g/l

2.41

251

2533

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

136

1.41

0.67

1.9

2.3

1.49

1.34

g/l

0.32

118

Melanoma in situ, other sites/unspecified

1.63

0.67

3.4

2.4

1.42

1.59

g/l

0.23

Pedal cyclist injured in collision with motor vehicle

418

0.78

0.67

1.2

2.1

1.15

1.44

g/l

1.46

376

Contact with machinery

204

2235

0.91

0.67

1.5

1.8

1.53

1.50

g/l

0.15

178

1951

Anomalies of dental arch relationship, including avohilmo

327

2747

1.08

0.67

2.1

1.9

1.36

1.45

g/l

0.90

275

2391

Malignant neoplasm of heart, mediastinum and pleura

224

1.31

0.66

1.1

1.7

2.05

1.51

g/l

1.43

197

Mouth breathing

889

8502

1.05

0.66

1.5

1.7

1.50

1.54

g/l

0.55

781

7330

Acute appendicitis, no complications

1188

11373

1.04

0.66

1.7

1.8

1.50

g/l

0.05

1042

9857

Female genital prolapse

508

2993

0.94

0.65

1.5

1.8

1.59

1.58

g/l

0.07

442

2546

Benign neoplasm: Bones of skull and face

127

0.62

0.65

1.4

2.2

1.24

1.41

g/l

—

112

Migraine, single triptan purchase ok & required. ICD-code if available is included

1461

10227

0.97

0.64

1.9

1.40

1.50

g/l

3.69

1255

8887

Triptan medication for migraine, single purchase ok

1461

10227

0.97

0.64

1.9

1.40

1.50

g/l

3.69

1255

8887

Sequelae of tuberculosis

369

1.23

0.64

1.9

1.7

1.45

1.53

g/l

0.21

334

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

369

1.23

0.64

1.9

1.35

1.50

g/l

0.69

337

Desensitization to allergens

570

1.18

0.64

1.8

2.1

1.28

1.36

g/l

0.36

518

Ethmoidectomy

241

2221

1.09

0.63

1.8

1.64

1.52

g/l

1.04

203

1924

Lesion of medial popliteal nerve

1.63

0.63

1.3

2.1

1.71

1.47

g/l

—

Other specified and unspecified disorders of eyelid

217

1.31

0.63

1.6

1.9

1.28

1.51

g/l

0.65

200

Femoral hernia

833

1.15

0.63

1.6

1.7

1.49

1.56

g/l

0.29

731

Benign neoplasm of other and unspecified sites

535

1.19

0.63

1.5

1.9

1.58

1.48

g/l

0.36

476

Crowding of teeth, including avohilmo

112

820

1.13

0.62

3.1

2.2

1.05

1.25

g/l

2.78

104

724

Malignant neoplasm of eye, brain and central nervous system

637

1.17

0.62

1.8

1.7

1.57

1.52

g/l

0.17

556

Carcinoma in situ of breast, other/unspecified

210

0.71

0.62

1.1

2.1

1.46

1.59

g/l

—

186

Cholesteatoma of middle ear

1015

0.87

0.61

2.0

1.8

1.54

1.52

g/l

0.06

891

Other lesions of median nerve

472

1.20

0.61

2.1

1.8

1.60

1.61

g/l

0.03

413

Use of levodopa decarbox-comt-inhibitor

704

0.84

0.61

1.5

1.9

1.73

1.56

g/l

1.08

622

Postpartum haemorrhage due to retained placenta

158

1430

1.11

0.61

2.5

2.1

0.99

1.27

g/l

5.30

137

1262

Any dementia

1290

8618

1.04

0.61

1.5

1.7

1.62

1.57

g/l

1.01

1057

7372

Malignant neoplasm of pancreas, including Hilmo

189

1728

1.10

0.61

1.4

1.6

1.63

1.56

g/l

0.45

162

1493

Long labour

304

2398

1.08

0.61

2.1

2.0

1.36

1.41

g/l

0.40

271

2103

Injury of blood vessels at lower leg level

1.56

0.60

1.5

1.9

1.54

1.56

g/l

0.01

Vasomotor rhinitis (mode)

138

1242

1.12

0.60

1.6

1.9

1.52

1.54

g/l

0.06

114

1080

Benign neoplasm of breast

213

1959

1.09

0.60

1.9

1.7

1.57

1.58

g/l

0.05

182

1680

Female infertility, tubal origin

519

1.18

0.59

2.1

1.8

1.51

1.47

g/l

0.14

447

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

309

1.24

0.59

1.2

1.7

2.00

1.50

g/l

1.49

269

Contact with and exposure to communicable diseases

425

4482

0.94

0.59

2.1

2.0

1.32

1.36

g/l

0.43

346

3938

Nontoxic goitre/thyroid nodule

663

6332

1.05

0.59

1.6

1.7

1.63

1.58

g/l

0.71

584

5411

Dental pulpitis, including avohilmo

2026

13313

0.97

0.58

1.7

1.8

1.46

1.49

g/l

0.74

1743

11585

Prolapse and hernia of ovary and fallopian tube

776

1.14

0.57

1.4

1.7

1.69

1.62

g/l

0.26

646

Foreign body on external eye

243

2616

0.93

0.56

1.6

1.8

1.64

1.50

g/l

1.34

205

2279

Dystonia

832

1.14

0.56

2.1

1.9

1.43

1.55

g/l

0.54

740

294

1.23

0.54

2.0

1.57

g/l

0.01

260

Chloasma

1.50

0.54

1.7

2.1

1.56

1.41

g/l

—

Oesophagitis, drug-induced

1.58

0.54

1.3

2.0

1.91

1.66

g/l

—

Contact with blunt object, undetermined intent

1.45

0.54

2.1

2.5

1.35

1.41

g/l

0.12

Communicating hydrocephalus

350

1.21

0.53

1.4

2.0

1.62

1.53

g/l

0.23

319

Lesion of sciatic nerve

918

0.88

0.53

2.0

1.8

1.54

1.55

g/l

0.01

792

Other appendicitis

151

1377

1.10

0.53

1.8

1.56

1.55

g/l

0.02

127

1198

Benign neoplasm: Brain, unspecified

1.47

0.53

2.4

2.1

1.55

1.53

g/l

0.03

Malignant neoplasm of hypopharynx

1.43

0.52

1.1

1.4

1.58

1.49

g/l

—

Postdysenteric arthropathy

126

1.37

0.52

1.5

2.1

1.45

1.51

g/l

0.10

113

Myositis ossificans

1.53

0.52

1.7

1.4

1.45

1.37

g/l

—

Use of levodopa decarboxylase inhibitor

386

3653

1.06

0.52

1.5

1.7

1.57

1.56

g/l

0.05

330

3155

Conductive hearing loss, unspecified

161

1475

1.10

0.52

1.8

1.62

1.53

g/l

0.60

145

1294

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

1.41

0.51

3.4

2.5

1.27

1.59

g/l

—

Unspecified dementia

303

2892

0.94

0.51

1.5

1.6

1.71

1.53

g/l

2.48

250

2459

Other vitreous opacities

753

1.14

0.51

1.5

1.8

1.38

1.55

g/l

1.10

662

Suppurative otitis media, unspecified

379

1.19

0.51

1.7

2.0

1.55

1.37

g/l

0.83

345

Alzheimer’s disease (Late onset)

731

6254

0.96

0.51

1.5

1.7

1.60

1.56

g/l

0.49

595

5340

Drug-induced headache, not elsewhere classified

1.52

0.50

1.5

2.1

0.97

1.38

g/l

—

Divergent concomitant strabismus

122

1105

1.11

0.50

1.6

1.9

1.53

1.52

g/l

0.03

107

975

Allergic rhinitis

525

4947

1.05

0.50

1.9

1.43

1.42

g/l

0.09

452

4309

Pterygium

615

0.86

0.50

1.4

1.8

1.41

1.53

g/l

0.51

544

ILD medications: pirfenidone

217

1.26

0.49

1.6

1.7

1.27

1.59

g/l

1.31

186

Benign neoplasm of male genital organs

429

1.18

0.48

1.3

1.9

1.75

1.52

g/l

0.86

383

Convergence insufficiency and excess

137

1.32

0.48

1.1

1.9

1.38

1.31

g/l

0.08

119

Migraine, unspecified, drug-induced

1.43

0.47

3.8

2.2

1.44

1.50

g/l

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

147

1.30

0.45

2.3

2.1

1.63

1.34

g/l

0.60

132

Obstructed labour due to malposition and malpresentation of fetus

262

2281

1.06

0.45

2.0

1.9

1.21

1.39

g/l

3.16

235

1999

Spasmodic torticollis

432

1.16

0.44

2.4

2.0

1.25

1.51

g/l

1.49

382

Lichen ruber planus, wide definition including periferal and oral lichen planus

493

4720

1.05

0.44

1.8

1.7

1.44

1.58

g/l

2.98

427

4075

Congenital malformations of ovaries, fallopian tubes and broad ligaments

583

1.14

0.43

2.0

1.35

1.43

g/l

0.28

506

Glaucoma secondary to eye trauma

122

1.33

0.43

1.6

2.0

1.45

1.50

g/l

0.09

114

Benign neoplasm: Retina

0.62

0.43

1.5

2.0

1.35

1.50

g/l

—

Abscess of Bartholin gland

285

1.20

0.43

2.6

2.0

1.88

1.43

g/l

1.17

247

Other ill-defined and unspecified causes of mortality

245

2308

1.07

0.42

1.4

1.6

1.69

1.54

g/l

1.62

202

1972

Multiple system atrophy (rare forms of Parkinsonism)

1.38

0.42

1.4

2.0

1.68

1.65

g/l

—

Retained (old) intraocular foreign body

0.00

0.42

0.0

2.6

—

1.67

—

Macular hole

138

1274

1.09

0.42

1.6

1.7

1.42

1.58

g/l

1.41

119

1100

conjunctival degenerations and deposits

342

1.18

0.41

2.3

1.7

1.60

1.54

g/l

0.16

307

Juvenile dermatomyositis

0.00

0.41

0.0

1.7

—

1.24

—

Follicular keratosis (Darier-White)

0.00

0.41

0.0

3.2

—

1.48

—

Caught, crushed, jammed or pinched in or between objects

785

1.11

0.41

1.6

2.0

1.35

1.47

g/l

0.75

687

Neuroendocrine tumor and carcinoma of lung

114

1.33

0.41

1.3

1.6

1.80

1.55

g/l

0.47

103

Labour and delivery complicated by umbilical cord complications

501

1.14

0.41

1.9

1.57

1.47

g/l

0.23

437

Oher contracture of tendon (sheath)

1.35

0.41

1.4

2.0

1.19

1.30

g/l

—

Malignant neoplasm of brain, including Hilmo

729

1.12

0.41

1.9

1.7

1.70

1.51

g/l

0.84

629

Maternal care related to the fetus and amniotic cavity and possible delivery problems

616

3476

1.04

0.40

2.0

1.9

1.26

1.47

g/l

7.17

524

3039

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.40

0.0

2.8

—

1.75

—

Benign neoplasm: Other/unspecified site

232

1.22

0.40

1.8

2.0

1.88

1.58

g/l

0.71

204

Benign neoplasm: Ribs, sternum and clavicle

1.45

0.40

1.4

1.24

1.61

g/l

—

Benign neoplasm: Pancreas

560

1.13

0.40

1.9

1.8

1.43

1.54

g/l

0.47

491

Prophylactic surgery

1.32

0.40

1.0

2.0

1.78

1.25

g/l

—

Presbyopia

124

1142

1.09

0.39

1.8

1.57

g/l

0.00

104

990

Plantar fascial fibromatosis

172

1605

1.07

0.39

1.6

1.7

1.53

1.56

g/l

0.13

150

1386

Glaucoma suspect

943

9161

1.03

0.39

1.6

1.7

1.50

1.59

g/l

2.32

800

7867

Endometriosis of ovary

288

2572

1.06

0.39

1.8

1.38

1.54

g/l

1.92

251

2210

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

142

1.28

0.39

2.2

1.6

1.27

1.50

g/l

0.52

127

Dementia due to Parkinson's disease

621

0.88

0.39

1.6

1.9

1.42

1.55

g/l

0.64

551

Noise effects on inner ear

800

0.90

0.38

1.4

1.8

1.43

1.54

g/l

0.50

697

Pneumoconiosis due to asbestos and other mineral fibres

514

0.87

0.38

1.8

1.7

1.62

1.47

g/l

0.57

440

Medical abortion

1267

6689

1.03

0.37

1.9

1.8

1.55

1.50

g/l

0.98

1090

5775

Other obstructed labour

877

1.10

0.37

1.9

1.8

1.40

1.56

g/l

0.85

772

Non-small cell lung cancer, squamous

955

0.91

0.37

1.6

1.95

1.51

g/l

3.62

808

Adenocarcinoma of pancreas

524

0.87

0.37

1.7

1.6

1.56

g/l

0.00

460

Benign mammary dysplasia

240

2534

0.94

0.37

1.7

1.53

1.60

g/l

0.65

211

2171

Contact urticaria

1.49

0.36

1.5

2.3

1.43

1.23

g/l

—

Lichen sclerosus et atrophicus

205

1932

1.06

0.36

1.6

1.7

1.66

1.59

g/l

0.41

166

1662

Carcinoma in situ of cervix uteri

133

1234

1.08

0.36

2.0

1.44

1.33

g/l

0.65

116

1085

Use of selegiline

974

0.91

0.36

1.6

1.8

1.58

1.53

g/l

0.16

843

Parkinson's disease, including avohilmo

426

4094

1.04

0.36

1.5

1.7

1.58

1.56

g/l

0.14

360

3522

Contact with other sharp object(s)

104

956

1.09

0.36

1.8

2.0

1.32

1.43

g/l

0.69

840

Discontinuity and dislocation of ear ossicles

0.62

0.36

1.8

2.1

2.32

1.51

g/l

—

Posteruptive colour changes of dental hard tissues

1.44

0.36

1.2

1.6

1.44

1.24

g/l

—

Spontaneous abortion

743

5126

0.97

0.35

2.0

1.9

1.36

1.47

g/l

3.09

652

4452

Childhood allergy (age < 16)

180

1393

1.07

0.35

2.9

2.4

1.14

1.13

g/l

0.08

160

1251

Hydatidiform mole

125

0.72

0.35

3.6

2.1

1.00

1.41

g/l

—

110

Brachial plexus disorders

115

1243

0.92

0.35

1.6

1.9

1.41

1.53

g/l

0.69

101

1085

Spinal enthesopathy

508

1.12

0.34

1.5

1.6

1.48

1.56

g/l

0.26

435

Left side

0.67

0.34

2.2

2.6

1.00

1.45

g/l

—

Endovascular or surgical operations to intracerebral aneurysms

112

1037

1.08

0.34

1.9

1.8

1.63

1.57

g/l

0.25

905

Vestibular neuronitis

180

1697

1.06

0.33

1.7

1.8

1.48

1.54

g/l

0.36

156

1462

Normotensive glaucoma

221

2097

1.06

0.33

1.6

1.7

1.43

1.56

g/l

1.41

185

1820

Carcinoma in situ of breast, intraductal

126

1352

0.93

0.33

1.7

1.63

1.61

g/l

0.06

105

1166

Undescended testicle

109

1.29

0.33

1.8

2.1

1.06

1.26

g/l

0.60

Certain zoonotic bacterial diseases

285

1.17

0.32

1.8

2.1

1.32

1.44

g/l

0.25

258

Alcoholic cardiomyopathy

1.32

0.32

1.5

1.35

1.45

g/l

0.22

Mandibular retrognathia

726

0.90

0.32

1.5

2.2

1.24

1.40

g/l

1.00

650

Other benign neoplasms of uterus

113

1050

1.08

0.32

1.7

1.66

1.57

g/l

0.45

903

FESS (DNB20)

225

2138

1.05

0.32

1.8

1.66

1.52

g/l

1.22

189

1854

Benign lipomatous neoplasm of other sites/unspecified

188

1778

1.06

0.32

1.9

1.7

1.58

1.56

g/l

0.13

160

1533

Systemic atrophies primarily affecting the central nervous system

831

0.91

0.32

1.7

1.8

1.54

1.52

g/l

0.06

730

Corneal degeneration

295

1.16

0.32

1.8

1.9

1.58

1.52

g/l

0.11

264

Impacted maxillary molar

696

0.90

0.32

3.2

2.2

1.22

1.21

g/l

0.03

616

Other noninflammatory disorders of cervix uteri

819

1.09

0.32

1.6

1.7

1.61

1.64

g/l

0.09

701

Ill-defined and unknown causes of mortality

263

2511

1.05

0.32

1.4

1.6

1.70

1.53

g/l

2.16

216

2139

Hypertrophy of breast in women and men

293

3061

0.96

0.31

1.7

1.8

1.51

1.53

g/l

0.12

255

2635

Intussusception

258

1.17

0.31

1.4

2.0

1.60

1.51

g/l

0.13

221

Vascular dementia (undefined)

116

1071

1.08

0.31

1.3

1.6

1.74

1.53

g/l

1.76

913

Benign neoplasm of other and unspecified female genital organs

638

1.10

0.31

1.8

1.67

1.57

g/l

0.28

554

Glaucoma-related operations

138

1296

1.07

0.30

1.6

1.8

1.52

1.54

g/l

0.11

119

1129

Dermatitis due to ingested food

301

1.15

0.30

1.6

2.2

1.22

1.15

g/l

0.14

270

Ehlers-Danlos syndrome, including avohilmo

111

1.27

0.30

1.4

2.3

1.56

1.32

g/l

—

Parkinson's disease, strict definition

380

3664

1.04

0.30

1.5

1.7

1.55

1.56

g/l

0.10

320

3166

Benign neoplasm: Conjunctiva

515

1.11

0.30

1.6

1.9

1.84

1.55

g/l

1.19

463

Benign neoplasm of eye and adnexa

226

2155

1.05

0.29

1.5

1.7

1.69

1.55

g/l

1.35

189

1854

Primary open-angle glaucoma, strict

705

7215

0.97

0.29

1.5

1.7

1.55

1.59

g/l

0.58

576

6165

Postprocedural disorders of eye and adnexa, not elsewhere classified

1.34

0.29

2.3

2.4

1.57

1.46

g/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.31

0.28

1.5

1.7

1.75

1.57

g/l

0.18

Undescended testis, unilateral

1.30

0.28

2.0

2.2

1.02

1.26

g/l

0.63

Degenerative diseases of the nervous system

1133

8309

0.98

0.28

1.5

1.7

1.60

1.57

g/l

0.47

924

7092

Benign neoplasm of thyroid gland

501

0.89

0.28

2.2

1.8

1.42

1.52

g/l

0.32

440

Endometriosis ASRM stages 3,4

359

3719

0.96

0.27

1.8

1.7

1.41

1.53

g/l

1.48

306

3201

Adhesive middle ear disease

215

0.83

0.27

1.3

2.3

1.55

1.43

g/l

0.24

194

Complications of labour and delivery

1031

5847

0.98

0.27

1.9

1.8

1.40

1.53

g/l

3.83

890

5059

Early lumbar disc prolapse operation

113

1205

0.94

0.27

1.8

1.53

1.39

g/l

0.76

100

1044

Erysipeloid, including avohilmo

1.32

0.27

1.5

2.5

1.79

1.47

g/l

—

Beningn neoplasm: Meninges, unspecified

253

1.15

0.26

1.4

1.9

1.51

1.54

g/l

0.08

227

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.67

0.26

1.6

1.5

1.61

1.31

g/l

—

Glaucoma, exfoliation

272

2828

0.96

0.26

1.8

1.6

1.50

1.55

g/l

0.39

232

2420

Struck by thrown, projected or falling objec

828

1.08

0.26

2.2

1.9

1.59

1.49

g/l

0.43

723

197

1.17

0.25

2.4

2.7

0.71

1.08

g/l

2.14

167

Adenocarcinoma and ductal carcinoma of pancreas

664

0.92

0.25

1.6

1.59

1.55

g/l

0.10

579

Benign neoplasm of bone and articular cartilage

124

1314

0.94

0.25

1.8

1.44

1.53

g/l

0.66

109

1153

Other disorders of male genital organs

695

1.08

0.25

1.7

1.56

1.49

g/l

0.27

599

Inflammatory disease of cervix uteri

973

0.93

0.24

1.4

1.8

1.55

1.59

g/l

0.14

842

Other and unspecified degenerative diseases of nervous system

610

1.09

0.24

1.5

1.8

1.62

1.56

g/l

0.21

534

Puerperal sepsis

171

1792

0.95

0.24

1.7

1.63

1.59

g/l

0.22

156

1557

Dementia due to Parkinsons disease, excluding more controls

505

1.09

0.23

1.6

1.7

1.42

1.51

g/l

0.37

428

Parkinson's disease

404

3927

1.03

0.23

1.5

1.7

1.58

1.57

g/l

0.11

341

3387

L02BG Aromatase inhibitors

606

5847

1.02

0.22

1.5

1.7

1.64

1.61

g/l

0.28

505

5031

Pleural plaque with presence of asbestos

207

1989

1.04

0.22

1.6

1.7

1.42

1.54

g/l

1.39

173

1712

Disorders of acoustic nerve

477

1.09

0.22

1.5

1.8

1.55

1.59

g/l

0.11

423

Pediculosis and phthiriasis

1.23

0.22

1.4

1.7

0.85

1.45

g/l

—

Other disorders of prostate

797

1.07

0.22

1.4

1.6

1.51

1.53

g/l

0.06

670

Spotted fever [tick-borne rickettsioses], including avohilmo

0.00

0.22

0.0

3.8

—

1.66

—

Soft tissue disorders in diseases classified elsewhere

0.00

0.22

0.0

1.8

—

1.02

—

Triptan medication for migraine, min. 3 purchases

941

7157

0.98

0.22

1.8

1.9

1.40

1.44

g/l

0.63

801

6264

Persons encountering health services in circumstances related to reproduction

1009

6880

0.98

0.22

2.1

1.8

1.41

1.54

g/l

4.09

862

5963

Fusion of the labia, including avohilmo

0.00

0.21

0.0

3.4

—

1.25

—

Congenital absence of the uterus

0.00

0.21

0.0

2.0

—

1.61

—

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

0.21

0.0

2.0

—

0.73

—

Occupational exposure to risk-factors

615

0.92

0.21

1.9

2.0

1.35

1.52

g/l

0.76

536

Malignant neoplasm of brain

460

1.09

0.21

1.7

1.8

1.58

1.51

g/l

0.16

407

Malignant neoplasm of placenta, including Hilmo

0.00

0.20

0.0

3.1

—

1.54

—

Abnormalities of forces of labour

107

1014

1.06

0.20

1.7

1.8

1.34

1.47

g/l

0.93

887

Pleural plaque without asbestos

918

1.06

0.20

1.6

1.8

1.64

1.51

g/l

0.79

799

Obstructive hydrocephalus

231

1.13

0.20

1.5

2.5

1.36

1.49

g/l

0.38

203

Frostbite with tissue necrosis

1.19

0.19

1.3

2.1

1.21

1.50

g/l

—

Oral lichen planus, including avohilmo , including avohilmo

113

1188

0.95

0.19

2.1

1.8

1.48

1.58

g/l

0.55

1038

Pregnancy, childbirth and the puerperium

646

3303

1.02

0.19

1.8

1.7

1.53

1.56

g/l

0.38

554

2817

Simple and mucopurulent chronic bronchitis

782

1.06

0.19

1.9

1.7

1.54

1.50

g/l

0.11

678

Polypectomy (DHB20)

134

1282

1.05

0.19

1.7

1.8

1.65

1.53

g/l

0.82

121

1110

Other specified disorders of external ear

784

1.06

0.18

1.7

1.8

1.56

1.53

g/l

0.12

682

Occlusion and stenosis of arteries, not leading to stroke

261

1.12

0.18

1.8

1.7

1.84

1.53

g/l

1.04

234

Chromomycosis and phaeomycotic abscess, including avohilmo

1.22

0.18

3.4

2.0

1.15

1.38

g/l

—

Other and unspecified spinal muscular atrophies

153

0.84

0.18

1.5

1.9

1.82

1.48

g/l

0.68

141

Varus deformity, not elsewhere classified

147

1.16

0.18

5.0

2.0

1.71

1.41

g/l

0.67

131

Loose body in joint

362

0.91

0.18

1.3

2.1

1.67

1.53

g/l

0.22

316

116

1105

1.05

0.17

1.3

1.8

1.46

1.55

g/l

0.46

101

922

Arteriovenous malformation of peripheral vessels

1.18

0.17

1.9

2.4

0.98

1.35

g/l

—

Endometriosis of fallopian tube

1.13

0.16

1.9

2.5

1.27

1.37

g/l

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.78

0.16

1.3

2.3

1.63

1.54

g/l

—

Postprocedural disorders of ear and mastoid process, not elsewhere classified

140

0.85

0.15

4.5

2.1

1.52

1.53

g/l

—

127

Benign neoplasm: Long bones of lower limb

419

1.08

0.15

2.1

2.2

1.47

1.44

g/l

0.09

373

Pedal cyclist injured in noncollision transport accidents

200

1941

1.03

0.15

1.6

1.8

1.42

1.50

g/l

0.48

172

1687

Benign neoplasm: Cranial nerves

488

1.07

0.15

1.5

1.8

1.63

1.54

g/l

0.24

432

Malignant neoplasm of pancreas

134

1390

0.96

0.15

1.5

1.6

1.66

1.55

g/l

0.67

115

1193

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

112

1.17

0.14

1.5

2.2

1.74

1.57

g/l

0.46

102

Malignant neoplasm of lip

131

1.15

0.14

1.5

1.8

1.73

1.63

g/l

0.17

115

Injury of muscle and tendon at shoulder and upper arm level

857

8684

0.99

0.14

2.0

1.7

1.58

1.56

g/l

0.18

756

7491

Benign neoplasm: Short bones of upper limb

198

1.12

0.14

1.9

2.4

1.55

1.45

g/l

0.17

176

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

614

0.94

0.14

1.8

1.40

1.61

g/l

0.74

542

Unspecified chronic bronchitis

665

1.05

0.14

1.6

1.7

1.60

1.56

g/l

0.15

572

Ankylosing hyperostosis [Forestier]

237

1.10

0.14

1.5

2.0

1.40

1.57

g/l

0.33

210

Other benign neoplasms of connective and other soft tissue

180

1747

1.03

0.14

1.7

1.8

1.45

1.55

g/l

0.91

154

1521

Benign neoplasm: Endocrine pancreas

113

1.16

0.13

1.3

2.1

1.74

1.51

g/l

0.77

Benign leiomyoma with endometriosis

269

2752

0.98

0.13

1.5

1.7

1.59

1.61

g/l

0.12

221

2373

Primary open-angle glaucoma

880

8559

0.99

0.12

1.6

1.7

1.54

1.59

g/l

0.96

724

7330

Other facial nerve disorders

426

0.94

0.12

2.2

1.9

1.75

1.50

g/l

1.05

374

Benign neoplasm: Scapula and long bones of upper limb

137

0.87

0.12

1.8

1.9

1.37

1.41

g/l

0.06

120

Motor neuron disease (with DMD)

323

0.93

0.12

2.0

1.7

1.46

1.47

g/l

0.03

283

Other mosquito-borne viral fevers, including avohilmo

1.16

0.12

1.3

1.8

1.66

1.51

g/l

0.25

Complications following abortion and ectopic and molar pregnancy

474

1.06

0.11

1.8

1.57

1.58

g/l

0.04

419

1.14

0.10

5.8

2.0

1.12

1.50

g/l

—

Endometriosis of pelvic peritoneum

227

2104

0.98

0.10

2.0

1.8

1.38

1.48

g/l

0.91

194

1820

Benign neoplasm: Choroid

129

1324

0.97

0.09

1.4

1.8

1.62

1.55

g/l

0.37

103

1153

Otosclerosis

134

1374

0.97

0.09

1.6

1.8

1.64

1.56

g/l

0.39

115

1187

Chalazion

201

2049

0.98

0.09

2.0

1.8

1.50

1.51

g/l

0.01

173

1759

Foreign object accidentally left in body during surgical and medical care

1.06

0.08

6.2

2.4

1.45

1.51

g/l

—

Benign neoplasm: Floor of mouth

1.04

0.08

1.3

2.1

1.44

1.51

g/l

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

0.80

0.08

1.2

2.7

1.35

1.36

g/l

—

Endometriosis ASRM stages 1,2

233

2369

0.98

0.08

1.9

1.8

1.38

1.48

g/l

0.87

200

2052

Motorcycle rider injured in other and unspecified transport accidents

784

0.97

0.08

2.2

1.9

1.50

1.49

g/l

0.01

681

Pedal cyclist injured in transport accident

429

4242

1.01

0.08

1.6

1.8

1.42

1.50

g/l

0.95

373

3673

Primary angle-closure glaucoma

915

1.03

0.07

1.3

1.8

1.50

1.55

g/l

0.23

798

Lateral epicondylitis

203

2065

0.98

0.07

1.6

1.7

1.60

1.52

g/l

0.58

178

1786

Alzheimer’s disease (Atypical or mixed), excluding more controls

244

1794

1.02

0.07

1.6

1.7

1.58

g/l

0.01

191

1518

Other and unspecified atrophic disorders of skin

1.04

0.07

3.6

2.8

1.13

1.40

g/l

—

Accidental poisoning by and exposure to other gases and vapours

1.04

0.07

4.3

2.6

1.34

1.59

g/l

—

Hand

1.04

0.07

2.3

2.1

1.58

1.46

g/l

—

Congenital malformations of eye, ear, face and neck

866

1.03

0.07

2.8

2.0

1.43

1.38

g/l

0.19

770

Lesion of plantar nerve

100

1025

0.97

0.07

1.5

1.7

1.79

1.59

g/l

1.06

880

Follicular adenocarcinoma of thyroid gland

0.87

0.07

3.9

1.5

1.63

1.51

g/l

—

Benign lipomatous neoplasm

643

6376

1.01

0.07

1.7

1.49

1.56

g/l

1.11

549

5497

Supervision of normal pregnancy

212

1229

0.98

0.07

1.9

1.29

1.49

g/l

2.66

184

1071

Melanocytic naevi of ear and external auricular canal

0.88

0.07

1.9

1.8

1.13

1.56

g/l

—

Other and unspecified disorders of psychological development

0.90

0.06

3.1

2.9

1.51

1.16

g/l

—

Motor neuron disease ALS

315

0.95

0.06

2.0

1.7

1.46

1.49

g/l

0.06

276

Right side

111

0.90

0.06

1.6

2.4

0.97

1.56

g/l

—

104

Multiple delivery

108

1103

0.98

0.06

2.2

1.8

1.22

1.56

g/l

3.65

963

Other and unspecified disease of Bartholin gland

414

1.04

0.06

1.5

2.0

1.73

1.57

g/l

0.45

357

Cyst of Bartholin Gland

444

1.04

0.06

1.4

2.0

1.12

1.51

g/l

3.19

391

Erosion and ectropion of cervix uteri

445

1.04

0.05

1.5

1.9

1.68

1.65

g/l

0.06

381

Mesial bite

110

0.91

0.05

1.2

3.0

1.98

1.22

g/l

—

101

Respiratory tuberculosis, not confirmed, including avohilmo

823

1.02

0.05

1.9

1.7

1.46

1.55

g/l

0.37

710

Non-small cell lung cancer, adenocarcinoma, helper endpoint

157

1549

1.01

0.04

1.8

1.7

1.83

1.53

g/l

2.69

138

1335

Use of ropinirole

714

1.02

0.04

1.6

1.8

1.40

1.55

g/l

0.73

630

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1206

9391

1.00

0.03

2.0

1.8

1.44

1.49

g/l

0.90

1033

8159

Other benign neoplasm of uterus: Other parts/unspecified

846

1.02

0.03

1.4

1.7

1.59

1.62

g/l

0.09

728

Frontotemporal dementia

102

1.08

0.03

1.4

2.1

1.76

1.57

g/l

0.22

Contact with nonpowered hand tool

711

0.98

0.02

2.0

1.9

1.58

1.53

g/l

0.18

621

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

251

2495

1.01

0.02

1.7

1.8

1.51

1.54

g/l

0.22

212

2156

Disorders of breast

922

8130

1.00

0.02

1.7

1.8

1.50

1.52

g/l

0.28

799

7005

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

589

0.98

0.02

2.0

1.7

1.43

1.56

g/l

0.51

517

Use of rasagiline

527

0.99

0.01

1.2

1.9

1.60

1.56

g/l

0.13

466

Carcinoma in situ of breast, lobular

1.07

0.01

3.4

2.3

1.82

1.49

g/l

—

Other disorders of breast

213

2123

1.00

0.00

1.7

1.53

1.54

g/l

0.06

185

1822

Medicines for HER+ breast cancer

712

6631

1.00

0.00

1.5

1.7

1.64

1.59

g/l

0.51

594

5693

Nontoxic single thyroid nodule

123

1225

1.00

0.00

1.9

1.8

1.54

1.55

g/l

0.03

106

1059

Chondromalacia

384

0.99

0.00

1.2

1.9

1.55

1.49

g/l

0.14

341

Benign neoplasm: Rectum/anal canal icd-9

178

1.01

0.00

2.0

1.9

1.74

1.56

g/l

0.23

160

Early lumbar disc prolapse, operated

107

1074

1.00

0.00

1.8

1.55

1.39

g/l

0.87

925

Other obstetric trauma

478

1.00

0.00

2.1

2.0

1.32

1.35

g/l

0.06

420

Peripheral retinal degeneration

502

1.00

0.00

1.5

1.8

1.49

1.60

g/l

0.36

439

Ectopic pregnancy

237

2368

1.00

0.00

1.8

1.51

1.50

g/l

0.04

197

2061

Inflammation of lacrimal passages (chronic)

249

1.00

0.00

1.2

1.8

1.70

1.53

g/l

0.22

221

Maternal care for known or suspected disproportion

342

0.99

0.00

1.8

1.7

1.20

1.39

g/l

0.62

297

Burn and corrosion of head and neck

289

1.00

0.00

1.6

1.9

1.59

1.44

g/l

0.41

255

Respiratory tuberculosis, not confirmed

813

1.00

0.00

1.9

1.7

1.44

1.55

g/l

0.53

703

Benign neoplasm: Mesothelial tissue of pleura

0.00

0.0

5.4

—

1.60

—

Maxillary prognathism

0.84

0.00

2.0

2.6

0.74

1.30

g/l

—

Disorders of branched-chain amino-acid metabolism, other/unspecified

0.00

0.0

1.2

—

1.60

—

Disorders of glycosaminoglycan metabolism, other/unspecified

0.00

0.0

1.2

—

1.63

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

0.0

1.4

—

1.73

—

Intrauterine hypoxia

0.00

0.0

2.4

—

1.04

—

Spotted fever [tick-borne rickettsioses]

0.00

0.0

4.0

—

1.70

—

Systemic sclerosis induced by drugs and chemicals

0.00

0.0

5.8

—

1.89

—

Post-traumatic hydrocephalus, unspecified

0.90

-0.00

1.4

1.9

2.01

1.46

g/l

—

Carcinoma in situ of cervix uteri, exocervix

0.87

-0.00

1.7

2.6

1.36

1.39

g/l

—

Carcinoma in situ of other/unspecified digestive organs

0.00

-0.00

0.0

1.1

—

1.39

—

Defects in post-translational modification of lysosomal enzymes

0.00

-0.00

0.0

4.5

—

1.25

—

Fusion of the labia

0.00

-0.00

0.0

4.0

—

1.23

—

Otorhinolaryngological devices associated with adverse incidents

0.00

-0.00

0.0

1.0

—

1.62

—

Exposure to vibration

0.00

-0.00

0.0

2.3

—

1.45

—

Typhus fever

0.00

-0.00

0.0

2.0

—

0.86

—

Lupus erythematosus, drug-induced

0.00

-0.00

0.0

1.2

—

2.21

—

Benign neoplasm: Mesothelial tissue of peritoneum

0.00

-0.00

0.0

1.9

—

1.56

—

Miliaria crystallina

0.00

-0.00

0.0

1.2

—

1.33

—

Pediculosis and phthiriasis, including avohilmo

1.01

-0.00

1.6

1.7

1.03

1.40

g/l

—

Dietary calcium deficiency

0.00

-0.00

0.0

1.0

—

1.29

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.96

-0.00

1.9

1.7

1.07

1.52

g/l

—

Testicular hyperfunction

0.00

-0.00

0.0

4.0

—

1.18

—

!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced

0.00

-0.00

0.0

1.0

—

1.56

—

Frontotemporal dementia, wide, incl. Pick's disease

120

1.00

-0.00

1.4

2.0

1.86

1.53

g/l

0.43

111

Other and unspecified postprocedural disorders of eye and adnexa

0.85

-0.00

3.6

2.7

1.63

1.34

g/l

—

Degenerative conditions of globe

0.93

-0.00

3.8

2.1

1.81

1.47

g/l

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

0.89

-0.00

1.8

2.1

1.31

1.57

g/l

—

Bacterial vaccines

0.00

-0.00

0.0

1.3

—

2.30

—

Congenital pneumonia

0.00

-0.00

0.0

2.4

—

0.91

—

Neuropathic heredofamilial amyloidosis

0.00

-0.00

0.0

1.0

—

1.61

—

Other conditions of integument specific to fetus and newborn

0.00

-0.00

0.0

1.4

—

0.83

—

Congenital malformation of vitreous humour

0.00

-0.00

0.0

1.8

—

1.40

—

Pityriasis lichenoides chronica

1.02

-0.00

3.3

2.1

1.40

1.54

g/l

—

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs

0.00

-0.00

0.0

1.4

—

1.58

—

Cholinergic urticaria

0.95

-0.00

1.5

1.9

1.29

1.46

g/l

—

Neonatal aspiration syndromes

0.00

-0.00

0.0

2.0

—

0.82

—

Mandibular hypoplasia

0.97

-0.00

1.6

2.5

0.85

1.38

g/l

—

Progressive external ophthalmoplegia

0.00

-0.00

0.0

1.0

—

1.45

—

Lipomatosis, not elsewhere classified, drug-induced

0.00

-0.00

0.0

1.8

—

1.55

—

Erythema marginatum

0.00

-0.00

0.0

6.2

—

1.23

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Haptoglobin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS